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Different types of Brønsted acid catalysts are commonly used in a wide variety of organic 
transformations and are of continuing interest because there is a general need to carry out reactions in a 
faster and higher yielding manner with greater selectivities. Phosphoric acid derivatives, with their fairly 
strong acidity and structural flexibility that enables them to be incorporated into rigid organic 
frameworks, are one of the most efficient and versatile classes of Brønsted acids. Herein, a novel type 
of electrostatically enhanced phosphoric acids that contain positively charged ion centers are 
synthesized and studied. The activities of achiral phosphoric acids with alkylated pyridinium ion 
moieties were examined in a variety of organic transformations. In addition, the activities and 
enantioselectivities of a series of chiral phosphonium ion tagged phosphoric acids were also evaluated 
in several different organic reactions. The study of electrostatically enhanced phosphoric acids was 
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Chapter 1: Background and Introduction 
 
1.1. Organocatalysts 
Organocatalysts refer to metal-free organic molecules that in substoichiometric amounts accelerate 
chemical reactions.1 Though occasional reports of metal-free species, such as amine 1 and proline 2,2 
appeared in the early literature during the twentieth century (Scheme 1), the significance of 
organocatalysis was not recognized until recently. This term was formally introduced in the early 2000s, 
and this area has witnessed rapid growth and become a well-established research field.1a,1c,1d,3 
 
 
Scheme 1. Early reports of amine and proline catalyzed reactions. 
 
Compared to organometallic catalysts, metal-free species are generally non-toxic, inexpensive, and 
robust to air and moisture.3a,4 Moreover, they are particularly useful in applications where metals cannot 
be tolerated such as pharmaceutical production.5 In addition, in some reactions substrates, products or 
impurities may poison metal catalysts, whereas organocatalysts offer a potential solution to this 
problem.6 All of these features make organocatalysts attractive alternatives to organometallic systems. 
Interactions between catalysts and substrates can be divided into two general categories: one where 
covalent bonds are formed and the other involves the formation of non-covalent complexes. In the 
former case, the catalyst and substrate form a covalent adduct structure within the catalytic cycle. 
Typical examples include enamine formation with amines to elevate the highest occupied molecular 
2 
 
orbital (HOMO) of the amine substrate,7 and iminium ion generation with imidazolidinones to lower 
the lowest unoccupied molecular orbital (LUMO) of the reactant (Figure 1(a)).8 In comparison, the latter 
case includes exclusively non-covalent interactions such as hydrogen bonding or ion pairing to lower 
the LUMO of the substrates. Most Brønsted acid catalysts belong to this latter category (Figure 1(b)).9 
 
 
Figure 1. Covalent and non-covalent organocatalysis. 
 
Seayad and List introduced a broad classification of organocatalysts based upon their mechanisms of 
reactions: Lewis acids, Lewis bases, Brønsted acids and Brønsted bases. The four categories are 
illustrated in Figure 2.10 Lewis base catalysis is initiated by the nucleophilic addition of the catalyst 
(LB:) to the substrate (S). Lewis acid catalysis is initiated by the nucleophilic addition of the substrate 
(S:) to the catalyst (LA). In contrast, Brønsted base (BB) or acid (BA) catalysis is initiated by 
deprotonation or protonation of the substrate by the catalyst. In all cases, subsequent product formation 
and catalyst regeneration complete the catalytic cycle. A multifunctional organocatalyst may promote 
more than one type of interaction in the mechanistic pathway. Obviously, this classification cannot be 





Figure 2. Catalytic cycles of organocatalysts. 
 
A number of metal-free molecules have proved themselves as successful organocatalysts. As 
summarized in Figure 3, common bases used in this regard include phosphines (3),11 amines (4),12  
 
 




guanidines (5),13 cinchonidines (6),14 etc. and common acids are diols (7),15 ureas (8),16 thioureas (9),17 
squaramides (10),18 α,α,α,α-tetraaryl-1,3-dioxolane-4,5-dimethanols (TADDOLs) (11),19 1,1’-bi-2-
naphthols (BINOLs) (12),19 phosphoric acids (13),19-20 etc. Currently, combinations of different 
functional groups are also prevalent in organocatalyst studies as they can promote unique synergistic 
activation behaviors.21 
 
1.2. Asymmetric Catalysis 
Chirality is a primary property of a molecule that makes it non-superimposable on its mirror image. 
This is a structurally well-defined feature that differentiates a chiral molecule with its mirror-inverted 
molecule, known as its enantiomer.22 Different structural features may cause point, axial or planar 
chirality of a molecule (Figure 4). The construction of point chirality, which can be caused by four  
 
 
Figure 4. Different types of molecular chirality. 
 
different groups at a tetrasubstituted carbon, is a major focus of this study, and is an area of great interest 
in the organic chemistry community.23 A pair of enantiomers in an achiral environment are not 
5 
 
distinguishable in terms of physical properties such as melting point, solubility, etc. However, in the 
chiral environment of living things, they may have completely different properties in biochemistry and 
pharmaceuticals.24 For this reason, the control of absolute configuration is crucial in the pharmaceutical 
industry and has become an essential part of modern organic synthesis.23b,25 
Several common methods are used to access enantiomerically pure compounds: (1) A racemic 
mixture can be separated by resolution. The enantiomers are reacted with a chiral resolving agent to 
form a pair of diastereomers, which enables the two compounds to be separated by conventional 
techniques before being converted back to their original structures.26 (2) A pair of enantiomers can be 
separated by chiral chromatography.27 (3) A synthesis can be performed with pre-existing chiral 
molecules, which are often naturally occurring products and which will become incorporated into the 
final product.28 (4) A chiral auxiliary can be applied to assist the formation of a chiral center.29 (5) A 
chiral catalyst can be used to generate a product enantioselectively directly from racemic materials.30 
All of these methods have advantages and drawbacks. Chiral resolutions and chromatographic 
separations are not efficient methods if one enantiomer is desired over the other since at least half of the 
product may be unused. Synthesis with naturally occurring chiral compounds is generally not ideal 
either because there are only a limited number of such available species. The major disadvantage of the 
chiral auxiliary method is the need for extra synthetic steps to introduce and remove the chiral templates. 
Chiral catalysis provides an attractive alternative strategy in that a broad range of reactions and 
substrates can be targeted and the products can be formed in high yields and good enantioselectivities 
without adding additional reaction steps. Given the asymmetry of chiral catalysts, two prochiral 
transition states with different activation energies typically are formed in the rate-determining step. The 
lower barrier pathway leads to the major enantiomer and the difference in the activation energies dictates 
the observed enantiomeric ratio of the product (Scheme 2).31 
In chiral catalysis, a well-organized transition state is required for successful enantiomer 
discriminations. And the stereochemical outcome is controlled by the chiral environment of the 
catalyst.21a,30,32 For hydrogen-bonding catalysts, the asymmetry is introduced by incorporating a chiral 




Scheme 2. Energy diagram for uncatalyzed and enantioselectively catalyzed reactions. 
 
between the catalyst and the substrate, but additional interactions arise from the secondary functional 
group resulting in three-dimensional preorganization of the transition state (Figure 5(a)).21c,33 
Phosphoric acid catalysts, on the other hand, tend to completely protonate substrates and form contact 
ion pairs along with a secondary hydrogen bond between the phosphoryl oxygen and the substrate. Both 
of these interactions promote the catalyst bound complex to organize in the “chiral channel” formed by 
bulky substituents and lead to the observed product enantioselectivity (Figure 5(b)).20a,34 
 
 
Figure 5. Strategies of asymmetry induction. 
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1.3. Brønsted Acid Catalysts 
A proton can be regarded as the smallest Lewis acid, though this term usually refers to boron, 
aluminum and transition metal containing compounds. The source of the proton can act as a hydrogen 
bond donor or a Brønsted acid, both of which are important activation modes in organocatalysis.9a,35 
Brønsted acid catalysts were traditionally employed only for the formation and cleavage of carbon-
oxygen bonds, but their activity for carbon-carbon bond formation has gradually been recognized over 
the past decade.34 
Lewis acid catalysts are usually generated in situ with a metal-centered compound and chiral ligands, 
and they activate substrates with the metal center (Figure 6(a)). In comparison, Brønsted acid catalysts 
are typically used directly and employ their acidic hydrogen to lower the LUMO of C=O, C=NR or 
C=CR2 containing compounds via a hydrogen bond or protonation. This electrophilically activates the 
substrate and facilitates nucleophilic attack (Figure 6(b)).34 
 
 
Figure 6. Lewis acid catalysis and Brønsted acid catalysis. 
 
Brønsted acids can be classified into two categories according to their acidities: (1) Hydrogen bonding 
catalysts. Diols (7), ureas (8), thioureas (9), squaramides (10), TADDOLs (11), and BINOL derivatives 
(12) belong to this type due to their relatively weak acidities (Figure 7(a)). (2) Strong acid catalysts. 
Phosphoric acids (13), phosphoramides (14), dicarboxylic acids (15), disulfonic acids (16), and 1,1’-
binaphthyl-2,2’-bis(sulfuryl)imides (JINGLEs) (17) are examples in this category (Figure 7(b)).9a,19,36 
Hydrogen bonding catalysts always promote general Brønsted acid catalysis, in which partial or 
complete protonation of the substrate occurs in the rate-determining step of the reaction. In contrast, 
strong acid catalysts usually undergo specific Brønsted acid catalysis in which a reversible protonation 





Figure 7. Common hydrogen bond and Brønsted acid catalysts. 
 
 
Figure 8. General and specific Brønsted acid catalysis. 
 
For hydrogen bonding catalysts, depending on the number and geometry of the active hydrogens they 
possess, they can activate substrates by forming one (Figure 9(a)), two (Figure 9(b)) or more hydrogen 
bonds.38 In contrast, strong acid catalysts usually activate reactants by protonation and formation of 





Figure 9. Common activation modes for hydrogen bond and strong acid catalysts. 
 
there is no clear boundary between these two modes of activation. For example, strong acids can 
hydrogen bond to a substrate if it is a weak base, or if the catalyst acidity is diminished by the reaction 
conditions.20a 
 
1.4. Catalytic Functionalities 
A catalytic functional component refers to the basic unit in the catalyst structure that plays a distinct 
role in the operating reaction mechanism.39 The number and type of these functionalities typically 
determine the activation behavior of the catalyst.40 For non-redox reactions, four major types of 
functionalities have been identified: Lewis and Brønsted bases which increase the HOMO energies of a 
nucleophile by serving as a source of electron density, and Lewis and Brønsted acids which decrease 
the LUMO energy of an electrophile by using the empty orbitals of a metal, proton or hydrogen bond 
donor.21d,39 Typical groups and the roles they serve are summarized in Figure 10.39 It is worth adding 
that in many cases one chemical motif represents one functional component in a catalyst, but this need 
not be the case. That is, some chemical functionalities are bifunctional and can perform more than one 
role in a transition structure.39 For instance, a phosphoric acid (-POOH) can serve as a Brønsted acid 
using its OH group and simultaneously act as a Lewis base by exploiting the phosphoryl oxygen atom.34 
Another common example is a primary or secondary amine, which serve as a Brønsted or Lewis base 




Figure 10. Representative catalytic functionalities and their roles in mechanisms. 
 
 
Figure 11. Examples of bifunctional chemical motifs. 
 
Aside from employing these motifs that are naturally bifunctional, a more prevalent modification 
method for organocatalysts is the introduction of extra functionalities into the scaffold. This enables 
synergistic activation to occur and can result in enhanced reactivity and selectivity.21b,33,40a For example, 
thioureas can have amine, phosphine or hydroxyl containing side chains on their chiral scaffold to bind 




Figure 12. Bifunctional thioureas. 
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1.5. Phosphoric acid catalysts 
1.5.1. Background 
Since the first discovery of axially chiral BINOL-derived phosphoric acids as catalysts by Akiyama 
and Terada, there has been a rapidly increasing number of reports based on these species and their 
derivatives.20a This research area is particularly intriguing because these phosphoric acids have the 
following attributes (Figure 13): 9a,20a,34,43 
(1) They are much stronger acids than neutral hydrogen bonding catalysts, typically making them 
more active and capable of promoting higher energy processes. 
(2) The phosphoryl oxygen can function as a Lewis base providing for the possibility of bifunctional 
catalysis. 
(3) The extent of steric hindrance is readily tunable by coupling different substituents at the 3,3’-
positions of the BINOL backbone. 
(4) Electronic effects are adjustable through modifications of the 3,3’-groups or by partial 
hydrogenation of the BINOL backbone. 
(5) Alternative axially chiral scaffolds, such as biphenyl, vaulted biaryl, TADDOL or 1,1’-
spirobiindane-7,7’-diol (SPINOL) backbones can be employed. 
(6) Phosphoric acid derivatives such as phosphoramides, thiophosphoric acids, imidodiphosphoric 
acids, and thiophosphoramides readily can be prepared. 
 
 
Figure 13. General features of 3,3’-BINOL-derived phosphoric acid catalysts. 
 
One of the two earliest reports on phosphoric acid catalysts was disclosed by Akiyama et al. In this 
study, an array of phenyl-based substituents at the 3,3’-positions of (R)-BINOL were examined in 
12 
 
Mannich-type reactions. Catalyst reactivity and enantioselectivity was found to be greatly influenced 
by the 3,3’-substituent. The parent compound gave racemic products in low yields, while 3,3’-phenyl-
derived substituents showed markedly improved reactivities and enantioselectivities. Among these latter 
catalysts, the 4-nitrophenyl substituent gave excellent yields and high enantiomeric excess (ee) values 
in reduced reaction times (Scheme 3).44 
 
 
Scheme 3. Mannich-type reactions by Akiyama et al. (2004). 
 
At almost the same time, Uraguchi and Tereda independently noticed that phenyl substituents with 
additional bulky functional groups at the 3,3’-positions of (R)-BINOL contributed to a dramatic increase 
in the enantiopurity of the product from a Mannich reaction. The bulkiest group examined (i.e., R = 4-
(2-naphthyl)phenyl, Scheme 4) was found to give the highest ee and yield.45 
 
 
Scheme 4. Direct Mannich reactions by Uraguchi and Tereda (2004). 
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Later, Akiyama et al. developed a similar catalyst with two trifluoromethyl groups at the meta 
positions of the 3,3’-phenyl substituents, and it outperformed the previous catalysts with 4-nitrophenyl 
groups in terms of both reactivity and enantioselectivity in a hydrophosphonylation reaction (i.e., 90% 
versus 99% yields and 23% versus 43% ee in 24 h, Scheme 5).46 
 
 
Scheme 5. Hydrophosphonylation of imines by Akiyama et al. (2005). 
 
These early studies focused on relatively simple phenyl-based substituents at the 3,3’-position of 
BINOL, but bulkier phosphoric acids were subsequently found to be more successful catalysts. 
Hoffmann et al. reported the application of 3,3’-bis(2,4,6-triisopropylphenyl)-1,1’-binaphthyl-2,2’-diyl 
hydrogenphosphate (TRIP) in the transfer hydrogenation of imines. This new catalyst gave the best ee 
of all of the phosphoric acids that were examined and did so in excellent yields (Scheme 6).47 TRIP has 
proved to be one of the most versatile and efficient phosphoric acid catalysts to date.48 
 
 
Scheme 6. Transfer hydrogenation by Hoffmann et al. (2005). 
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Storer et al. later reported the successful utility of another bulky phosphoric acid catalyst, 3,3’-
bis(triphenylsilyl)-1,1’-binaphthyl-2,2’-diyl hydrogenphosphate (TiPSY), in a reductive amination 
reaction. Compared with other previously developed phenyl-based substituents, the 3,3’-triphenylsilyl 




Scheme 7. Reductive aminations by Storer et al. (2006). 
 
In some organic transformations, BINOL-derived phosphoric acids give only moderate outcomes, but 
the partially hydrogenated analogue (i.e., 5,5’,6,6’,7,7’,8,8’-octahydro-1,1’-bi-2-naphthol, H8-BINOL) 
obtained by adding 4 equivalents of H2 to the 5,5’ to 8,8’ positions of the BINOL backbone, provided 
greatly improved catalyst performance. Chen et al. reported an enantioselective Biginelli reaction using 
a variety of BINOL- and H8-BINOL-derived phosphoric acids, and the latter species provided higher 
enantioselectivities (Scheme 8).50 Additional H8-BINOL-derived phosphoric acids with different 3,3’-
substituents subsequently were developed and applied to a variety of reactions.51 
 
 




An alternative method to tune the electronic effects of BINOLs is to introduce extra substituents at 
the 6,6’-positions. Akiyama et al. disclosed their study of an (R)-TRIP derivative with iodine atoms at 
the 6,6’-positions, and this new species outperformed TRIP by increasing the ee by 8% in a vinylogous 
Mannich-type reaction (Scheme 9). Computations revealed that the iodine atoms do not alter the 




Scheme 9. Vinylogous Mannich-type reactions by Akiyama et al. (2008). 
 
A similar (R)-TRIP derivative with nitro groups at the 6,6’-positions was reported by Harada et al. 
This new catalyst led to a significant 4.6-fold increase in the s factor for the kinetic resolution of 
secondary alcohols (Scheme 10).53 
 
 
Scheme 10. Kinetic resolution of secondary alcohols by Harada et al. (2013). 
 
Hermeke and Toy synthesized a 6,6’-phosphonium ion tagged (R)-TRIP catalyst and achieved 
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moderate to good enantioselectivity for two Friedel-Crafts reactions of indole and alkenes. Moreover, 




Scheme 11. A recyclable phosphoric acid catalyst for Friedel-Crafts reactions by Hermeke and Toy 
(2011). 
 
The development of alternative BINOL backbones is a continuing area of research.20a For example, 
Kashikura et al. reported a (S)-biphenol-derived phosphoric acid bearing bulky 9-anthryl groups. It was 
found to lead to faster reactions and greater enantioselectivities in a Mannich-type transformation 
compared to the analogous BINOL and H8-BINOL derivatives (Scheme 12).55 
 
 




A phosphoric acid with a 2,2’-diphenyl-(4-biphenanthrol) (VAPOL) backbone also proved its utility 
in an imine amidation reaction reported by Rowland et al. Compared with BINOL-derived phosphoric 
acids, the VAPOL-derivative 32 was found to give excellent enantioselectivity without sacrificing 
reactivity (Scheme 13).56 
 
 
Scheme 13. Imine amidation reactions catalyzed by a VAPOL-derived phosphoric acid (2005). 
 
As a novel chiral scaffold, spirocyclic phosphoric acids are advantageous in a number of reactions. 
Muller et al. reported their application in an asymmetric Fischer indolization, and they proved to be 
advantageous over other VAPOL, BINOL and H8-BINOL derivatives both in terms of reactivity and 
enantioselectivity (Scheme 14).57 
 
 
Scheme 14. Fischer indolizations catalyzed by a spirocyclic phosphoric acid (2011). 
 
TADDOL is a double hydrogen bond donor and Akiyama et al. developed a chiral phosphoric acid 
derived from it. This species (34) was tested in a Mannich-type reaction and provided excellent results. 
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Other aryl groups were examined and a 4-trifluoromethylphenyl substituent was found to give the best 
results (Scheme 15).58 
 
 
Scheme 15. Mannich-type reactions catalyzed by a TADDOL-derived phosphoric acid (2005). 
 
New phosphoric acid catalysts with further innovative designs have been reported in the last decade. 
Chen et al. demonstrated the synthesis and application of a chiral diphosphoric acid with two linked 
BINOL skeletons in a 1,3-dipolar cycloaddition reaction. Excellent yields and enantioselectivities were 
achieved in this study, whereas commonly used monophosphoric acids only gave poor to moderate ee 
values (Scheme 16).59 A density functional theory (DFT) computational study was able to rationalize 




Scheme 16. 1,3-Dipolar cycloadditions catalyzed by a bisphosphoric acid (2008). 
 
Momiyama et al. synthesized another diphosphoric acid with only a single BINOL skeleton and it 
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displayed excellent reactivity and enantioselectivity in a Diels-Alder reaction with only a 2.5 mol % 
catalyst loading. In comparison, the bulky monophosphoric acid TRIP gave poor yields and lower ee 
values even with a 5.0 mol % loading (Scheme 17).61 
 
 
Scheme 17. Diels-Alder reactions catalyzed by a bisphosphoric acid (2011). 
 
Zhou and Yamamoto applied a phosphoric acid bearing 2,4,6-trimethyl-3,5-dinitrophenyl substituents 
at the 3,3’-positions of (R)-BINOL in Mukaiyama–Mannich reactions and achieved excellent yields as 
well as enantioselectivities. In this new catalytic structure, the electronic effects of the NO2 groups 
endowed high reactivity, and the crowded environment created by the methyl and nitro substituents led 
to a strong chiral induction. The absence of the o-methyl groups or all three methyl substituents 
undermined the observed enantioselectivity (Scheme 18).62 
 
 




1.5.2. Activation Modes of Phosphoric Acids in Catalysis 
Investigating the mechanism of a catalyzed reaction can be beneficial since it elucidates the key points 
of a catalyst and may suggest a means for carrying out structural improvements. Three activation modes 
of phosphoric acids were proposed by Parmar et al.: Mono activation, dual activation and bifunctional 
activation.20a 
Mono activation promoted by the acidic hydrogen in a phosphoric acid is the most obvious and 
simplified mode of activation. This pathway was proposed for substrates that contain only one Lewis 
basic site. In this case the acidic site of the phosphoric acid protonates or hydrogen bonds to the most 




Figure 14. Mono activation by a phosphoric acid. 
 
Dual activation is the least common of the three pathways, but it can be a powerful activating 
mechanism. In this mode, two hydrogen bonds form between the catalyst and the substrate. They can 
consist of a bidentate hydrogen bond between the acidic site of the catalyst and two basic positions in 
the substrate (Figure 15 (a)). Alternatively, if the substrate has both acidic and basic sites they can 
interact with the phosphoryl oxygen atom and the acidic hydrogen leading to the formation of two 





Figure 15. Dual activation modes of a phosphoric acid. 
 
Bifunctional activation covers the majority of reactions catalyzed by phosphoric acids. In this 
pathway, the phosphoric acid uses its acidic site to form a hydrogen bond with a Lewis basic site in one 
substrate (i.e., the electrophile) and its phosphoryl oxygen to interact with the nucleophile. In this way, 
both substrates are simultaneously activated (Figure 16).64 
 
 
Figure 16. Bifunctional activation brought about by a phosphoric acid. 
 
1.5.3. Reactivity of Phosphoric Acid Catalysts 
1.5.3.1. Early Strategies of Reactivity Enhancement for Phosphoric Acid Catalysts 
A study by Kaupmees et al. chose a series of Brønsted acids and measured their acidities by 
ultraviolet-visible spectroscopy (UV-Vis) in acetonitrile (ACN). A first-order Nazarov cyclization was 
chosen as a model reaction and these Brønsted acids were tested as catalysts for this transformation. A 
clear relationship was found between the observed reaction rate and the catalyst acidities, and higher 





Figure 17. Plot of reaction rates for a Nazarov cyclization versus catalyst acidities. 
 
As early as the first report of the BINOL derived phosphoric acids by Akiyama et al., the rate 
acceleration of electron-withdrawing groups was noticed. By introducing a nitro group onto the para-
position of the 3,3’-phenyl substituents, the reaction time for a Mannich-type transformation could be 
shortened from 20 h to 4 h. In contrast, the introduction of electron-donating 2,4,6-trimethyl or p-
methoxy groups led to extended reaction times. In addition, the enantiomeric excess of products 
generated with the 4-nitrophenyl substituted BINOL-derived phosphoric acid also outperformed the 
other derivatives (Table 1).44 
Later, Akiyama et al. disclosed the results of an enantioselective hydrophosphonylation of imines 
catalyzed by phosphoric acids. In this study, the 3,5-(CF3)2 substituents on 3,3’-phenyl groups provided 
better rate accelerations than a 4-nitro substituent and gave complete conversion of the reactants in 24 
h, while the analogous catalyst without electron-withdrawing groups led to only a 70% yield in the same 
period of time. Moreover, the enantioselectivity of the 3,5-(CF3)2-phenyl substituted BINOL phosphoric 









entry Ar t (h) yield (%) ee (%) 
1 H 22 57 0 
2 Ph 20 100 27 
3 2,4,6-Me3C6H2 27 100 60 
4 4-MeOC6H4 46 99 52 
5 4-NO2C6H4 4 96 87 
 
aReactions performed with 0.162 mmol aldimine, 0.486 mmol ketene silyl acetal and 0.0486 mmol catalyst 
in toluene at -78 °C. 
 
Converting phosphoric acids to N-phosphoramides is another strategy to improve their reactivity 
since the latter species are more acidic. In a study by Lee and Kim, a comparison was done between a 
3,3’-(2-naphthyl)-BINOL based phosphoric acid and its N-phosphoramide derivative in a radical 
addition reaction. While the phosphoric acid only gave a 37% yield after 12 hours, the phosphoramide 
was found to give an improved yield (61%), indicating that the latter catalyst is more efficient. An 












entry Ar yield (%) ee (%) 
1 Ph 70 23 
2 4-NO2C6H4 90 23 
3 4-CF3C6H4 69 35 
4 3,5-(CF3)2C6H3 99 43 
 
aReactions performed with 0.135 mmol N-benzylidene-p-anisidine, 0.270 mmol diethyl phosphite and 0.0135 
mmol catalyst in toluene at 20 °C. 
 




entry X t (h) yield (%) ee (%) 
1 OH 12 37 3 
2 NHSO2CF3 12 61 21 
 
aReactions performed with 0.05 mmol imine, 0.25 mmol ethyl iodide, 0.15 mmol TTMSSH, 0.10 mmol Et3B 
and 0.15 mmol catalyst in toluene at -40 °C. bTTMSSH = tris(trimethylsilyl)silane. 
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Modification of the BINOL backbone is another method for reactivity enhancement. Wang et al. 
developed a phosphoric acid bearing a 5,5’-bitetralone scaffold. The acidity of the catalyst was increased 
by the introduction of electron-withdrawing carbonyl groups. This novel catalyst was found to 
outperform its BINOL and H8-BINOL analogues in terms of reactivity without harming the 
enantioselectivity (Table 4).67 
 




entry cat. k (M-1 h-1)b krel ee (%) 
1 38 0.242 1.00 92 
2 39 0.134 0.554 92 
3 40 0.385 1.59 93 
 
aReactions performed with 0.17 mmol indole, 0.21 mmol 2,2,2-trifluoroacetophenone and 0.0034 mmol 
catalyst in 0.6 mL of CD2Cl2 at 20 °C. bCalculated from a second-order fit of the original conversion data. 
 
Though not commonly studied, additives that can enhance the acidity of the phosphoric acid also 
should accelerate reactions. In a study by Hatano et al., 5 mol % of BINOL phosphoric acid was found 
to give no product for the Diels-Alder reaction between cyclopentadiene and methacrolein. In contrast, 
when an equivalent amount to the phosphoric acid of boron tribromide was added, a good yield was 
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obtained through the interaction of BBr3 and the phosphoryl oxygen. As a control, 5 mol % of BBr3 
without the phosphoric acid led to a significantly lower yield. In addition, BBr3 was found to influence 
the endo/exo ratio and the observed enantioselectivity suggesting the importance of an in situ generated 
1:1 phosphoric acid/BBr3 complex (Table 5).68 
 




entry Lewis acid (mol %) yield (%) endo/exo ee of exo-product (%) 
1 - 0 ndc nd 
2 BBr3 (2.5) 92 3:97 61 
3 BBr3 (5.0) 99 2:98 89 
4 BBr3 (7.5) 78 2:98 85 
5 BBr3 (10) 64 8:92 18 
6b BBr3 (5.0) 66 10:90 nd 
 
aReactions performed with 2.5 mmol cyclopentadiene, 0.50 mmol methacrolein, 0.025 mmol catalyst, and 0-
0.05 mmol boron tribromide in 2 mL of CH2Cl2 at -78 °C. bThe reaction was performed without phosphoric 
acid catalyst. cnd = not determined. 
 
1.5.3.2. Electrostatically Enhanced Acid Catalysts 
In a recent study by Samet et al., a series of phenol derivatives with different substituents were 
examined using infrared (IR) techniques. The O-H stretches of phenol in CCl4 and CCl4 with 1% (v/v) 
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CD3CN were measured, and a red shift in the latter solvent was observed (Figure 18(a)). This was 
attributed to the formation of a ArOH…NCCD3 hydrogen bond. Moreover, the red shift was found to 
be correlated to the acidity of the phenol. That is, weaker acids with electron-donating groups (e.g., CH3 
and OCH3) have smaller IR shifts while stronger acids with electron-withdrawing groups (e.g., NO2 and 
CF3, etc.) display larger red shifts. As a result, phenols with positively charged centers were observed 
to have even larger red shifts of the O-H stretch indicating that these species are much stronger acids 
than all of the noncharged analogues that were examined (Figure 18(b)).69 
 
 




The strong acidities of charged phenols were verified by using them as acid catalysts in a Friedel-
Crafts reaction of N-methylindole and trans-β-nitrostyrene. As shown in Table 6, when this 
transformation was performed in a non-polar solvent the positively charged phenols were found to lead 
to reactions rates that are several orders of magnitudes higher than for p-nitrophenol. These results, just 
like the IR shifts, are in much better accord with the gas-phase acidities of the phenols as opposed to 
the dimethyl sulfoxide (DMSO) pKa values (entry 1 and 3-4). The non-coordinating counteranion, 
tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (BArF4-), was also found to be crucial in this study since 
I- formed a hydrogen bond with the OH group and undermined the reactivity (entry 2). Dilute solutions 
in this case have lower polarities, so while the Friedel-Crafts occurred more slowly, the differences 
between charged and noncharged catalysts are larger (entry 5-7).69 
Later, Fan and Kass applied the charge-enhancement strategy to thiourea catalysts. In this work, 
mono- (47) and di-N-methylpyridinium thioureas (48) were synthesized and examined as catalysts for 
the reaction of N-methylindole with trans-β-nitrostyrene. Compared to their neutral analogues, N,N’-
diphenylthiourea (45) and Schreiner’s thiourea (46), the charged catalysts led to reaction rates that are 
orders-of-magnitude larger. These results indicate that the incorporation of charged centers into 
hydrogen bond donors can improve their catalytic performance (Table 7).70 
 







Continued Table 6. 
 
entry catalyst [β-NS] (mM) pKa (DMSO) △Goacid (kcal mol-1)b t1/2 (h) krel 
1 41 83 10.8 320.9 ± 2.0 1200 1 
2 42 83 12.5 ± 1.0c 261.4d 8400 0.14 
3 43 83 12.5 ± 1.0c 261.4d 42 29 
4 44 83 12.4 ± 1.1c 231.1e 1.6 750 
5 41 29 10.8 320.9 ± 2.0 4100 1 
6 43 29 12.5 ± 1.0c 261.4d 64 64 
7 44 29 12.4 ± 1.1c 231.1e 2.1 2000 
 
aReactions performed with 29 or 83 mM trans-β-nitrostyrene, 3 equiv of indole and 8.3 mM catalyst in CDCl3 
at 20 °C. bEquilibrium values are from ref 71 unless otherwise noted; some values are the average of two 
similar results. cMeasured in DMSO by bracketing using two colored indicators. dB3LYP/6-31+G(d,p) 
computations on the ammonium cation. eCalculated value is for 3-methylpyridinium phenol. 
 
This past year (2017), Fan and Kass expanded the above study to chiral thioureas. They synthesized 
a series of N-alkylated pyridinium containing thioureas with a chiral 2-indanol substituent and applied  
them in the Friedel-Crafts reaction of indole and trans-β-nitrostyrene. The analogous noncharged  
 





Continued Table 7. 
 
entry cat. k (M-1 h-1) t1/2 (h) krel 
1 - 2.8 × 10-3 1100 - 
2 45 3.9 × 10-3 820 0.035 
3 46 1.1 × 10-1 29 1.0 
4 47 7.1 × 10-1 4.5 6.5 
5 48 45 0.071 (4.3 m) 410 
 
aReactions performed with 239 mM N-methylindole, 80 mM trans-β-nitrostyrene and 8.3 mM catalyst in 
CDCl3 at 20 °C. 
 
bis(3,5-trifluoromethyl)phenyl substituted thiourea gave only trace conversion after 48 hours whereas 
the charged species led to good conversions and enantiomeric ratio (er) values (Table 8).72 
 




entry cat. conversion (%) er 
1 49 trace - 
2 50 76 91:9 
3 51 41 93:7 
 




1.5.4. Enantioselectivity with Phosphoric Acids 
The stereoselectivity of BINOL derived phosphoric acid catalysts rely primarily on structures with 
substituents at the 3,3’-positions to create a narrow chiral channel for the substrates to reach the acid 
center.20a,34 In most cases, increasing the size of the 3,3’-substituents is beneficial for strong asymmetric 
induction and high enantioselectivity (Figure 19 (a) and (b)). For this reason, most of the successful and 
widely used catalysts bear bulky groups at the 3,3’-positons of the BINOL backbone.43,73 Typical 
examples include 2,4,6-triisopropylphenyl, triphenylsilyl, and 9-anthracenyl, among others. On 
occasion, however, too much bulkiness (or particularly large substrates) can prevent the reaction from 
occurring (Figure 19 (c))74 or lead to reversed enantioselectivities.75 Thus in designing phosphoric acid 
catalysts, the Goldilocks approach needs to be adopted. That is, the substituents at the 3,3’-positions 




Figure 19. Relationship between catalyst bulkiness and reaction selectivity. 
 
Reid and Goodman introduced the idea of a remote environment angle (AREA(θ)) as a steric 
parameter to evaluate the size of the chiral cavity in BINOL-derived phosphoric acid catalysts. AREA(θ) 
was defined as the smallest angle between the center of a 3,3’-substituent atom and the vector from the 
center of the phosphorus atom to the midpoint of the two adjacent oxygen atoms. Obviously, small 3,3’-
substituents provide a large AREA(θ), and big groups correspond to a small AREA(θ) (Figure 20). 
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Accurate AREA(θ) values are most easily obtained by computations.76 
 
 
Figure 20. Relationship between AREA(θ) and bulkiness of 3,3’-substituents. 
 
In Uraguchi and Tereda’s study, a Mannich reaction was catalyzed by a series of chiral phosphoric 
acids with different 3,3’-substituents on the BINOL scaffold. A good correlation between computed 
AREA(θ) values and experimental enantioselectivity data was found. Apparently, a decreasing 
AREA(θ), which corresponds to a larger sized substituent, led to an improved ee (Figure 21).45,76 
 
 
Figure 21. Relationship between AREA(θ) and enantiomeric excess for a Mannich reaction. 
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Besides the bulkiness of substituents at the 3,3’-positions of the BINOL scaffold, the promotion of 
appropriate activation modes is also crucial for high enantioselectivity. The lack of appropriate 
functionality usually leads to little or no product selectivity.34,77 For example, Itoh et al. investigated the 
Friedel-Crafts alkylation of indole and trans-β-nitrostyrene. At -35 °C, after 48 h, the alkylation of 
indole gave a 76% yield and 91% ee whereas the reaction with N-methylindole gave an 11% yield of 
racemic product (Scheme 19). This difference was attributed to the presence or absence of an interaction 
between the phosphoryl oxygen and N-H group of indole. The difference in the results between indole 
and N-methylindole emphasizes the importance of the secondary functional group in the catalyst (i.e., 
the phosphoryl oxygen).78 
 
 
Scheme 19. Friedel-Crafts alkylation emphasizing the hydrogen bond formed between the phosphoryl 
oxygen and indole. 
 
Hatano et al. presented their investigation into the impact of salt impurities on phosphoric acid 
catalysts. The replacement of the acidic proton by a metal cation leads to the disappearance of hydrogen 
bonding between the catalyst and substrate, and this had a substantial impact on the reactivity of a 
Mannich-type reaction (Scheme 20). Interestingly, a metal cation can lead to improved 





Scheme 20. Mannich-type reaction emphasizing the role of the acidic hydrogen in a phosphoric acid 
catalyst. 
 
1.6. Focus of This Work 
In this dissertation, the powerful acidity enhancement strategy of introducing cationic groups to a 
catalyst structure is employed in the design of highly activated phosphoric acids. Chapter 2 demonstrates 
the synthesis of the simplest charge-containing phosphoric acids by replacing one or both of the phenyl 
groups in diphenyl phosphate (DPP) with 3-N-octylpyridinium rings. These species were then compared 
to DPP in several different transformations. Chapter 3 presents the expansion of this strategy to chiral 
BINOL-derived phosphoric acids. The procedures for incorporating triaryl phosphonium groups into 
the catalyst scaffold are introduced, followed by the application of these species in the Friedel-Crafts 
reactions between indoles and trifluoroacetophenone derivatives. Screening of catalysts, temperatures, 
solvents and substrates is presented, and a comparison to noncharged analogues is described. A 
mechanism based on experimental data is also proposed in this chapter. Chapter 4 reports on the 
application of phosphonium ion tagged phosphoric acids in a different Friedel-Crafts alkylation of 
indole by trans-β-nitrostyrene. A new pyridinium ion containing species was also introduced, which 
turned out to be not as good as phosphonium ion containing analogues. Further screenings of the reaction 
conditions using the optimized catalyst led to excellent enantioselectivities, and a subsequent 
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comparison to conventional noncharged chiral phosphoric acids that have proven to be highly successful 








Brønsted acids are among the most commonly employed catalysts and are used to promote a wide 
variety of chemical transformations.1,2 They provide an excellent alternative to transition-metal-
containing catalysts in that they tend to be tolerant of water and air and generally are environmentally 
friendlier.2,3 Substrate activation commonly takes place by proton transfer or hydrogen bonding, both of 
which lower the energy of the lowest unoccupied molecular orbitals (LUMO) and facilitate nucleophilic 
attack.4,5 Different types of Brønsted acid catalysts with a range of acidities have been developed 
including thioureas,6 α,α,α,α-tetraaryl-1,3-dioxolane-4,5-dimethanols (TADDOLs),7 1,1'-bi-2-naphthol 
(BINOL) derivatives,8 and phosphoric acids,9 and their utility has been amply demonstrated. Of these 
compounds, phosphoric acids are inherently the strongest acids, and their structural flexibility enables 
them to be introduced into rigid organic frameworks. The presence of a phosphoryl oxygen also can 
serve as a hydrogen bond accepting site, enabling dual or bifunctional activation modes that increase 
their catalytic potential.1,9a,10 
Diphenyl phosphate [(PhO)2P(O)OH, DPP] is widely used and can catalyze a variety of 
transformations such as Friedel-Crafts and Diels-Alder reactions11,12 and ring-opening 
polymerizations.13 Its reactivity is limited due to its modest acidity but can be enhanced by the presence 
of strong electron-withdrawing groups on the two aromatic rings.14 More acidic derivatives are of 
interest given Rueping et al.’s recent report demonstrating the relationship between catalyst acidity and 
activity.15 That is, more acidic catalysts led to faster rates of a Nazarov cyclization test reaction. 
The incorporation of a positively charged center into phenols and thioureas recently was found to  
 
____________________________ 
*Reprinted adapted with permission from: Ma, J.; Kass, S. R. Org. Lett. 2016, 18, 5812-5815. Copyright 




Figure 1. Charged phosphoric acids reported in this study. 
 
enhance their acidities and catalytic reactivities.16,17 We therefore decided to investigate charge-
containing phosphoric acid derivatives of DPP (1 and 2, Figure 1) and report the results herein. 
 
2.2. Results and Discussion 
Two electrostatically enhanced phosphoric acids 1 and 2 were envisioned in which one or both of the 
phenyl groups in DPP are replaced by N-alkylated pyridinium ions.18 The positively charged substituents 
should act as powerful electron-withdrawing groups in low polarity media, but not in polar solvents, 
and the long-chain octyl groups were selected to enhance the solubility of these salts in solvents such as 
dichloromethane, chloroform, and toluene. A noncoordinating counteranion is required to avoid 
deactivating hydrogen bonds with the phosphoryl hydroxyl group, and tetrakis(3,5-
bis(trifluoromethyl)phenyl)borate (BArF4−) was chosen for this purpose since it also has good solubility 
and reactivity characteristics.19-21 
Both catalysts were synthesized as illustrated in Scheme 1 starting with commercially available 3-
hydroxypyridine. Its N-alkylation with 1-iodooctane afforded the pyridinium iodide salt (3) in a 
reasonable yield (66%) as previously described.16 Upon reaction of 3 with phenyl dichlorophosphate or 
phosphorus oxychloride followed by an aqueous hydrolysis, the halide salts corresponding to 1 and 2 
were produced (4 and 5). Ion exchange with NaBArF4 in CH2Cl2 occurred readily since the sodium 
halide salts are not soluble and precipitate out of solution. A sulfuric acid wash was subsequently carried 
out to ensure that the target compounds were produced in their protonated form (HCl is not suitable; 
presumably, it leads to loss of the octyl group) and this was verified via titration. 
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Scheme 1. Synthetic route for catalysts 1 and 2. 
 
 
To evaluate the catalytic reactivity of 1 and 2, the room-temperature Friedel-Crafts alkylation of 
indole and N-methylindole with β-nitrostyrene were examined at various catalyst loadings in 




kinetic data displayed second-order behavior as expected. Rate constants, and background corrected 
half-lives and relative rates under the different conditions that were employed are summarized in Table 
1. In the absence of a catalyst, neither indole nor N-methylindole reacts with β-nitrostyrene in CD2Cl2 
or CDCl3 for all practical purposes. That is, the reaction half-lives were estimated to be 9 months or 
more (see Tables S1 and S2 for the kinetic data); a control experiment in which CH2Cl2 was washed 
with H2SO4 as done in the preparation of 1 and 2 had no impact on the background rate of the reaction 
with indole. These transformations are accelerated by 10 mol % of DPP, but it is an ineffective catalyst 
in that it takes between 3 and 48 weeks for half of the starting material to be converted to product 
depending upon the reaction conditions. Incorporation of an electron-withdrawing nitro group in DPP 
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at the 3-position of both phenyl rings [(3-O2NC6H4O)2P(O)OH, DPP*] has a modest accelerating effect 
corresponding to a factor of 4.5. Monocharged phosphoric acid derivative 1, however, speeds up the 
reactions of indole and N-methylindole relative to DPP by factors of 12 and 210 in CD2Cl2 (entries 4 
and 14) and 7.2 and 78 in CDCl3 (entries 10 and 20). These differences can be enhanced by 1 order of 
magnitude if a second charged center is incorporated into the catalyst. That is, k2/kDPP = 120 and 2100  
 
Table 1. Kinetic data of Friedel-Crafts reactions.a 
 
entry solvent R cat. mol % k (M-1 h-1) t1/2 (h)b krelb 
1 CD2Cl2 H - - 0.000544 19400 - 
2 CD2Cl2 H DPP 10 0.0185 587 1.0 
3 CD2Cl2 H DPP* 10 0.0813 131 4.5 
4 CD2Cl2 H 1 10 0.215 49.2 12 
5 CD2Cl2 H 2 10 2.06 5.12 120 
6 CD2Cl2 H 2 5.0 0.904 11.7 100c 
7 CD2Cl2 H 2 2.0 0.367 28.8 100c 
8 CDCl3 H - - 0.000396 26600 - 
9 CDCl3 H DPP 5.0 0.0203 530 1.0 
10 CDCl3 H 1 5.0 0.143 74.0 7.2 
11 CDCl3 H 2 5.0 0.750 14.1 38 
12 CD2Cl2 Me - - 0.000324 32600 - 
13 CD2Cl2 Me DPP 10 0.00176 7350 1.0 
14 CD2Cl2 Me 1 10 0.297 35.6 210 
15 CD2Cl2 Me 2 10 3.06 3.45 2100 
16 CD2Cl2 Me 2 5.0 1.39 7.59 1900c 
17 CD2Cl2 Me 2 2.5 0.771 13.7 2200c 
18 CDCl3 Me - - 0.00156 6760 - 
19 CDCl3 Me DPP 5.0 0.00286 8110 1.0 
20 CDCl3 Me 1 5.0 0.103 104 78 
21 CDCl3 Me 2 5.0 1.13 9.35 870 
 
aBoth reactant concentrations were 94.8 mM. bBackground corrected half-lives and relative rates. cLinearly 





for indole and N-methylindole in CD2Cl2 (entries 5 and 15) and 38 and 870, respectively, in CDCl3 
(entries 11 and 21). As a result, the half-lives for these reactions are reduced to as little as 3.5 h. 
Bifunctional activation brought about by phosphoric acid derivatives has been invoked 
previously1,9a,10,22 and would involve a N-H···O=P hydrogen bond when indole is used as the reactant 
(Scheme S1). With N-methylindole, this interaction is absent, and consequently, one might expect this 
latter transformation to proceed more slowly. This is the case for the DPP-catalyzed reactions where 
kindole/kN-methylindole = 13-15 in CD2Cl2 and CDCl3. When 1 and 2 were used, kN-methylindole/kindole = 1.4−1.5 
except for when the former catalyst is used in CDCl3, then kindole/kN-methylindole = 1.4. These results are 
consistent with bifunctional activation being involved in the rate-determining step when DPP is used, 
but it is unclear if this is important with the charge-containing phosphoric acids. These species 
undoubtedly are more acidic than DPP, and thus, their N-H···O=P hydrogen bonds should be weaker. 
However, N-methylindole is more nucleophilic than indole, and this could counterbalance the loss of 
the hydrogen bond when 1 and 2 are used. 
A small solvent effect (≤∼2) is observed for the Friedel-Crafts reactions when CD2Cl2 and CDCl3 are 
used. If DPP is the catalyst, the background corrected rate constants are ∼2 times larger in the latter 
solvent upon making a 2-fold linear correction for the catalyst loading (i.e., 5 vs 10 mol %). In contrast, 
this transformation takes place 1.2-1.5 times faster in the former medium when 1 and 2 are employed, 
except for when 1 is used in the reaction with indole and then kCDCl3/kCD2Cl2 = 1.3. Presumably the more 
polar solvent tends to lead to faster reactions with the charged catalysts, as observed with charged 
thioureas,17 because it stabilizes the polar transition state. Lack of solubility under the reaction 
conditions prevented toluene from being explored, but 2 was found to be unreactive in THF-d8 since it 
is a hydrogen bond acceptor and a more polar solvent. Chlorobenzene is also a poorer solvent for this 
reaction than CD2Cl2 and CDCl3 even though it is less polar by some measures.23,24 
Catalyst loading was examined with 2 in CD2Cl2 (entries 5-7 and 15-17), and smaller amounts of it 
led to slower transformations with both indole and N-methylindole. Linear relationships between the 
mol % of 2 and the background-corrected reaction rate constants are observed in both cases (Figure S1). 
This indicates that these Friedel-Crafts reactions are first order in catalyst, which contrasts with the 
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second-order behavior reported for a charged thiourea.17 
To examine the catalytic abilities of 1 and 2 further, Diels-Alder reactions between 1,3-




These reactions were monitored by 1H NMR to obtain the reactant and product concentrations at 
different times (Table S3). Both transformations displayed second-order behavior, and the resulting data 
are summarized in Table 2. For the reaction with MVK, 1.0 mol % of DPP was found to be a very poor 
catalyst as the rate constant is only 25% larger than for the noncatalyzed transformation (entries 1 and 
2). DPP* is almost 20 times more reactive (entry 3), but the endo/exo selectivity for these three processes 
is the same. Our monocharged phosphoric acid, however, is 1000 times more active than DPP (entry 4) 
and reduces the reaction half-life to under 5 min. It also increases the endo/exo ratio from 81:19 to 88:12 
as commonly observed with Lewis acids.25 The doubly charged derivative is even better in that it is 
2500 times more reactive than DPP and t1/2 = 1.5 min without any loss in the diastereoselectivity relative 
to 1 (entry 5). Moreover, a reduced catalyst loading of 0.1 mol % still leads to a very efficient 
transformation (i.e., t1/2 = 17 min) without any falloff in the selectivity. 
Similar results were obtained for the Diels-Alder reaction between 1,3-cyclopentadiene and 
acrylonitrile, but all three catalysts (DPP, 1 and 2) are less effective. Diphenyl phosphate only enhances 
the reaction rate of the noncatalyzed process by 7% (entries 7 and 8), and this difference is well within 
the experimental uncertainties of the two measurements; we estimate the errors in the rate constants to 
be ±10%. There is also no change in the observed endo/exo ratio of 65:35, and thus, 1 mol % of DPP 





Table 2. Kinetic data of Diels-Alder reactions.a 
 
entry R cat. mol % k (M-1 h-1) t1/2 (h)b endo/exo krelb 
1 Ac - - 0.660 15.2 81:19 - 
2 Ac DPP 1.0 0.823 61.3 81:19 1.0 
3 Ac DPP* 1.0 3.89 3.26 82:18 19 
4 Ac 1 1.0 163 3.7 min 88:12 1000 
5 Ac 2 1.0 412 1.5 min 88:12 2500 
6 Ac 2 0.10 35.9 17 min 87:13 - 
7 CN - - 0.0689 143 65:35 - 
8 CN DPP 1.0 0.0744 2170 65:35 1.0 
9 CN 1 1.0 0.119 203 70:30 11 
10a CN 2 1.0 0.302 43 75:25 50 
11a CN 2 5.0 1.58 6.6 76:24 - 
 
aBoth reactant concentrations were 100 mM. bBackground corrected half-lives and relative rates. 
 
improves the diastereoselectivity, but the reaction is still slow with an observed nonbackground 
corrected half-life of 84 h and an endo/exo ratio of 70:30 (entry 9). This kinetic acceleration, however, 
does correspond to a factor of 11 compared to DPP. A further improvement is found with the doubly 
charged catalyst 2 in terms of the rate (k2/kDPP = 50) and the product selectivity (endo/exo = 75:25, entry 
10). The apparent half-life for this reaction is 33 h, but this is for a 1 mol % loading, and when 5 mol % 
is employed (entry 11) this decreases to 6.6 h. 
A ring-opening polymerization of δ-valerolactone with benzyl alcohol as the initiator in four different 




The conversion of the monomer in these living polymerizations was followed by 1H NMR (Table S4), 
and the data can be fit using a first-order kinetic model.13,27,28 No conversion was observed over the 
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course of one month in the absence of a catalyst, whereas the ring-opening polymerization is facile when 
0.5 mol % of DPP or 2 is used. Rate constants for the propagation stage are provided along with reaction 
half-lives and relative rates in Table 3. In all four solvents, our doubly charged catalyst outperforms 
DPP by a factor of about two. The actual reaction rates vary by a factor of 12 regardless of the catalysts 
with the faster processes occurring in benzene-d6 and toluene-d8 and the slower ones taking place in 
CD2Cl2 and CDCl3. When smaller concentrations of the monomer are used, the polymerization takes 
longer but krel increases. This was also observed for the Friedel-Crafts and Diels-Alder reactions 
presumably because the reactants are more polar than the solvent and enhance the polarity of the 
medium. 
The effects of the two catalysts on the number-average molecular weights (Mn,NMR) of the polymers 
at different conversions were also investigated by 1H NMR. In all four solvents, Mn,NMR was found to 
be similar at equivalent conversions of the monomer regardless of the catalyst (Figure S2). 
 
Table 3. Kinetic data of polymerizations.a 
 
entry solvent cat. k (h-1) t1/2 (h) krel 
1 C6D5CD3 DPP 0.444 1.6 1.0 
2 C6D5CD3 2 0.833 0.8 1.9 
3 C6D6 DPP 0.325 2.1 1.0 
4 C6D6 2 0.574 1.2 1.8 
5 CD2Cl2 DPP 0.0380 18 1.0 
6 CD2Cl2 2 0.0759 9.1 2.0 
7 CDCl3 DPP 0.0460 15 1.0 
8 CDCl3 2 0.108 6.4 2.3 
 
aExperiments performed with 0.5 M δ-valerolactone, 1.0 mol % of PhCH2OH, and 0.5 mol % of the catalyst. 
 
2.3. Conclusion 
In summary, we successfully designed and synthesized two electrostatically enhanced phosphoric 
acid derivatives (1 and 2). To the best of our knowledge, these compounds are the first examples of 
phosphoric acids with positively charged centers incorporated to enhance their acidities and catalytic 
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abilities in nonpolar media. This was evaluated by investigating a series of acid-catalyzed processes and 
comparing the catalytic efficiencies of 1 and 2 with diphenyl phosphate (DPP) and di(3-nitrophenyl) 
phosphate (DPP*), their noncharged analogues. Impressively, both charged phosphoric acid derivatives 
out-performed DPP and DPP* in all of the reactions that were examined, in some cases by more than 3 
orders of magnitude. Extension of this strategy to other Brønsted acid catalysts such as chiral phosphoric 
acid derivatives is a promising research avenue and currently is the focus of ongoing efforts in our group. 
 
2.4. Experimental Section 
2.4.1. General Information 
Reactions were carried out in 120 ˚C oven-dried glassware including nuclear magnetic resonance 
(NMR) tubes. Chemical reagents were used as supplied unless otherwise noted and came from Sigma-
Aldrich except for sodium tetrakis(3,5-bis(trifluoromethyl)phenyl)borate which was obtained from 
Matrix Scientific. Deuterated solvents were purchased from Cambridge Isotope Laboratories except for 
tetrahydrofuran-d8 which was supplied by Sigma-Aldrich. Flash chromatography purifications were 
performed with a CombiFlash® Rf automated flash chromatography system equipped with RediSep Rf 
gold® normal-phase 40 g silica gel columns manufactured by Teledyne Isco. Inc. A standard flow rate 
of 40 mL min–1 was employed and linear gradients were used in switching from one solvent to another; 
when two times are given the first is the duration of the linear gradient and the second is the length of 
time that the eluent was used. Proton, carbon, fluorine and phosphorous nuclear magnetic resonance 
spectra were recorded with Varian Inova 500 MHz and Bruker Avance III HD Nanobay 400 MHz 
instruments. Chemical shifts are reported in ppm (δ) and were referenced as follows: 1H spectra, CDCl3 
(7.27 δ), CD2Cl2 (5.32 δ), C6D6 (7.16 δ), C6D5CD3 (7.09 δ) and THF-d8 (3.58 δ); 13C spectra, CDCl3 
(77.0 δ), CD2Cl2 (54.0 δ) and DMSO-d6 (39.5 δ); 19F spectra, CF3COOH (-76.55 δ, external calibrant); 
31P spectra, 85% H3PO4 in H2O (0.00 δ, external calibrant). IR spectra were obtained with an attenuated 
total reflectance (ATR) source using a Nicolet iS5 Fourier transform infrared (FT-IR) spectrometer. 
High-resolution electrospray ionization mass spectra (HRMS-ESI) were recorded with a Bruker ESI-





2.4.2. Synthesis Procedures  
N-Octyl-3-hydroxypyridinium iodide (3). 3-Hydroxypyridine (1.00 g, 10.5 mmol) was transferred into 
a 250 mL round bottomed flask under a dry nitrogen atmosphere and 30 mL isopropanol was added with 
stirring. The resulting suspension was heated to 40 ˚C with an oil bath and when the solid dissolved, 
1.90 mL (2.53 g, 10.5 mmol) of 1-iodooctane was quickly added via syringe and the temperature was 
increased to 110 ˚C. After refluxing the reaction mixture for 8 h it was allowed to cool to room 
temperature and the solvent was removed with a rotary evaporator to afford an orange oil. Purification 
by medium pressure liquid chromatography (MPLC) was carried out with CH2Cl2 (10 min), EtOAc (2 
and 10 min) and 1 : 1 EtOAc/MeOH (15 and 5 min) to afford 2.32 g (66%) of the title compound as a 
viscous yellow oil. 1H NMR (500 MHz, CD2Cl2) δ 8.58 (s, 1H), 8.11 (d, J = 5.9 Hz, 1H), 8.01 (d, J = 
8.3 Hz, 1H), 7.72 (dd, J = 5.9 and 8.8 Hz, 1H), 4.48 (t, J = 7.8 Hz, 2H), 2.00 (m, 2H), 1.29 (m, 11H), 
0.87 (t, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CD2Cl2) δ 161.2, 133.3, 133.2, 132.8, 128.7, 62.8, 32.2, 
31.9, 29.5, 29.4, 26.6, 23.1, 14.3. HRMS-ESI: calcd for C13H22NO+ (M – I–)+ 208.1696, found 208.1685. 
Phenyl 1,3-N-octylpyridinium phosphate iodide/chloride (4). N-Octyl-3-hydroxypyridinium iodide 
(1.00 g, 2.98 mmol) was added into a 250 mL round bottomed flask under a dry nitrogen atmosphere 
and dissolved in 30 mL of anhydrous acetonitrile with stirring. When the resulting solution became 
homogeneous, 490 µL of phenyl dichlorophosphate (0.692 g, 3.28 mmol) was slowly added via syringe. 
After gentle reflux for 10 h the reaction mixture was allowed to cool to room temperature and quenched 
with 5 mL of H2O. The resulting solution was stirred for 15 min and concentrated under reduced pressure 
to afford a yellowish oil. It was then dissolved in 30 mL of CH2Cl2 and extracted with H2O (30 mL) and 
brine (30 mL) before being dried over Na2SO4. Purification by MPLC using EtOAc (10 min) and 1 : 1 
EtOAc/MeOH (15 and 5 min) gave 0.96 g (72%, assuming a 1 : 1 Cl–/I– ratio) of 4 as a white solid (mp 
117 - 120 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 9.03 (s, 1H), 8.34 (d, J = 7.8 Hz, 1H), 8.24 (d, J = 5.4 Hz, 
1H), 7.80 (dd, J = 5.9 and 8.3 Hz, 1H), 7.23 (t, J = 7.9 Hz, 2H), 7.18 (d, J = 7.8 Hz, 2H), 7.03 (t, J = 7.3 
Hz, 1H), 4.51 (t, J = 7.9 Hz, 2H), 2.39 (bs, 1H, OH), 1.91 (m, 2H), 1.27 (m, 10H), 0.86 (t, J = 6.8 Hz, 
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3H). 13C NMR (100 MHz, CD2Cl2) δ 155.0, 153.6, 137.7, 137.5, 136.5, 129.7, 128.8, 123.9, 120.9, 62.8, 
32.2, 32.1, 29.50, 29.46, 26.6, 23.1, 14.3. 31P NMR (162 MHz, CD2Cl2) δ -11.04. HRMS-ESI: calcd for 
C19H27NO4P+ (M – X–)+ 364.1672, found 364.1663. 
Phenyl 1,3-N-octylpyridinium phosphate tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (1). Phenyl 
1,3-N-octylpyridinium phosphate iodide/chloride (0.100 g, 0.208 - 0.250 mmol) and sodium 
tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (0.221 g, 0.250 mmol) were mixed together in a 20 mL 
vial and dissolved in 8 mL of anhydrous CH2Cl2. Molecular sieves (4 Å, 0.2 g) that had been activated 
at 300 ˚C overnight were added and the resulting solution was stirred at 20 ˚C for 3 h. A sodium halide 
precipitate formed and was filtered through a syringe containing a 0.45 µm polytetrafluorethylene 
(PTFE) membrane. The reaction mixture was subsequently washed 3 times with 8 mL portions of 2.0 
M H2SO4 and then with H2O until the aqueous layer became pH neutral. Sodium sulfate was used to dry 
the CH2Cl2 and then it was concentrated under reduced pressure to afford 0.24 g (85%) of 1 as a yellow 
solid (mp 63 - 66 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 8.64 (s, 1H), 8.28 (d, J = 8.3 Hz, 1H), 8.18 (d, J 
= 5.9 Hz, 1H), 7.85 (dd, J = 6.4 and 8.3 Hz, 1H), 7.72 (s, 8H), 7.55 (s, 4H), 7.31 (t, J = 7.3 Hz, 2H), 
7.20 (t, J = 7.4 Hz, 1H), 7.16 (d, J = 7.8 Hz, 2H), 4.66 (bs, 1H, OH), 4.41 (t, J = 7.8 Hz, 2H), 1.93 (m, 
2H), 1.24 (m, 10H), 0.85 (t, J = 6.9 Hz, 3H). 13C NMR (100 MHz, CD2Cl2): δ 162.3 (q, 1JB-C = 49.6 
Hz), 152.6, 150.8, 139.4, 138.0, 137.4, 135.4, 130.7, 130.0, 129.4 (qq, 3JB-C = 2.9 Hz, 2JF-C = 31.4 Hz), 
126.6, 125.2 (q, 1JF-C = 270 Hz), 120.4, 118.1 (septet, 3JF-C = 3.3 Hz), 64.1, 32.1, 31.9, 29.4, 29.2, 26.5, 
23.0, 14.2. 19F NMR (376 MHz, CD2Cl2) δ -62.77. 31P NMR (162 MHz, CD2Cl2) δ -13.13. HRMS-ESI: 
calcd for C19H27NO4P+ (M – BArF4–)+ 364.1672, found 364.1663, calcd for C32H12BF24– (BArF4–) 
863.0654, found: 863.0693. 
Di(1,3-N-octylpyridinium) phosphate iodide/chloride (5). N-Octyl-3-hydroxypyridinium iodide (1.00 
g, 2.98 mmol) was added into a 250 mL round bottomed flask under N2 and mixed with 30 mL of 
anhydrous acetonitrile. When the salt dissolved into this stirred solution, 130 µL of phosphorus 
oxychloride (0.214 g, 1.39 mmol) was injected in one portion into the flask and the reaction mixture 
was heated to 100 - 105 ˚C and refluxed for 10 h. Upon cooling to room temperature, 5 mL of H2O was 
added and the resulting solution was stirred for an additional 15 min. It was subsequently concentrated 
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with a rotary evaporator to give a sticky brown oil which was dissolved in 30 mL of CH2Cl2, washed 
with H2O (30 mL) and brine (30 mL), dried over Na2SO4 and concentrated under reduced pressure. 
Purification by MPLC using CH2Cl2 (10 min), EtOAc (2 and 5 min) and then 1 : 1 EtOAc/MeOH (15 
and 5 min) afforded 0.55 g (62% assuming a 1 : 1 Cl–/I– ratio) of a light yellow solid (mp 61 - 63 ˚C). 
1H NMR (500 MHz, CDCl3) δ 9.36 (s, 2H), 8.59 (d, J = 8.8 Hz, 2H), 8.35 (d, J = 5.9 Hz, 2H), 7.95 (dd, 
J = 5.9 and 8.3 Hz, 2H), 4.78 (t, J = 7.3 Hz, 4H), 2.60 (bs, 1H, OH), 2.01 (m, 4H), 1.29 (m, 20H), 0.87 
(t, J = 6.9 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 152.9, 138.3, 137.5, 136.9, 128.7, 62.5, 31.52, 31.50, 
28.9, 28.8, 26.0, 22.4, 13.9. 31P NMR (162 MHz, CDCl3) δ -12.88. HRMS-ESI: calcd for C26H42N2O4P+ 
(M – H+ – 2X–, X = Cl and I)+ 477.2877, found 477.2886. 
Di(1,3-N-octylpyridinium) phosphate tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (2). In a 20 mL 
vial, di(1,3-N-octylpyridinium) phosphate iodide/chloride (0.100 g, 0.137 - 0.182 mmol) and sodium 
tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (0.323 g, 0.364 mmol) were mixed together and 
dissolved in 8 mL of anhydrous CH2Cl2. Activated 4 Å molecular sieves that had been dried at 300 ˚C 
overnight were added and the reaction mixture was stirred at room temperature for 3 h. During this time 
the sodium halide salt precipitated and then the white solid was filtered away by passing the CH2Cl2 
solution through a syringe with a 0.45 µm PTFE membrane. The organic material was washed 3 times 
with 8 mL of 2.0 M sulfuric acid followed by water until the aqueous phase became pH neutral. It was 
then dried with Na2SO4 and concentrated under reduced pressure to give 0.30 g (86%) of a yellow solid 
(mp 48 - 50 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 8.62 (s, 2H), 8.26 (d, J = 8.3 Hz, 2H), 8.13 (d, J = 5.9 
Hz, 2H), 7.76 (dd, J = 5.9 and 8.3 Hz, 2H), 7.71 (s, 16H), 7.55 (s, 8H), 4.40 (t, J = 7.8 Hz, 4H), 2.15 
(bs, OH), 1.94 (m, 4H), 1.26 (m, 20H), 0.85 (t, J = 6.9 Hz, 6H). 13C NMR (100 MHz, DMSO-d6) δ 
160.9 (q, 1JB-C = 49.6 Hz), 152.5, 139.2, 137.3, 136.1, 136.0, 134.0, 128.3 (qq, 3JB-C = 2.9 Hz, 2JF-C = 
31.4 Hz), 124.0 (q, 1JF-C = 270 Hz), 117.6 (septet, 3JF-C = 3.3 Hz), 61.0, 31.1, 30.7, 28.4, 28.3, 25.4, 22.0, 
13.8. 19F NMR (376 MHz, CD2Cl2) δ -62.74. 31P NMR (162 MHz, CD2Cl2) δ -13.28. ATR-IR: 2936, 
2862, 1610, 1501, 1353, 1272, 1108, 838, 681 cm-1. HRMS-ESI: calcd for C26H42N2O4P+ (M – H+ – 
2BArF4–)+  477.2877, found 477.2899. calcd for C32H12BF24– (BArF4–) 863.0654, found 863.0622. 
Di(3-nitrophenyl) phosphate (DPP*). 3-Nitrophenol (0.500 g, 3.59 mmol) was dissolved in 25 mL of 
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anhydrous acetonitrile in a 100 mL round bottomed flask under a dry nitrogen atmosphere. Pyridine 
(0.87 mL, 0.854 g, 10.8 mmol) was injected into the flask in one portion, followed by the rapid addition 
of phosphorus oxychloride (0.17 mL, 0.276 g, 1.80 mmol). The resulting solution was gently refluxed 
for 14 h and then the volatile material was removed with a rotary evaporator. Extraction of the residue 
with 30 mL of CH2Cl2 resulted in an organic solution that was washed with 30 mL of water, 30 mL of 
brine, and then dried over Na2SO4. Purification of the concentrated residue was carried out by MPLC 
with 1:1 hexanes/CH2Cl2 (1 min) and CH2Cl2 (10 min and 10 min). Upon rotary evaporation, the desired 
material was dissolved in 3 mL of CHCl3 in a 18 × 23 mm vial and 3 mL of 2 M H2SO4 was added. This 
solution was heated to 50 ˚C and stirred for 4 h, after which the organic layer was separated, washed 
with water until the aqueous layer became pH neutral, and dried over Na2SO4. Concentration under 
reduced pressure afforded 0.19 g (31%) of a white solid (mp 105 - 107 ̊ C). 1H NMR (500 MHz, CD2Cl2): 
δ 8.16 (d, J = 7.8 Hz, 2H), 8.13 (s, 2H), 7.67 (d, J = 8.3 Hz, 2H), 7.64 (t, J = 7.8 Hz, 2H), 1.61 (s, OH). 
13C NMR (100 MHz, CD2Cl2) : δ 150.7, 150.6, 131.7, 126.9, 121.8, 116.2. 31P NMR (162 MHz, CD2Cl2): 
δ -18.53. HRMS-ESI: calcd for C12H8N2O8P– (M – H+)– 339.0024, found 339.0026. 
 
2.4.3. Kinetic Studies 
Preparation of 20 mM Catalyst Stock Solutions. Catalysts 1 (0.1280 g, 0.1043 mmol) and 2 (0.1443 
g, 0.06547 mmol) were placed in separate 23 × 85 mm vials and dissolved in 5.22 and 3.27 mL of 
CH2Cl2, respectively. The vials were capped, sealed with parafilm and stored in a freezer at –20 ˚C until 
needed. 
General Procedure for Friedel-Crafts Kinetic Studies. In a dry 15 × 45 mm vial, 427 µL (for a 10 
mol % catalyst loading) of a 20 mM catalyst solution was added and the solvent (CH2Cl2) was removed 
under vacuum. A second dry 15 × 45 mm vial was filled with 10.0 mg (0.0854 mmol)of indole or 11.2 
mg (0.0854 mmol) of N-methylindole and 12.8 mg (0.0854 mmol) of trans-β-nitrostyrene and was 
dissolved in 900 µL of CD2Cl2, CDCl3, THF-d8 or C6H5Cl to afford 94.8 mM solutions; smaller amounts 
of the reactants were used to produce lower concentrations. After stirring for 30 s and upon complete 
dissolution of the reactants, this material was transferred via syringe to the catalyst-containing vial. The 
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resulting solution was vigorously shaken to ensure good mixing and the starting time was recorded. This 
material was transferred to an oven-dried NMR tube for kinetic measurements and the reaction progress 
was monitored by 1H NMR using the relative integration of the signals at 6.58 (indole), 6.51 (N-
methylindole) and 4.96 (both products) δ; in THF-d8 these resonances are at 6.39 (indole) and 5.08 
(products). The one exception was for the chlorobenzene experiments in which the solvent was changed 
for the kinetic measurements to CDCl3. For slow reactions taking ≥ 24 h, additional solvent was added 
at 24 h intervals to maintain the total volume at 900 µL due to small changes caused by evaporation. 
General Procedure of Kinetic Studies of Diels-Alder Reactions. Cyclopentadiene was freshly 
prepared by cracking dicyclopentadiene at 190 ˚C and fractionally distilling it between 37 - 45 ˚C; the 
purity was verified by 1H NMR and found to be ≥ 99.8 %. In a dry 15 × 45 mm vial, 63.5 mg (80.8 µL 
and 0.960 mmol) of cyclopentadiene was measured out with a microliter syringe, the vial was 
immediately capped and 2400 µL of CDCl3 was added. In another dry 15 × 45 mm vial, 67.2 mg (79.9 
µL and 0.960 mmol) of methyl vinyl ketone or 51.0 mg (63.0 µL and 0.960 mmol) of acrylonitrile was 
weighed out and immediately dissolved into 2400 µL of CDCl3. To a third vial of the same size, 400 µL 
of the 20 mM catalyst stock solution was added for a 1.0 mol % loading and the solvent was removed 
under vacuum. The catalyst was redissolved in 400 µL of CDCl3 and added to a NMR tube containing 
200 µL of the cyclopentadiene solution and an equal volume of the methyl vinyl ketone or acrylonitrile 
solution (this affords 100 mM reactant concentrations) with vigorous mixing for ~5 - 10 sec. The initial 
time was recorded and the reaction progress was monitored by 1H NMR. For the reaction with methyl 
vinyl ketone, the reaction progress was determined by integrating the signals at 6.47 (cyclopentadiene) 
and 5.86 (product) δ and the endo:exo ratio was obtained using the product resonances at 2.22 (exo) and 
2.14 (endo) δ. For the transformation with acrylonitrile, the signals at 5.67 (acyrlonitrile) and 3.24 
(product) δ were used to measure the rate constants and the absorptions at 3.24 (endo and exo) and 2.85 
(endo) δ were used to obtain the endo:exo ratios. 
General Procedure of Kinetic Studies of Ring-opening Polymerizations. In a dry 15 × 45 mm vial, 
800 mg (8.00 mmol) of δ-valerolactone was weighed out and 8.4 µL (8.7 mg, 0.080 mmol) of benzyl 
alcohol was added via a 10 µL syringe. This mixture was stirred for 10 min at room temperature and 
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then 40 mg portions were weighed out into four 15 × 45 mm vials and 800 µL of a deuterated solvent 
was added in each case in order to afford 0.50 M monomer solutions; more or less of the lactone solution 
was used to produce different concentrations. Four different 15 × 45 mm vials were each charged with 
100 µL portions of the 20 mM stock solution of the catalyst and the solvent was removed under reduced 
pressure. The monomer containing solutions were then transferred into these vials, these mixtures were 
shaken for 10 s and then transferred into NMR tubes. Each reaction was monitored by 1H NMR using 
the δ-valerolactone signals at 3.64 (toluene-d8), 3.60 (benzene-d6), 4.28 (CD2Cl2) and 4.32 (CDCl3) δ 
and polymer resonances at 3.93 & 3.42 (toluene-d8), 3.94 & 3.42 (benzene-d6), 4.03 & 3.58 (CD2Cl2) 
and 4.05 & 3.62 (CDCl3) δ, where the first chemical shift is for the polymer chain CH2's excluding the 
end group and the latter one is for the CH2 end group. The number-average molecular weights were 
determined using the polymer signals just noted and the initiator (benzyl alcohol) resonances at 4.95 
(toluene-d8), 4.99 (benzene-d6), 5.07 (CD2Cl2) and 5.09 (CDCl3) δ. 
 
2.4.4. Catalyst Titration 
A NaOH pellet (0.198 g, 4.95 mmol) was weighed in a 23 × 85 mm vial and dissolved in 5.0 mL of 
deionized water. It was then diluted with 9.9 mL of methanol and stirred to afford the titrant solution. 
Catalyst 2 (0.735 g, 0.333 mmol) was placed in a second vial and 1.0 mL of methanol was added with 
stirring. The titrant was added to the catalyst solution in 0.05 mL portions using a 1.0 mL syringe and 
the pH was measured after each addition using pH paper. The endpoint was observed after adding 0.95–




Chapter 3: Asymmetric Arylation of 2,2,2-Trifluoroacetophenones Catalyzed by 
Chiral Electrostatically-Enhanced Phosphoric Acids* 
 
3.1. Background 
Indoles are among the most important type of nitrogen-containing heterocyclic scaffolds, as they are 
widely found in natural products,1 pharmaceuticals2 and synthetic chemicals.3 Most of these indole-
based compounds possess special chemical properties as well as bioactivities, and thus, they have 
attracted widespread attention.4 Fluorinated species are another important class of organic materials 
since the small size and high electronegativity of a fluorine atom lead to compounds with remarkably 
different properties than their fluorine-free analogues.5 A combination of fluorine substituents on indole 
frameworks leading to novel bioactivities and pharmaceutical properties made the synthesis of such 
compounds inviting targets.6,7 
A number of strategies have been devised to incorporate fluorine atoms into indole derivatives.7c,8 
Given the electron-rich nature and the enhanced reactivity in electrophilic alkylations (especially at the 
C-3 position) of this heterocycle,9 one of the most straightforward methods for synthesizing these 
derivatives is to carry out a Friedel-Crafts alkylation with an indole and a fluorine-containing 
electrophile.10 This type of transformation is also a powerful method for the formation of carbon-carbon 
bonds that can be applied to construct optically active compounds.11 In general, these reactions proceed 
in good yields and high enantioselectivities with suitable catalysts. For the specific case of Friedel-
Crafts alkylations of indole derivatives with 2,2,2-trifluoromethyl aryl ketones, inorganic bases,12 
cinchona alkaloids,13 guanidine,14 trifluoromethanesulfonic acid,15 and phosphoric acids16 were reported 
to be successful catalysts. Most of these studies, however, focused on either racemic products or bis-
coupled adducts. There are only a few reports on asymmetric alkylations, and these required either long 
reaction times (i.e., up to 96 h)16 or harsh reaction conditions (i.e., up to 9 kbar pressure)13 presumably  
____________________________ 
*Reprinted adapted with permission from: Ma, J.; Kass, S. R. Org. Lett. 2018, 20, 2689–2692. Copyright 
2018 American Chemical Society. 
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because it is a challenge to trigger the alkylation and terminate it at the monoarylated stage.15,16 More 
effective enantioselective catalysts, consequently, are still needed for this transformation. 
In general, there is a good correlation between reactivity and the acidity of related organocatalysts.17 
For this reason, electron-withdrawing substituents such as trifluoromethyl or nitro groups are sometimes 
incorporated into phenyl rings at the 3 and 3' positions of BINOL-derived phosphoric acids.18,19 In 
previous studies from our laboratory, positively charged ion centers were found to enhance the catalytic 
reactivities of phenols,20 thioureas21 and phosphoric acids22 by orders of magnitude. This approach was 
also used to obtain good to excellent enantioselectivities for the alkylation of indoles with trans-β-
nitrostyrene derivatives using chiral thioureas.23 As a result, we decided to develop a series of BINOL-
based phosphoric acid catalysts possessing 3,3'-phosphonium ion substituents (Figure 1) that were 
prepared using reported synthetic methods.24 These large groups provide needed steric bulk and two 
acidity-enhancing positively charged ion centers. Their performance in the Friedel-Crafts reactions of 
indole derivatives with 2,2,2-trifluoromethyl aryl ketones are reported herein. 
 
 
Figure 1. Catalysts involved in this work. 
 
3.2. Results and Discussion 
This investigation was initiated by examining the reaction of indole (3a) with 2,2,2-
trifluoroacetophenone (4a) using the tri(p-tolyl)phosphonium ion containing phosphoric acid at the 3,3'-
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positions of the (R)-BINOL backbone (i.e., 2b) along with the noncoordinating tetrakis(3,5-
bis(trifluoromethyl)phenyl)borate (BArF4–) counterion; more common and interacting anions lead to 
less active catalysts.20-22 At room temperature in CH2Cl2 with a 5 mol % catalyst loading, both the 
desired and undesired mono- and bis-coupled products (5a and 6, respectively) were formed, 
respectively (eq 1). This led to a loss of yield for the former species, as previously has been reported 




To our delight, when the reaction temperature was reduced to 0 °C, the formation of the bis-coupled 
byproduct was nearly eliminated and a dramatic increase in the ee from 17% to 85% was observed 
(entry 2). A further decrease to -30 °C only led to a 1% increase in the ee at the expense of a much 
longer reaction time (entry 3), and this result was surpassed by adding 3 Å molecular sieves (MS) at 
0 °C (i.e., 87% ee, entry 4). Other MS (4 Å, 5 Å and 13X) decreased both the yield and the 
enantioselectivity (entries 5-7).  Attempts to improve this transformation with inorganic salts (Na2SO4, 
NaCl, MgSO4 and CaCl2) as drying agents also led to poorer results (entries 8-11). An increase in the 
catalyst loading to 10 mol % did not improve the enantioselectivity further (entry 12) so the other 
phosphonium ion containing species were screened with 5 mol % catalyst at 0 °C in the presence of 3 
Å MS. The triphenylphosphonium containing derivative 2a gave a much lower yield (30%) and 
selectivity (77% ee) (entry 13), while the tri(p-ethylphenyl) and tri(p-propylphenyl)phosphonium 
derivatives 2c and 2d gave similar results to 2b (entries 14-15). Interestingly, the diphenyl(p-
tolyl)phosphonium ion tagged catalyst 2e, which is sterically similar to 2a and electronically in between 
2a and 2b, afforded the product with a reduced yield and ee relative to 2b of 68% and 84%, respectively. 
These results suggest that the large difference between 2a and 2b is due to electronic effects brought 
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about by replacing a hydrogen atom with a methyl group on each of the phenyl rings attached to the 
phosphorous atom. A lower temperature experiment at -30 °C was also performed with 3 Å MS and a 
3% increase in ee to 90% was observed (entry 17). A further drop in the temperature to -50 °C was 
impractical due to reduced catalyst solubility. 
 
Table 1. Optimization of reaction conditions.a 
 
entry cat. t (oC) additive time (h) yield 5a (%)b ee (%)c 
1 2b 20 - 5 48 17 
2 2b 0 - 22 90 85 
3 2b -30 - 96 87 86 
4d 2b 0 3 Å MS 22 92 87 
5d 2b 0 4 Å MS 22 87 66 
6d 2b 0 5 Å MS 21 79 80 
7d 2b 0 13X MS 21 58 85 
8e 2b 0 Na2SO4 20 81 83 
9e 2b 0 NaCl 20 86 80 
10e 2b 0 MgSO4 20 83 80 
11e 2b 0 CaCl2 20 81 80 
12d,f 2b 0 3 Å MS 20 87 87 
13d 2a 0 3 Å MS 22 30g 77 
14d 2c 0 3 Å MS 22 91 86 
15d 2d 0 3 Å MS 22 86 86 
16d 2e 0 3 Å MS 22 68g 84 
17d 2b -30 3 Å MS 40 85 90 
 
aExperiments performed with 0.140 mmol indole, 0.168 mmol 2,2,2-trifluoroacetophenone, 0.007 mmol 
catalyst in 0.25 mL CH2Cl2. bIsolated yield. cDetermined by chiral HPLC. d5 mg of MS were used. e1.0 equiv 
of salt was used. f0.014 mmol catalyst was employed. gStarting material was present. 
 
Reaction media were examined next with catalyst 2b and the results are summarized in Table 2. 
Solvents were found to have a large influence on the reactivity and enantioselectivity. For example, 
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CHCl3 (entry 2) led to both a lower yield and enantioselectivity than CH2Cl2 (entry 1). Chlorobenzene 
(entry 3) and 1,2-dichloroethane (DCE, entry 4) gave similar results (91% and 89% yields along with 
62% and 63% ee), neither of which is as good as CH2Cl2. Several mixtures using CH2Cl2 and aromatic 
solvents (i.e., benzene, toluene, m-xylene) or CCl4 were also tested (entries 5-8). None of these 
screenings led to better results than when CH2Cl2 was used. 
 
Table 2. Screening of reaction solvents.a 
 
entry solvent time (h) yield 5a (%)b ee (%)c 
1 CH2Cl2 22 92 87 
2 CHCl3 22 37 67 
3 C6H5Cl 22 91 62 
4 DCE 22 89 63 
5 1:1 CH2Cl2/C6H6 20 86 84 
6 1:1 CH2Cl2/C6H5CH3 20 81 83 
7 1:1 CH2Cl2/1,3-(CH3)2C6H4 20 88 83 
8 1:1 CH2Cl2/CCl4 20 89 85 
 
aExperiments performed with 0.140 mmol indole, 0.168 mmol 2,2,2-trifluoroacetophenone, 0.007 mmol 
catalyst 2b and 5 mg of 3 Å MS in 0.25 mL of solvent at 0 °C. bIsolated yield. cDetermined by chiral HPLC. 
 
The scope of this transformation was examined at 0 °C using 5 mol % 2b, CH2Cl2 as the solvent and 
3 Å MS as a drying agent (eq 2). As summarized in Table 3, a wide variety of substituents including 
electron-withdrawing and electron-donating groups on either reactant were tolerated. With a few 
exceptions, excellent yields (82-94%) and good enantioselectivities (79-91% ee) were obtained at 0 °C 
(entry 1-19). Halide substituents at the 5-positon of indole did not affect the selectivity (85-87% ee) 
(entries 1-2) relative to the parent compound (i.e., R3, R4 = H) whereas electron-donating groups at the 






while 6-methylindole (3e) gave the worst product enantiomeric purity (48% ee), its isomer 7-
methylindole (3h) provided the highest enantioselectivity (91% ee, entry 7). This difference should be 
quite helpful in developing computational models for the mechanism of this reaction. Other substituents 
at the 7-position of indole (Cl, Br, Et) had no impact on the enantiomeric excess (entries 5-6 and 8), but 
7-bromoindole (3g) slowed the reaction leading to approximately half the yield over the same time 
period. Introduction of electron-withdrawing groups (F, Cl, Br and CF3) to the para position of 2,2,2-
trifluoroacetophenone gave slight improvements of 1-3% in the ee (entries 9-11 and 13), whereas an 
electron-donating methyl group at the same location lowered the enantioselectivity by an equivalent 
amount (entry 12). Halogen substituents at one or both of the meta positions in 2,2,2-
trifluoroacetophenone had little, if any, impact on the reaction outcome (entries 14-17). 
Perfluoroacetophenone (4k) was found to give both a low yield (28%) and ee (64%, entry 18) while 2-
chloro-2,2-difluoroacetophenone (4l) also gave a low yield (36%) but without much difference in the 
enantioselectivity (i.e., an 84% ee was observed, entry 19). For the two reactions that gave ≥ 90% ee at 
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0 °C (entries 7 and 9), a decrease in temperature to -30 °C resulted in improved selectivities of 95% and 
93% ee (entries 20-21). The former transformation was further examined with a decreased catalyst 
loading of 1.5 mol %, and the enantioselectivity was preserved with a measured ee of 96% (entry 22).  
 























aExperiments performed with 0.140 mmol indole, 0.168 mmol 2,2,2-trifluoroacetophenone, 5 mol % 2b and 
5 mg of 3 Å MS in 0.25 mL of CH2Cl2 at 0 °C. bIsolated yield. cDetermined by chiral HPLC. dReaction run 
at -30 °C with 10 mg 3 Å MS. e1.5 mol % catalyst. fLarger scale reaction with 0.840 mmol 7-methylindole, 
1.008 mmol 2,2,2-trifluoroacetophenone, 1.5 mol % 2b and 30 mg 3 Å MS in 1.50 mL of CH2Cl2 at -30 °C; 
247.5 mg of product was produced. 
entry substrate adduct time (h) yield (%)b ee (%)c 
1 3b + 4a 5b 26 85 85 
2 3c + 4a 5c 26 82 87 
3 3d + 4a 5d 20 84 79 
4 3e + 4a 5e 20 83 48 
5 3f + 4a 5f 28 87 87 
6 3g + 4a 5g 28 41 88 
7 3h + 4a 5h 14 92 91 
8 3i + 4a 5i 20 85 88 
9 3a + 4b 5j 20 92 90 
10 3a + 4c 5k 20 88 89 
11 3a + 4d 5l 20 94 89 
12 3a + 4e 5m 28 86 85 
13 3a + 4f 5n 20 90 88 
14 3a + 4g 5o 20 89 85 
15 3a + 4h 5p 20 91 86 
16 3a + 4i 5q 20 85 86 
17 3a + 4j 5r 20 88 88 
18 3a + 4k 5s 24 28 64 
19 3a + 4l 5t 28 36 84 
20d 3h + 4a 5h 18 96 95 
21d 3a + 4b 5j 42 91 93 
22d,e 3h + 4a 5h 65 93 96 
23f 3h + 4a 5h 70 96 96 
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A larger scale reaction was also performed with six times more material and reactant weights in excess 
of 100 mg along with a catalyst loading of 1.5 mol %. This led to similar results to the small-scale 
transformation and afforded a 96% yield and a 96% ee (entry 23). 
 To compare the reactivity and enantioselectivity of our charged BINOL phosphoric acid derivative 
2b with noncharged analogues, three different structures (1a-1c) were used. These species included the 
unsubstituted BINOL phosphoric acid (1a), a sterically similar structure with triphenylsilyl substituents 
at the 3 and 3'-positions (1b), and 3,3'-bis(2,4,6-triisopropylphenyl)-BINOL phosphoric acid (1c). The 
last of these derivatives is known as TRIP and is one of the most successful phosphoric acid catalysts 
that has been reported.25 7-Methylindole (3h) and 2,2,2-trifluoroacetophenone (4a) in CH2Cl2 at -30 °C 
with a 1.5 mol % catalyst loading was used as the test reaction, and the results after 65 h are given in 
Table 4. The least sterically hindered parent structure with hydrogen atoms at the 3 and 3'-positions (1a) 
was ineffective. Only a 1% yield was obtained and this material was essentially racemic (i.e., 1% ee, 
entry 1). The catalyst 1b with two triphenylsilyl substituents only gave a yield of 9%, but this product 
was formed in 93% ee (entry 2). TRIP is more reactive, but only resulted in a 43% yield. The observed 
ee of 97%, however, is quite impressive (entry 3). Our charged phosphonium ion tagged phosphoric 
acid catalyst 2b proved to be superior in that an excellent yield of 93% was obtained along with a 96% 
ee (entry 4). Assuming second-order kinetics for these processes,26 one can estimate that 2b is more 
 
Table 4. Catalyst comparisons.a 
 
entry catalyst yield (%)b ee (%)c 
1 1a 1 1 
2 1b 9 93 
3 1c 43 97 
4 2b 93 96 
 
aExperiments performed with 0.140 mmol 7-methylindole, 0.168 mmol 2,2,2-trifluoroacetophenone, 1.5 mol% 
of the desired catalyst and 10 mg of 3Å MS in 0.25 mL of CH2Cl2 at -30 °C. bIsolated yield after 65 h. 




reactive than 1a-1c by factors of 690, 70, and 10, respectively, but still is as selective as the best of these 
noncharged species. 
To investigate the role of hydrogen bonding between the phosphoryl oxygen and indole substrate, a 
reaction lacking this interaction was performed with 1-methylindole and 2,2,2-trifluoroacetophe-none 




show that the selectivity is significantly lower and the yield is worse than when indole is used (92% 
yield and 87% ee in 22 h). These findings indicate that indole reacts 2.6 times faster than N-methylindole 
even though the latter compound is a better nucleophile. This suggests that the P=O••H–N hydrogen 
bond is important both in terms of the reaction rate and the enantioselectivity as previously reported.27 
 
3.3. Conclusion 
In summary, we demonstrated a successful application of chiral electrostatically enhanced phosphoric 
acids to a Friedel-Crafts alkylation to generate fluorinated indole derivatives. A wide scope of substrates 
is tolerated, giving the corresponding products in good yields and enantioselectivities. A larger synthetic 
scale reaction affording 250 mg of product was carried out with little, if any, change in the performance 
of the reaction. Our charged catalyst 2b was also found to outperform noncharged analogues in terms 
of reaction rates by orders of magnitude, yet still gave as good or better enantioselectivities. 
 
3.4. Experimental Section 
3.4.1. General Information 
Unless otherwise noted, all reagents involved in this work were commercially available and used 
without further purification. Organic solvents used in reactions were dried over 3 Å molecular sieves 
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that had been activated in an oven overnight. Flash chromatography purifications were performed with 
a CombiFlash® Rf automated system installed with RediSep Rf gold® 4 gram or 40 gram silica gel 
columns manufactured by Teledyne Isco Inc. Nuclear magnetic resonance (NMR) spectra were recorded 
with Varian Inova 500 MHz and Bruker Avance III HD Nanobay 400 MHz instruments. Chemical shifts 
are reported in ppm (δ) using the following reference signals: 1H and 13C NMR: 7.26 and 77.0 δ (CDCl3), 
and 5.32 and 54.0 δ (CD2Cl2); 19F NMR: -76.55 δ, external calibrant (CF3COOH); 31P NMR: 0.00 δ, 
external calibrant (85% H3PO4 in H2O). High-resolution electrospray ionization mass spectra (HRMS-
ESI) data were obtained with a Bruker ESI-BioTOF instrument using methanol solutions and 
polyethylene glycol (PEG) or polypropylene glycol (PPG) as an internal standard. Chiral HPLC 
analyses were carried out with an Agilent system equipped with RegisCell and RegisPack columns. 
 
3.4.2. General Procedure for the Friedel-Crafts Reaction 
Catalyst (1.5–10 mol %) and 3 Å molecular sieves (5–10 mg) were added to a 17 × 60 mm vial and 
purged for 30 s with dry nitrogen to remove oxygen and moisture. The vial was sealed and cooled to the 
designated reaction temperature using a cooling bath (or left at room temperature in a few cases). The 
indole and 2,2,2-trifluoromethyl aryl ketone were weighed in separate vials and 250 μL of CH2Cl2 was 
added to the indole container. After mixing for 5 s, the solution was transferred to the vial with the 2,2,2-
trifluoromethyl aryl ketone and vigorously mixed for 10 s. Immediately thereafter this solution was 
added to the vial with the catalyst and molecular sieves, and swirled for 20–30 s until the solution 
became homogeneous. After the elapsed reaction time, the reaction mixture was directly loaded onto a 
4 gram silica gel column followed by an injection of 0.2–0.3 mL of CH2Cl2 that had been used to rinse 
the vial and molecular sieves. A 1 min wash with hexanes was followed by a linear gradient of hexanes 
to CH2Cl2 over a 7 min period and then the latter solvent was used until the end of the purification. 
Racemic reference products were obtained at room temperature using diphenyl phosphate as the catalyst 





3.4.3. Synthesis Procedures 
BINOL phosphoric acids. The parent compound 1a was purchased from Oakwood Chemical while 
1b and 1c were synthesized as previously described.28 
Tris(p-alkylphenyl)phosphine (7c-7d): In a flame dried 100 mL two-necked round bottomed flask 
equipped with dropping funnel and septum, anhydrous Et2O (10 mL) was injected, followed by the 
addition of ground magnesium turning (0.315 g, 13.0 mmol). The desired p-alkylphenyl bromide (10.8 
mmol) and Et2O (10 mL) were mixed and then 5-10 drops were slowly added under an argon atmosphere 
to initiate Grignard reagent formation. After bubbles were observed, the rest of the solution was added 
dropwise over a 20 min period under reflux. After 1 h at room temperature this solution was transferred 
via syringe to a flame-dried 250 mL round bottomed flask and cooled to 0 °C with an ice-water bath. A 
solution of PCl3 (0.41 g, 2.70 mmol) in anhydrous THF (10 mL) was slowly added over 10 minutes, 
and then the reaction mixture was allowed to warm up to room temperature overnight before being 
quenched with 10 mL of water. The volatiles were evaporated under vacuum and CH2Cl2 (50 mL) was 
added to extract the product. The resulting organic material was washed with water (30 mL) and brine 
(30 mL), and dried over Na2SO4. Concentration with a rotary evaporator afforded a viscous oil which 
was purified by medium pressure liquid chromatography (MPLC) using hexanes as the eluent. 
Tris(p-ethylphenyl)phosphine (7c). This material was formed as a white solid (0.60 g, mp 98 - 102 °C) 
in a 64% yield. 1H NMR (500 MHz, CD2Cl2): δ 7.24 (t, J = 7.4 Hz, 6H), 7.19 (d, J = 6.9 Hz, 6H), 2.66 
(q, J = 7.8 Hz, 6H), 1.24 (t, J = 7.3 Hz, 9H). 13C NMR (100 MHz, CD2Cl2): δ 145.6, 135.2 (d, J = 10.2 
Hz), 134.2 (d, J = 19.7 Hz), 128.6 (d, J = 7.3 Hz), 29.2, 15.8. 31P NMR (162 MHz, CD2Cl2): δ -7.96. 
HRMS-ESI: Calc for C24H28P+ (M + H+)+ 347.1923, found 347.1936. 
Tris(p-n-propylphenyl)phosphine (7d). A white solid (0.51 g, mp 55 - 57 °C) was formed in a 49% 
yield. 1H NMR (500 MHz, CDCl3): δ 7.22 (t, J = 7.8 Hz, 6H), 7.14 (d, J = 7.9 Hz, 6H), 2.58 (t, J = 7.5 
Hz, 6H), 1.71-1.60 (m, 6H), 0.94 (t, J = 7.3 Hz, 9H). 13C NMR (100 MHz, CDCl3): δ 143.2, 134.4 (d, J 
= 8.8 Hz), 133.6 (d, J = 19.7 Hz), 128.6 (d, J = 7.3 Hz), 37.8, 24.4, 13.9. 31P NMR (162 MHz, CD2Cl2): 
δ -7.73. HRMS-ESI: Calc for C27H34P+ (M + H+)+ 389.2398, found 389.2399. 
General procedure for synthesis of 9a-9e. Starting material 8 was synthesized as previously 
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described29 while triphenylphosphine (7a), tri(p-tolyl)phosphine (7b) and diphenyl(p-tolyl)phosphine 
(7e) were obtained from Sigma-Aldrich. In a 23 × 85 mm glass vial equipped with a balloon, 8 (0.538 
g, 1.0 mmol), Pd2(dba)3 (0.055 g, 0.060 mmol) and triarylphosphine (3.0 mmol) were mixed. After 
degassing this mixture for 10 minutes, 0.30 mL of ethylene glycol was added. The resulting mixture 
was heated to 130 °C for 16 h with stirring. Upon cooling the reaction mixture to room temperature, it 
was diluted with 30 mL of CH2Cl2, washed with water (2 × 20 mL), and dried over Na2SO4. The product 
was dried under vacuum and redissolved into 4 mL of CH2Cl2 before being slowly added in 100 mL of 
Et2O with stirring. The resulting yellow precipitate was filtered and collected. If the resulting product 
displayed more than one spot upon thin layer chromatography (TLC) with a 4:1 EtOAc/MeOH mixture, 
then it was purified by MPLC using a 2-min wash with EtOAc followed by a linear gradient to 4:1 
EtOAc/MeOH mixture over a 5 min time frame. The desired product was then concentrated with a 
rotary evaporator. 
(R)-(2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(triphenylphosphonium) iodide (9a). A yellow 
solid (0.88 g, mp 222 - 230 °C) was obtained in an 83% yield. 1H NMR (500 MHz, CDCl3): δ 7.79-7.72 
(m, 6H), 7.72-7.62 (m, 14H), 7.62-7.50 (m, 14H), 7.32 (d, J = 8.5 Hz, 2H), 7.27 (t, J = 7.4 Hz, 2H), 7.20 
(d, J = 7.6 Hz, 2H), 4.31 (bs, OH, 2H). 13C NMR (100 MHz, CDCl3): δ 161.9 (d, J = 3.7 Hz), 138.7 (d, 
J = 9.8 Hz), 138.5 (d, J = 1.9 Hz), 134.1 (d, J = 3.0 Hz), 134.0 (d, J = 10.2 Hz), 129.7 (d, J = 12.9 Hz), 
129.5, 128.7, 126.5, 126.3, 122.6, 120.6 (d, J = 7.0 Hz), 120.3 (d, J = 91.4 Hz), 111.0 (d, J = 94.9 Hz). 
31P NMR (162 MHz, CDCl3): δ 22.15. HRMS-ESI: Calc for C56H41O2P2+ (M - H+ - 2I-)+ 807.2576, 
found 807.2604. 
(R)-(2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(tri-p-tolylphosphonium) iodide (9b). A 
yellow solid (0.90 g, mp 210 - 215 °C) was obtained in a 78% yield. 1H NMR (500 MHz, CD2Cl2): δ 
7.74-7.49 (m, 16H), 7.48-7.34 (m, 12H), 7.29-7.16 (m, 6H), 5.33 (s, OH, 2H), 2.46 (s, 18H). 13C NMR 
(100 MHz, CDCl3): δ 162.0 (d, J = 3.8 Hz), 145.0 (d, J = 3.0 Hz), 138.6 (d, J = 10.0 Hz), 138.4, 134.0 
(d, J = 10.6 Hz), 133.5 (d, J = 10.6 Hz), 131.0 (d, J = 13.0 Hz), 130.4 (d, J = 13.3 Hz), 129.4, 128.6, 
126.4 (d, J = 14.4 Hz), 122.4, 117.3 (d, J = 93.9 Hz), 111.6 (d, J = 94.6 Hz), 21.8. 31P NMR (162 MHz, 
CD2Cl2): δ 21.62. HRMS-ESI: Calc for C62H53O2P2+ (M - H+ - 2I-)+ 891.3515, found 891.3493. 
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(R)-(2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(tris(4-ethylphenyl)phosphonium) iodide (9c). 
A yellow solid (1.05 g, mp 194 - 202 °C) was obtained in an 85% yield. 1H NMR (500 MHz, CD2Cl2): 
δ 7.69-7.62 (m, 4H), 7.61-7.53 (m, 12H), 7.50-7.34 (m, 12H), 7.28-7.17 (m, 6H), 5.33 (s, OH, 2H), 2.76 
(q, J = 7.6 Hz, 12H), 1.27 (t, J = 7.6 Hz, 18H). 13C NMR (100 MHz, CD2Cl2): δ 162.8 (d, J = 3.9 Hz), 
151.8 (d, J = 2.9 Hz), 139.4 (d, J = 9.9 Hz), 139.0, 134.7 (d, J =10.6 Hz), 134.3 (d, J = 10.6 Hz), 129.9, 
129.7 (d, J =13.2 Hz), 129.0, 126.8 (d, J = 16.0 Hz), 122.9, 120.8 (d, J =8.5 Hz), 118.0 (d, J = 93.8 Hz), 
112.1 (d, J = 94.6 Hz), 29.4, 15.2. 31P NMR (162 MHz, CD2Cl2): δ 21.61. HRMS-ESI: Calc for 
C68H65O2P2+ (M - H+ - 2I-)+ 975.4454, found 975.4451. 
(R)-(2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(tris(4-propylphenyl)phosphonium) iodide 
(9d). A yellow solid (0.91 g, mp 147 - 152 °C) was obtained in a 69% yield. 1H NMR (500 MHz, 
CD2Cl2): δ 7.67-7.50 (m, 16H), 7.49-7.33 (m, 12H), 7.30-7.15 (m, 6H), 5.33 (bs, OH, 2H), 2.69 (t, J = 
8.3 Hz, 12H), 1.75-1.60 (m, 12H), 0.95 (t, J = 7.4 Hz, 18H). 13C NMR (100 MHz, CD2Cl2): δ 162.8 (d, 
J = 3.9 Hz), 150.3 (d, J = 3.0 Hz), 139.5 (d, J = 9.9 Hz), 139.0, 134.6 (d, J = 10.6 Hz), 134.2 (d, J = 
10.6 Hz), 130.8 (d, J = 13.0 Hz), 130.3 (d, J = 13.2 Hz), 129.9, 129.0, 126.8 (d, J = 15.7 Hz), 122.9, 
118.1 (d, J = 93.7 Hz), 112.3 (d, J = 94.7 Hz), 38.5, 24.6, 14.1. 19F NMR (376 MHz, CD2Cl2): δ -62.84. 
31P NMR (162 MHz, CD2Cl2): δ 21.45. HRMS-ESI: Calc for C74H77O2P2+ (M - H+ - 2I-)+ 1059.5393, 
found 1059.5376. 
(R)-(2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(diphenyl(p-tolyl)phosphonium) iodide (9e). A 
yellow solid (0.762 g, mp 208 - 216 °C) was obtained in a 70% yield. 1H NMR (500 MHz, CDCl3): δ 
7.70 (t, J = 7.2 Hz, 4H), 7.67-7.58 (m, 10H), 7.58-7.44 (m, 14H), 7.39-7.32 (m, 4H), 7.28 (d, J = 8.6 
Hz, 2H), 7.25-7.20 (m, 2H), 7.17 (t, J = 7.3 Hz, 2H), 6.83 (bs, OH, 2H), 2.44 (s, 6H). 13C NMR (100 
MHz, CDCl3): δ 161.8 (d, J = 3.8 Hz), 145.2 (d, J = 3.0 Hz), 138.6 (d, J = 10.2 Hz), 138.3 (d, J = 1.9 
Hz), 134.1 (d, J = 10.6 Hz), 133.932, 133.927 (d, J = 6.4 Hz), 133.8 (d, J = 3.8 Hz), 130.4 (d, J = 13.3 
Hz), 129.6 (d, J = 12.9 Hz), 129.4, 128.6, 126.4, 122.5, 120.51 (d, J = 91.4 Hz), 120.46 (d, J = 6.2 Hz), 
116.6 (d, J = 93.8 Hz), 111.1 (d, J = 94.8 Hz), 21.7. 31P NMR (162 MHz, CDCl3): δ 22.01. HRMS-ESI: 
Calc for C58H45O2P2+ (M - H+ - 2I-)+ 835.2889, found 835.2905. 
General procedure for synthesis of 10a-10e. In a balloon equipped 23 × 85 mm glass vial filled with 
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dry N2, 0.500 mmol of the desired iodide 9a-9e was dissolved in 5 mL of pyridine and then 0.28 mL of 
POCl3 (0.46 g, 3.00 mmol) was added over a 3 min period with stirring. It was then heated to 85 °C for 
20 h and slowly quenched with 1 mL of water after being cooled down to room temperature. The reaction 
mixture was subsequently heated to 85 °C for 1 h, allowed to cool back down to room temperature, and 
concentrated with a rotary evaporator. The residue was dissolved in 30 mL of CH2Cl2, washed with 30 
mL of water and 30 mL of brine, and then dried with Na2SO4 and concentrated under reduced pressure. 
Purification of the product was achieved by dissolving it in 4 mL of CH2Cl2 and adding this solution 
dropwise into 100 mL of Et2O to afford a precipitate that was subsequently collected and dried. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(triphenyl-
phosphonium) chloride (10a). This material was obtained in an 81% yield (0.38 g) as a yellow solid 
(mp 244 - 250 °C). 1H NMR (500 MHz, CDCl3): δ 8.00 (d, J = 16.4 Hz, 2H), 7.88 (d, J = 8.7 Hz, 2H), 
7.83-7.72 (m, 18H), 7.72-7.64 (m, 12H), 7.61-7.52 (m, 4H), 7.29 (d, J = 8.3 Hz, 2H), 1.87 (bs, OH, 1H). 
13C NMR (100 MHz, CD2Cl2): δ 141.6 (d, J = 8.5 Hz), 136.7, 135.7 (d, J = 10.5 Hz), 135.4 (d, J = 3.0 
Hz), 131.2, 130.9 (d, J = 12.9 Hz), 130.3 (d, J = 13.1 Hz), 130.2, 129.8 (d, J = 14.4 Hz), 127.4, 127.0, 
125.4 (d, J = 8.2 Hz), 119.8 (d, J = 90.4 Hz), 111.4 (d, J = 93.8 Hz). 31P NMR (162 MHz, CDCl3): δ 
23.01, 0.89. HRMS-ESI: Calc for C56H40O4P3+ (M - H - 2Cl-)+ 869.2134, found 869.2135. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(tri-p-
tolylphosphonium) chloride (10b). This material was obtained in a 90% yield (0.46 g) as a yellow solid 
(mp 241 - 245 °C). 1H NMR (500 MHz, CD2Cl2): δ 8.05 (d, J = 16.1 Hz, 2H), 7.88 (d, J = 8.0 Hz, 2H), 
7.75-7.59 (m, 12H), 7.57 (t, J = 7.3 Hz, 2H), 7.54-7.40 (m, 14H), 7.31 (d, J = 8.3 Hz, 2H), 2.48 (s, 18H), 
2.03 (bs, OH, 1H). 13C NMR (100 MHz, CD2Cl2): δ 151.6 (d, J = 3.4 Hz), 146.8 (d, J = 3.0 Hz), 141.5 
(d, J = 8.5 Hz), 136.6, 135.5 (d, J = 10.8 Hz), 131.00 (d, J = 13.5 Hz), 130.98, 130.1, 129.7 (d, J = 14.1 
Hz), 127.2, 127.0, 125.2 (d, J = 7.1 Hz), 116.6 (d, J = 93.3 Hz), 112.3 (d, J = 91.3 Hz), 22.1. 31P NMR 
(162 MHz, CD2Cl2): δ 22.24, 1.59. HRMS-ESI: Calc for C62H52O4P3+ (M - H+ - 2Cl-)+ 953.3073, found 
953.3081. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(tris(4-
ethylphenyl)phosphonium) chloride (10c). This material was obtained in a 71% yield (0.39 g) as a 
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yellow solid (mp 201 - 207 °C). 1H NMR (500 MHz, CD2Cl2): δ 8.07 (d, J = 16.1 Hz, 2H), 7.89 (d, J = 
8.1 Hz, 2H), 7.76-7.61 (m, 12H), 7.57 (t, J = 7.2 Hz, 2H), 7.54-7.40 (m, 14H), 7.33 (d, J = 8.5 Hz, 2H), 
2.79 (q, J = 7.6 Hz, 12H), 2.18 (s, OH, 1H), 1.28 (t, J = 7.7 Hz, 18H). 13C NMR (100 MHz, CD2Cl2): δ 
152.6 (d, J = 3.0 Hz), 141.4 (d, J = 8.2 Hz), 136.6, 135.6 (d, J = 10.8 Hz), 130.9, 130.1, 129.8 (d, J = 
13.5 Hz), 129.5 (d, J = 15.8 Hz), 128.5 (d, J = 12.3 Hz), 127.2, 127.0, 125.2 (d, J = 7.0 Hz), 116.8 (d, J 
= 93.0 Hz), 112.3 (d, J = 91.0 Hz), 29.4, 15.1. 31P NMR (162 MHz, CD2Cl2): δ 22.01, 1.57. HRMS-ESI: 
Calc for C68H64O4P3+ (M - H+ - 2Cl-)+ 1037.4012, found 1037.3991. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(tris(4-
propylphenyl)phosphonium) chloride (10d). This material was obtained in an 85% yield (0.51 g) as a 
yellow solid (mp 161 - 166 °C). 1H NMR (500 MHz, CDCl3): δ 7.93 (d, J = 16.3 Hz, 2H), 7.82 (d, J = 
7.8 Hz, 2H), 7.65-7.57 (m, 12H), 7.57-7.46 (m, 6H), 7.44-7.38 (m, 10H), 7.23 (d, J = 8.3 Hz, 2H), 2.67 
(t, J = 7.2 Hz, 13H), 1.71-1.62 (m, 12H), 0.95 (t, J = 7.4 Hz, 18H). 13C NMR (100 MHz, CDCl3): δ 
150.4 (d, J = 3.0 Hz), 140.7 (d, J = 8.6 Hz), 136.2, 134.9 (d, J = 10.8 Hz), 132.0 (d, J = 10.2 Hz), 130.7, 
130.0 (d, J = 13.5 Hz), 129.6, 129.0 (d, J = 14.3 Hz), 128.5 (d, J = 12.3 Hz), 126.7, 126.4, 116.0 (d, J = 
93.0 Hz), 111.8 (d, J = 90.6 Hz), 38.0, 23.8, 13.8. 31P NMR (162 MHz, CD2Cl2): δ 22.44, 1.08. HRMS-
ESI: Calc for C74H76O4P3+ (M - H+ - 2Cl-)+ 1121.4951, found 1121.4983. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis-(diphenyl(p-
tolyl)phosphonium) chloride (10e). This material was obtained in an 89% yield (0.433 g) as a yellow 
solid (mp 234 - 240 °C). 1H NMR (500 MHz, CDCl3): δ 7.98 (d, J = 16.3 Hz, 2H), 7.86 (d, J = 7.7 Hz, 
2H), 7.80-7.69 (m, 12H), 7.68-7.58 (m, 12H), 7.57-7.49 (m, 4H), 7.48-7.40 (m, 4H), 7.27 (d, J = 8.2 
Hz, 2H), 2.47 (s, 6H), 2.06 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 150.8 (d, J = 3.6 Hz), 146.4 
(d, J = 3.1 Hz), 140.9 (d, J = 8.6 Hz), 136.2, 134.94 (d, J = 10.6 Hz), 134.93 (d, J = 3.1 Hz), 130.93, 
130.90 (d, J = 13.5 Hz), 129.98 (d, J = 13.1 Hz), 129.96 (d, J = 13.1 Hz), 129.2 (d, J = 14.0 Hz), 126.9, 
126.5, 119.2 (d, J = 90.6 Hz), 119.1 (d, J = 90.7 Hz), 115.2 (d, J = 92.9 Hz), 111.05 (d, J = 91.2 Hz), 
111.02 (d, J = 91.1 Hz), 21.9. 31P NMR (162 MHz, CDCl3): δ 22.90, 0.89. HRMS-ESI: Calc for 
C58H44O4P3+ (M - H+ - 2Cl-)+ 897.2447, found 897.2424. 
General procedure for synthesis of 2a-2e. In a 23 × 85 mm vial, one of the chlorides 10a-10e (0.200 
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mmol), sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (0.372 g, 0.420 mmol) and 3 Å molecular 
sieves (0.05 g) were mixed along with 8 mL of CH2Cl2. The solution was stirred at room temperature 
for 3 h and then filtered through a syringe equipped with a 0.45 μm PTFE membrane. It was 
subsequently washed twice with 8 mL of 2.0 M H2SO4 and three times with 8 mL of water before being 
dried over Na2SO4. Removal of the solvent with a rotary evaporator afforded the desired BArF4 salt. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(triphenyl-
phosphonium) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (2a). A yellow solid (0.493 g, mp 85 - 
89 °C) was obtained in a 95% yield. 1H NMR (500 MHz, CD2Cl2): δ 8.15 (d, J = 16.5 Hz, 2H), 7.96 (d, 
J = 8.1 Hz, 2H), 7.81-7.76 (m, 4H), 7.74-7.69 (s, 18H), 7.69-7.59 (m, 24H), 7.59-7.54 (m, 4H), 7.52 (s, 
8H), 7.26 (d, J = 8.4 Hz, 2H), 3.56 (bs, OH, 1H). 13C NMR (100 MHz, CD2Cl2): δ 162.4 (q, J = 49.6 
Hz), 147.0 (d, J = 3.0 Hz), 143.4 (d, J = 6.9 Hz), 136.4, 136.3, 135.4, 135.2 (d, J = 10.5 Hz), 132.9, 
131.3 (d, J = 13.4 Hz), 131.0 (d, J = 13.2 Hz), 130.8 (d, J = 11.8 Hz), 129.8, 129.5 (qq, J = 2.92 and 
31.4 Hz), 127.2, 125.2 (q, J = 271 Hz), 124.1 (d, J = 6.4 Hz), 118.09 (septet, J = 3.64 Hz), 118.05 (d, J 
= 90.6 Hz), 110.3 (d, J = 90.8 Hz). 19F NMR (376 MHz, CD2Cl2): δ -62.83. 31P NMR (162 MHz, CD2Cl2): 
δ 22.37, -2.97. HRMS-ESI: Calc for C56H40O4P3+ (M - H+ - 2BArF4-)+ 869.2134, found 869.2180. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(tri-p-
tolylphosphonium) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (2b). A yellow solid (0.491 g, mp 108 
- 115 °C) was obtained in a 92% yield. 1H NMR (500 MHz, CD2Cl2): δ 8.14 (d, J = 16.0 Hz, 2H), 7.96 
(d, J = 8.1 Hz, 2H), 7.73 (s, 16H), 7.69-7.47 (m, 26H), 7.47-7.37 (m, 10H), 7.24 (d, J = 8.4 Hz, 2H), 
4.07 (bs, OH, 1H), 2.42 (s, 18H). 13C NMR (100 MHz, CD2Cl2): δ 162.3 (q, J = 49.6 Hz), 148.1 (d, J = 
3.7 Hz), 143.3 (d, J = 10.4 Hz), 136.2, 135.4, 135.0 (d, J = 10.9 Hz), 132.7, 131.7 (d, J = 13.5 Hz), 
130.7 (d, J = 6.9 Hz), 130.4 (d, J = 13.8 Hz), 129.44 (qq, J = 2.92 and 31.4 Hz), 129.36, 128.5 (d, J = 
13.4 Hz), 127.5, 127.1, 125.1 (q, J = 270 Hz), 118.0 (septet, J = 3.64 Hz), 114.7 (d, J = 92.9 Hz), 111.2 
(d, J = 91.6 Hz), 22.1. 19F NMR (376 MHz, CD2Cl2): δ -62.82. 31P NMR (162 MHz, CD2Cl2): δ 21.75, 
-3.23. HRMS-ESI: Calc for C62H52O4P3+ (M - H+ - 2BArF4-)+ 953.3073, found 953.3098. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(tris(4-
ethylphenyl)phosphonium) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (2c). A yellow solid (0.494 g, 
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mp 106 - 112 °C) was obtained in an 89% yield. 1H NMR (500 MHz, CD2Cl2): δ 8.15 (d, J = 16.2 Hz, 
2H), 7.96 (d, J = 8.2 Hz, 2H), 7.71 (s, 16H), 7.64 (t, J = 7.5 Hz, 2H), 7.60-7.54 (m, 14H), 7.53 (s, 8H), 
7.50-7.40 (m, 12H), 7.25 (d, J = 8.6 Hz, 2H), 3.19 (s, OH, 1H), 2.74 (q, J = 7.5 Hz, 12H), 1.23 (t, J = 
7.6 Hz, 18H). 13C NMR (100 MHz, CD2Cl2): δ 162.3 (q, J = 49.6 Hz), 153.9 (d, J = 3.6 Hz), 143.2 (d, 
J = 8.8 Hz), 136.2, 135.4, 135.2 (d, J = 10.9 Hz), 132.6, 131.2 (d, J = 12.9 Hz), 130.8 (d, J = 15.8 Hz), 
130.5 (d, J = 13.6 Hz), 129.4 (qq, J = 2.92 and 31.4 Hz), 129.2, 128.6 (d, J = 12.7 Hz), 127.2, 127.1, 
125.1 (q, J = 270 Hz), 118.0 (septet, J = 3.64 Hz), 115.1 (d, J = 93.5 Hz), 111.3 (d, J = 90.6 Hz), 29.5, 
15.1. 19F NMR (376 MHz, CD2Cl2): δ -62.84. 31P NMR (162 MHz, CD2Cl2): δ 21.45, -2.65. HRMS-
ESI: Calc for C68H64O4P3+ (M - H+ - 2BArF4-)+ 1037.4012, found 1037.4038. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(tris(4-
propylphenyl)phosphonium) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (2d). A yellow solid (0.455 
g, mp 92 - 96 °C) was obtained in an 80% yield. 1H NMR (500 MHz, CD2Cl2): δ 8.15 (d, J = 16.2 Hz, 
2H), 7.96 (d, J = 8.3 Hz, 2H), 7.75-7.69 (m, 18H), 7.64 (t, J = 7.4 Hz, 2H), 7.60-7.51 (m, 22H), 7.48-
7.43 (m, 10H), 7.24 (d, J = 8.5 Hz, 2H), 3.23 (bs, OH, 1H), 2.68 (t, J = 7.5 Hz, 12H), 1.71-1.58 (m, 
12H), 0.93 (t, J = 7.3 Hz, 18H). 13C NMR (100 MHz, CD2Cl2): δ 162.3 (q, J = 49.6 Hz), 152.6 (d, J = 
2.9 Hz), 143.3 (d, J = 7.6 Hz), 136.2, 135.4, 135.1 (d, J = 10.9 Hz), 132.7, 131.1 (d, J = 13.6 Hz), 130.9 
(d, J = 13.6 Hz), 130.8 (d, J = 12.7 Hz), 129.5 (qq, J = 2.92 and 31.4 Hz), 129.4, 128.2 (d, J = 9.6 Hz), 
127.18, 127.15, 125.2 (q, J = 270 Hz), 118.1 (septet, J = 3.64 Hz), 115.0 (d, J = 93.2 Hz), 111.3 (d, J = 
94.0 Hz), 38.5, 24.6, 14.0. 19F NMR (376 MHz, CD2Cl2): δ -62.81. 31P NMR (162 MHz, CD2Cl2): δ 
21.40, -3.15. HRMS-ESI: Calc for C74H76O4P3+ (M - H+ - 2BArF4-)+ 1121.4951, found 1121.4986. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'f][1,3,2]dioxaphosphepine-2,6-diyl)bis(diphen-yl(p-
tolyl)phosphonium) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (2e). A red solid (0.477 g, mp 104 - 
108 °C) was obtained in a 91% yield. 1H NMR (500 MHz, CD2Cl2): δ 8.16 (d, J = 16.3 Hz, 2H), 7.97 
(d, J = 8.1 Hz, 2H), 7.83-7.76 (m, 4H), 7.72 (s, 16H), 7.70-7.59 (m, 18H), 7.58-7.51 (m, 14H), 7.48-
7.43 (m, 4H), 7.25 (d, J = 8.6 Hz, 2H), 3.55 (bs, OH, 1H) 2.44 (s, 6H). 13C NMR (100 MHz, CD2Cl2): 
δ 162.4 (q, J = 49.65 Hz), 148.5 (d, J = 3.1 Hz), 143.5 (d, J = 7.8 Hz), 136.2 (d, J = 7.7 Hz), 135.4, 
135.15 (d, J = 2.8 Hz), 135.05 (d, J = 10.5 Hz), 135.0 (d, J = 3.2 Hz), 132.9, 131.9 (d, J = 13.7 Hz), 
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131.0 (d, J = 13.2 Hz), 130.9 (d, J = 13.2 Hz), 129.8 (d, J = 11.5 Hz), 129.5, 129.4 (qq, J = 2.76 and 
31.3 Hz), 127.2, 125.1 (q, J = 271 Hz), 118.2 (d, J = 90.8 Hz), 118.1 (d, J = 90.6 Hz), 118.05 (septet, J 
= 3.89 Hz), 113.9 (d, J = 93.3 Hz), 110.6 (d, J = 90.5 Hz), 110.5 (d, J = 90.7 Hz), 22.1. 19F NMR (376 
MHz, CD2Cl2): δ -62.82. 31P NMR (162 MHz, CD2Cl2): δ 22.14, -3.60. HRMS-ESI: Calc for 
C58H45O4P32+ (M - 2BArF4-)2+ 449.1260, found 449.1288. 
 
3.4.4. Characterizations of Friedel-Crafts Adducts from Reactions Run at 0 ˚C 
 
2,2,2-Trifluoro-1-(1H-indole-3-yl)-1-phenylethanol (5a). A white solid (37.6 mg) was isolated. 1H NMR 
(500 MHz, CDCl3): δ 8.25 (bs, NH, 1H), 7.64-7.55 (m, 2H), 7.50-7.44 (m, 1H), 7.41-7.32 (m, 4H), 7.21-
7.12 (m, 2H), 6.96 (t, J = 7.3 Hz, 1H), 2.89 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 137.6, 136.2, 
128.5, 127.9, 127.6 (d, J = 0.8 Hz), 125.3 (q, J = 284.3 Hz), 125.1, 123.2 (q, J = 3.0 Hz), 122.7, 120.9, 
120.3, 114.1, 111.2, 77.0 (q, J = 29.6 Hz). 19F NMR (376 MHz, CDCl3): δ -76.75. HRMS-ESI: calc for 
C16H11F3NO– (M - H+)– 290.0798, found 290.0812. 
 
 
2,2,2-trifluoro-1-(5-fluoro-1H-indole-3-yl)-1-phenylethanol (5b). A white solid (36.9 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.26 (bs, NH, 1H), 7.62-7.54 (m, 2H), 7.52-7.46 (m, 1H), 7.40-7.32 (m, 
3H), 7.29 (dd, J = 4.4 and 8.9 Hz, 1H), 6.96-6.88 (m, 1H), 6.80 (J = 2.4 and 9.9 Hz, 1H), 2.64 (bs, OH, 
1H). 13C NMR (100 MHz, CDCl3): δ 157.7 (d, J = 234.2 Hz), 137.2, 132.7, 128.7, 128.0, 127.5, 125.7 
(d, J = 10.4 Hz), 125.3 (q, J = 284.4 Hz), 124.8 (q, J = 3.0 Hz), 114.4 (d, J = 4.8 Hz), 111.9 (d, J = 9.7 
Hz), 111.4 (d, J = 26.5 Hz), 106.0 (d, J = 24.5 Hz), 77.1 (d, J = 26.5 Hz). 19F NMR (376 MHz, CDCl3): 




2,2,2-Trifluoro-1-(5-bromo-1H-indole-3-yl)-1-phenylethanol (5c). A white solid (42.6 mg) was 
isolated. 1H NMR (500 MHz, CDCl3): δ 8.29 (bs, NH, 1H), 7.60-7.52 (m, 2H), 7.47-7.41 (m, 1H), 
7.40-7.31 (m, 4H), 7.27-7.22 (m, 2H), 2.85 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 137.2, 
134.9, 128.8, 128.1, 127.4 (d, J = 3.3 Hz), 126.9, 125.2 (q, J = 284.5 Hz), 125.8, 124.3 (q, J = 3.0 Hz), 
123.5, 113.9, 113.6, 112.6, 76.9 (q, J = 29.5 Hz). 19F NMR (376 MHz, CDCl3): δ -76.86. HRMS-ESI: 
calc for C16H10BrF3NO– (M - H+)– 367.9903 and 369.9883, found 367.9901 and 369.9876. 
 
2,2,2-Trifluoro-1-(5-methoxyl-1H-indole-3-yl)-1-phenylethanol (5d). A white solid (37.6 mg) was 
isolated. 1H NMR (500 MHz, CDCl3): δ 8.19 (bs, NH, 1H), 7.64-7.56 (m, 2H), 7.46-7.39 (m, 1H), 7.38-
7.32 (m, 3H), 7.26-7.22 (m, 2H), 3.56 (s, 3H), 2.40 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 154.0, 
137.6, 131.3, 128.4, 127.9 (d, J = 0.4 Hz), 127.6, 125.7, 125.4 (q, J = 284.4 Hz), 123.7 (q, J = 3.0 Hz), 
113.8, 113.0, 111.9, 102.5, 76.9 (q, J = 29.6 Hz), 55.5. 19F NMR (376 MHz, CDCl3): δ -76.75. HRMS-
ESI: calc for C17H13F3NO2– (M - H+)– 320.0904, found 320.0902. 
 
2,2,2-Trifluoro-1-(6-methyl-1H-indole-3-yl)-1-phenylethanol (5e). A white solid (35.5 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.10 (bs, NH, 1H), 7.64-7.56 (m, 2H), 7.51-7.30 (m, 4H), 7.17 (s, 1H), 
7.02 (d, J = 8.3 Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 2.86 (bs, OH, 1H), 2.42 (s, 3H). 13C NMR (100 MHz, 
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CDCl3): δ 137.7, 136.7, 132.7, 128.4, 127.9, 127.6 (d, J = 0.6 Hz), 125.3 (q, J = 284.3 Hz), 122.9, 122.6 
(q, J = 2.9 Hz), 122.1, 120.5, 113.9, 111.1, 77.0 (q, J = 29.5 Hz), 21.5. 19F NMR (376 MHz, CDCl3): δ 
-76.79. HRMS-ESI: calc for C17H13F3NO– (M - H+)– 304.0955, found 304.0941. 
 
2,2,2-Trifluoro-1-(7-chloro-1H-indole-3-yl)-1-phenylethanol (5f). A white solid (39.5 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.47 (bs, NH, 1H), 7.62-7.54 (m, 2H), 7.51 (s, 1H), 7.40-7.32 (m, 3H), 
7.17 (d, J = 7.7 Hz, 1H), 7.06 (d, J = 8.1 Hz, 1H), 6.88 (t, J = 8.0 Hz, 1H), 2.86 (bs, OH, 1H). 13C NMR 
(100 MHz, CDCl3): δ 137.3, 133.6, 128.7, 128.0, 127.5 (d, J = 1.0 Hz), 126.6, 125.2 (q, J = 284.5 Hz), 
123.7 (q, J = 3.0 Hz), 122.1, 121.1, 119.7, 116.7, 115.4, 76.9 (q, J = 29.7 Hz). 19F NMR (376 MHz, 
CDCl3): δ -76.84. HRMS-ESI: Calc for C16H10ClF3NO– (M - H+)– 324.0408 and 326.0379, found 
324.0400 and 326.0379. 
 
2,2,2-Trifluoro-1-(7-bromo-1H-indole-3-yl)-1-phenylethanol (5g). A white solid (21.0 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.43 (bs, NH, 1H), 7.62-7.55 (m, 2H), 7.52 (s, 1H), 7.40-7.28 (m, 4H), 
7.10 (d, J = 8.1 Hz, 1H), 6.83 (t, J = 8.0 Hz, 1H), 2.85 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 
137.3, 135.0, 128.7, 128.0, 127.5 (d, J = 1.0 Hz), 126.4, 125.2 (q, J = 284.5 Hz), 125.1, 123.6 (q, J = 
2.9 Hz), 121.5, 120.3, 115.5, 104.7, 77.0 (q, J = 29.6 Hz). 19F NMR (376 MHz, CDCl3): δ -76.79. 




2,2,2-Trifluoro-1-(7-methyl-1H-indole-3-yl)-1-phenylethanol (5h). A white solid (39.4 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.14 (bs, NH, 1H), 7.64-7.55 (m, 2H), 7.50-7.43 (m, 1H), 7.38-7.31 (m, 
3H), 7.03-6.96 (m, 2H), 6.88 (t, J = 7.6 Hz, 1H), 2.89 (bs, OH, 1H), 2.50 (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ 137.7, 135.8, 128.4, 127.9, 127.6 (d, J = 0.5 Hz), 125.3 (q, J = 284.3 Hz), 124.6, 123.2, 122.9 
(q, J = 3.0 Hz), 120.5, 120.4, 118.6, 114.6, 77.0 (q, J = 29.5 Hz), 16.5. 19F NMR (376 MHz, CDCl3): δ 
-76.74. HRMS-ESI: calc for C17H13F3NO– (M - H+)– 304.0955, found 304.0950. 
 
2,2,2-Trifluoro-1-(7-ethyl-1H-indole-3-yl)-1-phenylethanol (5i). A white solid (38.1 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.22 (bs, NH, 1H), 7.65-7.57 (m, 2H), 7.49-7.43 (m, 1H), 7.38-7.32 (m, 
3H), 7.06-6.98 (m, 2H), 6.96 (t, J = 8.0 Hz, 1H), 2.92-2.84 (m, 3H), 1.39 (t, J = 7.6 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ 137.7, 135.2, 128.4, 127.9, 127.6 (d, J = 1.0 Hz), 126.6, 125.3 (q, J = 284.4 Hz), 
124.9, 122.8 (q, J = 3.0 Hz), 121.2, 120.5, 118.6, 114.5, 77.0 (q, J = 29.4 Hz), 23.9, 13.7. 19F NMR (376 
MHz, CDCl3): δ -76.78. HRMS-ESI: Calc for C18H15F3NO– (M - H+)– 318.1111, found 318.1113. 
 
2,2,2-Trifluoro-1-(4-fluorophenyl)-1-(1H-indole-3-yl)ethanol (5j). A white solid (40.0 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.27 (bs, NH, 1H), 7.60-7.50 (m, 2H), 7.47 (s, 1H), 7.39 (d, J = 8.2 Hz, 
1H), 7.20 (t, J = 7.7 Hz, 1H), 7.13 (d, J = 7.9 Hz, 1H), 7.06-6.92 (t, J = 7.6 Hz, 3H), 2.89 (bs, OH, 1H). 
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13C NMR (100 MHz, CDCl3): δ 162.8 (d, J = 245.9 Hz), 136.3, 133.4 (d, J = 3.2 Hz), 129.7 (d, J = 8.3 
Hz), 125.2 (q, J = 284.0 Hz), 125.0, 123.1 (q, J = 3.0 Hz), 122.9, 120.8, 120.4, 114.8 (d, J = 21.5 Hz), 
113.8, 111.3, 76.6 (q, J = 29.8 Hz), 19F NMR (376 MHz, CDCl3): δ -77.08, -113.82. HRMS-ESI: calc 
for C16H10F4NO– (M - H+)– 308.0704, found 308.0708. 
 
1-(4-Chlorophenyl)-2,2,2-trifluoro-1-(1H-indole-3-yl)ethanol (5k). A white solid (40.0 mg) was 
isolated. 1H NMR (500 MHz, CDCl3): δ 8.27 (bs, NH, 1H), 7.53 (d, J = 8.5 Hz, 2H), 7.49-7.44 (m, 1H), 
7.39 (d, J = 8.2 Hz, 1H), 7.34-7.28 (m, 2H), 7.23-7.17 (m, 1H), 7.13 (d, J = 8.1 Hz, 1H), 6.98 (t, J = 8.0 
Hz, 1H), 2.89 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 136.24, 136.20, 134.6, 129.2, 128.1, 125.1 
(q, J = 284.3 Hz), 124.9, 123.1 (q, J = 3.1 Hz), 122.9, 120.8, 120.4, 113.5, 111.3, 76.6 (q, J = 29.8 Hz). 
19F NMR (376 MHz, CDCl3): δ -77.02. HRMS-ESI: calc for C16H10ClF3NO– (M - H+)– 324.0408 and 
326.0379, found 324.0394 and 326.0373. 
 
1-(4-Bromophenyl)-2,2,2-trifluoro-1-(1H-indole-3-yl)ethanol (5l). A white solid (48.7 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.28 (bs, NH, 1H), 7.51-7.42 (m, 5H), 7.39 (d, J = 8.2 Hz, 1H), 7.23-
7.17 (m, 1H), 7.13 (d, J = 8.0 Hz, 1H), 6.98 (t, J = 8.05 Hz, 1H), 2.89 (bs, OH, 1H). 13C NMR (100 
MHz, CDCl3): δ 136.7, 136.2, 131.1, 129.5 (d, J = 0.5 Hz), 127.9, 125.0 (q, J = 284.4 Hz), 124.9, 123.1 
(q, J = 3.1 Hz), 123.0, 121.8, 120.4, 113.4, 111.3, 76.7 (q, J = 29.7 Hz). 19F NMR (376 MHz, CDCl3): 





2,2,2-Trifluoro-1-(1H-indole-3-yl)-1-p-tolylethanol (5m). A white solid (36.7 mg) was isolated. 1H 
NMR (500 MHz, CDCl3): δ 8.24 (bs, NH, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.46-7.42 (m, 1H), 7.38 (d, J 
= 7.9 Hz, 1H), 7.19 (d, J = 7.6 Hz, 2H), 7.16 (d, J = 8.5 Hz, 2H), 6.97 (t, J = 7.4 Hz, 1H), 2.87 (bs, OH, 
1H), 2.36 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 138.3, 136.2, 134.7, 128.7, 127.5 (d, J = 0.6 Hz), 
125.4 (q, J = 284.3 Hz), 125.2, 123.1 (q, J = 3.0 Hz), 122.7, 121.0, 120.2, 114.2, 111.2, 76.9 (q, J = 29.4 
Hz), 21.1. 19F NMR (376 MHz, CDCl3): δ -76.88. HRMS-ESI: calc for C17H13F3NO– (M - H+)– 
304.0955, found 304.0955. 
 
2,2,2-Trifluoro-1-(4-trifluoromethylphenyl)-1-(1H-indole-3-yl)ethanol (5n). A white solid (45.1 mg) 
was isolated. 1H NMR (500 MHz, CDCl3): δ 8.30 (bs, NH, 1H), 7.73 (d, J = 8.2 Hz, 2H), 7.61 (d, J = 
8.3 Hz, 2H), 7.54-7.48 (m, 1H), 7.41 (d, J = 8.3 Hz, 1H), 7.21 (t, J = 7.3 Hz, 1H), 7.11 (d, J = 8.1 Hz, 
1H), 6.98 (t, J = 7.3 Hz, 1H), 2.96 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 141.5, 136.3, 130.7 
(d, J = 32.3 Hz), 128.2, 125.0 (q, J = 284.4 Hz), 124.9 (q, J = 3.7 Hz), 124.8, 124.0 (q, J = 270.5 Hz), 
123.2 (d, J = 3.1 Hz), 123.1, 120.6, 120.5, 113.3, 111.4, 76.8 (q, J = 30.0 Hz). 19F NMR (376 MHz, 




1-(3-Chlorophenyl)-2,2,2-trifluoro-1-(1H-indole-3-yl)ethanol (5o). A white solid (40.8 mg) was 
isolated. 1H NMR (500 MHz, CDCl3): δ 8.29 (bs, NH, 1H), 7.66 (s, 1H), 7.51-7.46 (m, 1H), 7.43 (d, J 
= 7.8 Hz, 1H), 7.39 (d, J = 8.2 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 7.26 (t, J = 8.0 Hz, 1H), 7.21 (d, J = 
7.8 Hz, 1H), 7.17 (d, J = 8.2 Hz, 1H), 6.98 (r, J = 7.8 Hz, 1H), 2.57 (bs, OH, 1H). 13C NMR (100 MHz, 
CDCl3): δ 139.7, 136.2, 134.0, 129.2, 128.8, 127.8 (d, J = 1.0 Hz), 126.0, 125.0 (q, J = 284.5 Hz), 124.9, 
123.1 (q, J = 3.0 Hz), 122.9, 120.8, 120.5, 113.4, 111.3, 76.6 (q, J = 29.8 Hz). 19F NMR (376 MHz, 
CDCl3): δ -76.84. HRMS-ESI: calc for C16H10ClF3NO– (M - H+)– 324.0408 and 326.0379, found 
324.0417 and 326.0394. 
 
2,2,2-Trifluoro-1-(1H-indole-3-yl)-1-3,5-difluorophenylethanol (5p). A white solid (41.5 mg) was 
isolated. 1H NMR (500 MHz, CDCl3): δ 8.31 (bs, NH, 1H), 7.51-7.46 (m, 1H), 7.41 (d, J = 8.2 Hz, 1H) 
7.24-7.17 (m, 2H), 7.14 (d, J = 6.7 Hz, 2H), 7.04-6.96 (m, 1H), 6.85-6.74 (m, 1H), 2.95 (bs, OH, 1H). 
13C NMR (100 MHz, CDCl3): δ 162.6 (dd, J = 12.3 and 246.4 Hz), 141.7 (t, J = 8.9 Hz), 136.2, 124.8 
(q, J = 284.5 Hz), 124.7, 123.11, 123.06 (q, J = 3.1 Hz), 120.6 (d, J = 11.5 Hz), 112.9, 111.4, 111.099 
(d, J = 26.4 Hz), 111.098 (d, J = 11.2 Hz), 104.1 (t, J = 25.2 Hz), 76.5 (q, J = 29.9 Hz). 19F NMR (376 
MHz, CDCl3): δ -76.93, -109.72. HRMS-ESI: calc for C16H9F5NO– (M - H+)– 326.0610, found 326.0626. 
 
1-(3-Chloro-5-fluorophenyl)-2,2,2-trifluoro-1-(1H-indole-3-yl)ethanol (5q). A white solid (40.8 mg) 
was isolated. 1H NMR (500 MHz, CDCl3): δ 8.29 (bs, NH, 1H), 7.52-7.46 (m, 1H), 7.45-7.38 (m, 2H), 
7.25-7.16 (m, 3H), 7.12-7.06 (m, 1H), 7.02 (t, J = 8.0 Hz, 1H), 2.93 (bs, OH, 1H). 13C NMR (100 MHz, 
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CDCl3): δ 162.3 (d, J = 247.5 Hz), 141.5 (d, J = 8.1 Hz), 136.2, 134.7 (d, J = 10.4 Hz), 124.8 (q, J = 
284.5 Hz), 124.7, 123.9 (d, J = 1.7 Hz), 123.13, 123.09 (q, J = 3.1 Hz), 120.6 (d, J = 15.3 Hz), 116.5 (d, 
J = 24.6 Hz), 113.8 (d, J = 23.5 Hz), 112.8, 111.4, 76.8 (q, J = 29.4 Hz). 19F NMR (376 MHz, CDCl3): 
δ -76.92, -110.91. HRMS-ESI: calc for C16H9ClF4NO– (M - H+)– 342.0314 and 344.0285, found 
342.0322 and 344.0300. 
 
1-(3.5-Dichlorophenyl)-2,2,2-trifluoro-1-(1H-indole-3-yl)ethanol (5r). A white solid (44.6 mg) was 
isolated. 1H NMR (500 MHz, CDCl3): δ 8.30 (bs, NH, 1H), 7.53-7.45 (m, 3H), 7.41 (d, J = 8.2 Hz, 1H), 
7.35 (t, J = 1.9 Hz, 1H), 7.25-7.17 (m, 2H), 7.02 (t, J = 7.3 Hz, 1H), 2.92 (bs, OH, 1H). 13C NMR (100 
MHz, CDCl3): δ 141.1, 136.2, 134.7, 128.9, 126.4 (d, J = 1.1 Hz), 124.8 (q, J = 284.6 Hz), 124.6, 123.2, 
123.1 (q, J = 3.1 Hz), 120.7, 120.5, 112.7, 111.4, 76.7 (q, J = 30.1 Hz). 19F NMR (376 MHz, CDCl3): δ 
-76.87. HRMS-ESI: calc for C16H9Cl2F3NO– (M - H+)– 358.0019 (35Cl/35Cl) and 359.9989 (35Cl/37Cl), 
found 358.0005 and 359.9989. 
 
2,2,2-Trifluoro-1-(1H-indole-3-yl)-1-2,3,4,5,6-pentafluorophenylethanol (5s). A white solid (14.8 mg) 
was isolated. 1H NMR (500 MHz, CDCl3): δ 8.32 (bs, NH, 1H), 7.46-7.38 (m, 2H), 7.28 (t, J = 8.1 Hz, 
1H), 7.25 (t, J = 7.8 Hz, 1H), 7.06 (t, J = 7.8 Hz, 1H), 3.32 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): 
δ 144.8 (dm, J = 253.9 Hz), 141.6 (dm, J = 255.3 Hz), 137.9 (dm, J = 251.7 Hz), 136.0, 128.8, 126.0, 
124.7, 123.2, 122.3 (m), 120.7, 119.2, 111.9 (t, J = 1.9 Hz), 111.7, 76.7 (q, J = 33.5 Hz). 19F NMR (376 
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MHz, CDCl3): δ -78.18 (t, J = 8.8 Hz), -136.48 (ddq, J = 4.3, 17.7 and 24.4 Hz), -151.82 (tt, J = 4.8 and 
21.8 Hz), -161.19 (m). HRMS-ESI: calc for C16H6F8NO– (M - H+)– 380.0327, found 380.0334. 
 
2-Chloro-2,2-difluoro-1-(1H-indole-3-yl)-1-phenylethanol (5t). A white solid (15.5 mg) was isolated. 
1H NMR (500 MHz, CDCl3): δ 8.24 (bs, NH, 1H), 7.65-7.58 (m, 2H), 7.54-7.50 (m, 1H), 7.38 (d, J = 
8.2 Hz, 1H), 7.36-7.30 (m, 3H), 7.23 (d, J = 8.0 Hz, 1H), 7.20-7.14 (m, 1H), 6.98-6.91 (m, 1H), 3.06 
(bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 138.1, 136.1, 131.4 (t, J = 300.5 Hz), 128.4, 128.0, 127.7, 
125.5, 123.2 (t, J = 3.7 Hz), 122.7, 131.1, 120.2, 114.6, 111.1, 80.6 (t, J = 25.2 Hz). 19F NMR (376 MHz, 
CDCl3): δ -60.54. HRMS-ESI: calc for C16H11ClF2NO– (M - H+)– 306.0503 and 308.0473, found 
306.0487 and 308.0506. 
 
2,2,2-Trifluoro-1-(1-methyl-indole-3-yl)-1-phenylethanol (5u). A white solid (30.4 mg) was isolated. 1H 
NMR (500 MHz, CDCl3): δ 7.65-7.58 (m, 2H), 7.38-7.30 (m, 5H), 7.22 (t, J = 7.2 Hz, 1H), 7.14 (d, J = 
8.0 Hz, 1H), 6.96 (t, J = 7.3 Hz, 1H), 3.85 (s, 3H), 2.83 (bs, OH, 1H). 13C NMR (100 MHz, CDCl3): δ 
137.8, 137.1, 128.4, 127.9, 127.8 (d, J = 2.8 Hz), 127.7, 125.7, 125.3 (q, J = 284.4 Hz), 122.3, 121.0, 
119.8, 112.4, 109.4, 77.0 (q, J = 29.4 Hz), 33.0. 19F NMR (376 MHz, CDCl3): δ -76.73. HRMS-ESI: 




3-(2,2,2-Trifluoro-1-(1H-indole-3-yl)-1-phenylyl)-1H-indole (6). 1H NMR (500 MHz, CDCl3): δ 8.08 
(bs, NH, 2H), 7.54 (d, J = 6.90 Hz, 2H), 7.37 (d, J = 8.2 Hz, 2H), 7.34-7.27 (m, 3H), 7.20 (d, J = 8.3 
Hz, 2H), 7.16 (t, J = 8.0 Hz, 2H), 6.97-6.91 (m, 2H), 6.88 (d, J = 2.6 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ 139.3, 136.7, 129.6 (d, J = 2.0 Hz), 127.9, 127.5, 126.7, 126.4, 126.3, 122.3 (q, J = 3.3 Hz), 
122.0, 119.7, 115.5, 111.1, 55.8. 19F NMR (376 MHz, CDCl3): δ -62.55. HRMS-ESI: calc for 




Chapter 4: Electrostatically Enhanced Phosphoric Acids and Their Applications in 
Asymmetric Friedel-Crafts Alkylations 
 
4.1. Introduction 
Over the past decade or so a large body of novel Brønsted acids have emerged as effective 
organocatalysts for a variety of organic transformations.1 These species are excellent alternatives to 
metal-containing catalysts as they typically are moisture and air tolerant, and are considered to be 
environmentally friendlier in nature.2 Among these Brønsted acid catalysts, phosphoric acids bearing a 
1,1'-bi-2-naphthol (BINOL) backbone have been extensively investigated. Hundreds of derivatives have 
been prepared as they provide a means for carrying out enantioselective acid-catalyzed processes.3 This 
includes asymmetric carbon-carbon bond forming transformations4 which are extremely valuable, but 
can be synthetically challenging to carry out.5 
BINOL-derived phosphoric acids are generally more active catalysts than other chiral Brønsted acids 
such as BINOL derivatives,6 thioureas,7 and α,α,α,α-tetraaryl-1,3-dioxolane-4,5-dimethanols 
(TADDOLs)8 due to their greater acidities.9 To broaden their scope and develop more reactive 
derivatives, several strategies have been employed. These include introducing electron withdrawing 
groups into the catalyst backbone,10 modifying the phosphate functional group (e.g., to 
phosphoramides),11 and employing acidic achiral additives.12  
More recently, incorporation of positively charged pyridinium ion centers without the introduction of 
new hydrogen bond donating sites were found to improve the catalytic abilities of phenols,13 thioureas,14 
and phosphoric acids15 by orders of magnitude. In addition, several chiral charge-activated thioureas 
were reported and found to display excellent reactivities and good enantioselectivities in Friedel-Crafts 
alkylations of indoles with trans-β-nitrostyrenes.16 Chiral phosphonium ion-containing (R)-BINOL-
derived phosphoric acids were also recently reported and found to give good to excellent 
enantioselectivities in the reactions of indoles with 2,2,2-trifluoroacetophenones.17 To build upon these 
efforts a number of new derivatives are reported, and both charged and noncharged catalysts were 







Figure 1. Catalysts used in this work; different counteranions for 2a were also studied. 
   
4.2. Results and Discussion 
Our study was initiated by synthesizing 1a and 1b, two (R)-BINOL derived phosphoric acids with N-
octylpyridinium groups at the 3,3'-backbone positions. A noncoordinating tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate anion (BArF4–) was incorporated as the counterion because it 
enhances reactivity and solubility in nonpolar media.15,18 Catalytic activities for the Friedel-Crafts 
alkylation of indole with trans-β-nitrostyrene were examined at different temperatures in CH2Cl2 with 
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a 10 mol % catalyst loading and 3 Å molecular sieves (MS) to remove adventitious moisture (Table 1). 
Disappointingly, the enantioselectivities were poor with the best results of only 21% and 16% ee at -30 
˚C for 1a and 1b, respectively (entries 1-6). These findings led us to examine bulky triaryl phosphonium 
ion derivatives 2a-2e as conveniently prepared alternatives.17,19 
 
Table 1. Optimizations of catalysts and reaction conditions.a 
 
entry cat. T (˚C) time (h) yield (%)b ee (%)c 
1 1a 20 24 70 -14 
2 1a 0 48 58 -16 
3 1a -30 73 26 -21 
4 1b 20 24 70 -12 
5 1b 0 48 64 -13 
6 1b -30 73 30 -16 
7 2a 20 8 59 35 
8 2a 0 24 50 36 
9 2a -30 46 38 40 
10 2b 20 5 68 50 
11 2b 0 24 75 59 
12 2b -30 46 81 70 
13 2c 20 5 67 36 
14 2c 0 24 71 46 
15 2c -30 46 83 61 
16 2d 20 5 69 34 
17 2d 0 24 73 46 
18 2d -30 46 85 61 
19 2e 20 5 73 47 
20 2e 0 24 63 51 
21 2e -30 46 60 57 
 
aReactions were performed with 0.1 mmol indole, 0.2 mmol trans-β-nitrostyrene, 0.01 mmol catalyst and 10 
mg of 3 Å MS in 0.5 mL of CH2Cl2. bIsolated yield. cDetermined by chiral HPLC. 
 
To our delight, the preliminary screening results for the phosphonium ion-tagged phosphoric acids 
(entries 7-21) revealed that they are both more reactive and enantioselective than their pyridinium ion-
containing analogues; intriguingly they also led to a reversal in the preferred enantiomer. The parent 
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derivative 2a only gave an ee of 35-40% at temperatures ranging from 20 to -30 ˚C (entries 7-9), but 
incorporation of p-methyl substituents on to each phenyl group led to significant improvements in the 
reaction conversions and stereoselectivities (entries 10-12). That is, over the same time period at -30 ˚C, 
the isolated yield increased from 38% to 81% and the ee improved from 40% to 70%. A further decrease 
in temperature to -50 ˚C was not practical in that less than a 10% conversion was observed after 48 
hours. Replacement of the p-methyl groups by larger ethyl or n-propyl substituents had little impact on 
the product yield, but led to ~10-15% lower ee values over the studied temperature range (entries 13-
18). 
To address whether the improvement in the stereoselectivity brought about by the p-methyl groups is 
due to steric or electronic effects, the diphenyl(p-tolyl)phosphonium ion-tagged BINOL phosphoric acid 
2e was prepared and investigated. Its steric requirements should be very similar to those of the 
unsubstituted phosphoric acid 2a because the Ar3P group can rotate readily enabling any unfavorable 
interactions brought about by the methyl group to be minimized. Electronically, 2e should be 
intermediate in behavior to 2a and 2b since these compounds have 2, 0 and 6 methyl groups, respectively. 
The observed enantioselectivities with 2e at 20, 0 and -30 ˚C (entries 19-21) are between the results for 
2a and 2b. This indicates that the larger ee values for 2b compared to 2a are primarily due to the electron 
donating effects of the six methyl groups in the former compound. 
The effect of the counterion was examined next by taking the chloride anion precursor to 1a and 





BArF4– salt 2a at -30 ˚C and their reactivity order is as follows: BF4– < PF6– < B(C6F5)4– < BArF4– (Table 
2). The resulting enantioselectivities also seem to track with this order and is as follows: BF4– ≈ PF6– < 
B(C6F5)4– < BArF4–. Consequently, all of the remaining experiments were carried out with BArF4– salts. 
 
Table 2. Counteranion screening results.a 
 
entry cat. time (h) yield (%)b ee (%)c 
1 2f 48 18 <1 
2 2g 48 23 <1 
3 2h 48 33 33 
4 2a 46 38 40 
 
aReactions were performed at -30 ˚C with 0.1 mmol indole, 0.2 mmol trans-β-nitrostyrene, 0.01 mmol of the 
indicated catalyst and 10 mg of 3 Å MS in 0.5 mL of CH2Cl2. bIsolated yield. cDetermined by chiral HPLC. 
 
Reaction additives and media were explored next at -30 ˚C with 2b as the catalyst (Table 3). Lower 
yields and enantioselectivities were found for the reactions carried out without MS or with additives 
other than 3 Å MS (entries 2-5). Of the single component solvents that were examined with 3 Å MS 
(entries 1 and 6-11), CH2Cl2 gave both the highest yield and ee; 81% and 70%, respectively. 1,2-
Dichloroethane (DCE) and chlorobenzene are somewhat worse media for this transformation in terms 
of both the yield and enantioselectivity, but the results in CHCl3 surprisingly are much poorer (i.e., a 
54% yield and an ee of 41% were obtained; entries 1 and 6-8). Hydrogen bond accepting solvents such 
as EtOAc and THF completely deactivate the catalyst shutting down product formation (entries 9-10). 
Benzonitrile, a weaker hydrogen bond acceptor than the two oxygen-containing solvents, does not retard 
the catalyst as strongly (entry 11). It still is a very ineffective medium, and affords the product with a 
7% lower ee than in CH2Cl2.  
In an attempt to improve these results, a number of binary solvent mixtures with a less polar 
component (i.e., benzene, toluene, m-xylene, and carbon tetrachloride) were tested (entries 12-17). A 




Table 3. Reaction medium screening.a 
 
entry solvent time (h) yield (%)b ee (%)c 
1 CH2Cl2 46 81 70 
2d CH2Cl2 47 54 67 
3e CH2Cl2 48 73 57 
4f CH2Cl2 48 62 57 
5g CH2Cl2 48 61 62 
6 DCEh 46 73 63 
7 C6H5Cl 45 77 64 
8 CHCl3 45 54 41 
9 EtOAc 164 trace – 
10 THF 164 trace – 
11 C6H5CN 140 43 63 
12 CH2Cl2/C6H6 1:1 46 76 71 
13 CH2Cl2/C6H5CH3 1:1 47 83 66 
14 CH2Cl2/m-xylene 1:1 47 76 63 
15 CH2Cl2/CCl4 1:1 48 86 70 
16 CH2Cl2/C6H6 1:2 50 88 72 
17 1,2-DCE/C6H6 1:1 45 77 65 
 
aReactions were performed at -30 ˚C with 0.1 mmol indole, 0.2 mmol trans-β-nitrostyrene, 0.01 mmol of 2b 
and 10 mg of 3 Å MS (unless otherwise noted) in 0.5 mL of the specified solvent; mixtures are on a volume 
to volume basis. bIsolated yield. cDetermined by chiral HPLC. dNo MS were used. e10 mg of 4 Å MS were 
used. f10 mg of 5 Å MS were used. g10 mg of 13X MS were used. hDCE = 1,2-dichloroethane. 
 
to the former solvent (entry 12). The opposite trend was observed with a 1:1 CH2Cl2/toluene mixture in 
that the yield was 2% higher but the ee dropped 4% (entry 13). Unfortunately, m-xylene was ineffective 
as a cosolvent in both regards and led to a ~6% decrease in the yield and ee (entry 14). Carbon 
tetrachloride and dichloromethane in a 1:1 ratio gave an improved yield (86%) without affecting the ee 
(entry 15). Higher proportions of benzene were also investigated since it is the only cosolvent that led 
to a higher observed ee. A 1:2 CH2Cl2/C6H6 mixture afforded our best result, an 88% isolated yield and 
a 72% ee (entry 16). A further increase in benzene to a 1:3 solvent combination is not feasible because 
the catalyst does not dissolve in this medium. Finally, a previously reported 1:1 DCE/C6H6 solvent 
combination was examined,20 but it led to a reduction in both the yield and enantioselectivity (entry 17). 
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Under our optimal conditions, the reactivity of charged catalyst 2b was compared to two similar and 
well-established noncharged analogues, (R)-3,3'-bis(2,4,6-triisopropylphenyl)-BINOL phosphoric acid 
(TRIP, 3a)21 and (R)-3,3'-bis(triphenylsilyl)-BINOL phosphoric acid (3b, Figure 1).22 The reactions of 
indole with trans-β-nitrostyrene were followed at the same three time points by 1H NMR spectroscopy, 
and enantioselectivies were measured by chiral HPLC. Second-order rate constants and the resulting ee 
values are given in Table 4. Both TRIP and its 3,3'-bis(triphenylsilyl) analogue are equally effective in 
this transformation with k = 0.030 ± 0.003 M–1 h–1 and ee values of 49% and 48%, respectively (entries 
1 and 2). The charged triarylphosphonium ion-containing catalyst 2b was found to be ~5 times more 
reactive and significantly more selective with an ee of 72% (entry 3). 
 
Table 4. Comparison of charged and noncharged catalysts.a 
 
entry cat. k (M–1 h–1)b ee (%)c 
1 3a 2.7 x 10–2 49 
2 3b 3.3 x 10–2 48 
3 2b 1.6 x 10–1 72 
 
aReactions were carried out at -30 ˚C with 0.1 mmol indole, 0.2 mmol trans-β-nitrostyrene, 0.01 mmol of 2b 
and 10 mg of 3 Å MS in 0.5 mL of a 1:2 CH2Cl2/C6H6 mixture. bDetermined by 1H NMR. cMeasured by 
chiral HPLC. 
  
The scope of this reaction was also addressed (eq 3), and the results are summarized in Table 5. A 
wide range of indoles (4a-4k) and trans-β-nitrostyrenes (5a-5f) bearing electron-donating and electron-
withdrawing groups are tolerated and afford high conversions (75 - >99%) with enantiomeric excesses 
ranging from 60-90%. Indoles 4b-4d and 4f with an electron-withdrawing halogen atom at the 5- or 6-
position react more slowly than the parent compound (i.e., 4a) and afforded ~10% lower conversions 
after an ~33% longer time period, but had little impact upon the ee (i.e., the values ranged from 69-73%, 
entries 1-4 and 6). A chlorine atom at the 7-position (4e) behaved differently in that it had a bigger 






needed to produce the product but it also was formed with an increased ee of 83%. An electron donating 
methoxy substituent at the 5- or 6-position (4g and 4h) accelerated the transformation as expected, led 
to high conversions of 97 and 96%, respectively in shorter time periods, and had little effect (± 4%) on 
the observed ee (entries 7 and 8). Alkyl groups at the 6- and 7-positions (4i-4k) also led to very efficient 
transformations but had little impact on the speed of the transformation (entries 9-11). A methyl group, 
however, was found to have the largest influence on the enantioselectivity of all the substituents that 
were studied. 6-Methylindole (4i) gave the smallest ee (60%) in the reaction with trans-β-nitrostyrene 
whereas its 7-methyl isomer (4j) afforded the highest value (90% ee). 7-Ethylindole (4k) also displayed 
good enantioselectivity (85% ee), but it is not as large as when the smaller methyl-containing indole 
was used. These results indicate that subtle changes in the location and size of an indole substituent can 
influence the product selectivity, and that incorporation of a chlorine, methyl or ethyl group at the 7-
position is particularly favorable from a stereochemical point of view. Incorporation of electron-
withdrawing halogen atoms or an electron-donating methoxy group into the aromatic ring of trans-β-




Table 5. Substrate scope.a 
 
entry reactants pdt time (h) conv. (%)b ee (%)c 
1 4a + 5a 6a 50 88 72 
2 4b + 5a 6b 68 81 72 
3 4c + 5a 6c 66 75 73 
4 4d + 5a 6d 66 79 70 
5 4e + 5a 6e 114 88 83 
6 4f + 5a 6f 68 78 69 
7 4g + 5a 6g 40 97 68 
8 4h + 5a 6h 39 96 76 
9 4i + 5a 6i 47 92 60 
10 4j + 5a 6j 58 99 90 
11 4k + 5a 6k 58 98 85 
12d,f 4a + 5b 6l 64 >99 74 
13 4a + 5c 6m 39 >99 65 
14 4a + 5d 6n 39 >99 74 
15e,g 4a + 5e 6o 64 >99 70 
16d 4a + 5f 6p 68 91 79 
17h 4j + 5a 6j 64 >99 90 
 
aReactions were carried out at -30 ˚C with 0.1 mmol of the indole, 0.2 mmol of the trans-β-nitrostyrene, 0.01 
mmol of 2b and 10 mg of 3 Å MS in 0.5 mL of a 1:2 CH2Cl2/C6H6 mixture. bDetermined by 1H NMR. 
cMeasured by chiral HPLC. dA 1:1 CH2Cl2/C6H6 mixture was used as the solvent. eA 2:1 CH2Cl2/C6H6 
mixture was used as the solvent. fThis reaction was run at half of the typical concentrations. gThis reaction 
was run at 2/3 of the usual concentrations in 1 mL of solvent and with 20 mg of 3 Å MS. hThis reaction was 
scaled up by a factor of 10. 
 
12-16). The products were formed with moderate ee ranging from 70-79% except for 5c, which led to 
a lower value of 65%, presumably because of the ortho chlorine atom. The reaction of 4j with 5a was 
also scaled up by a factor of 10 (entry 17) to afford >250 mg of product without any loss in the yield or 
ee. 
1-Methylindole (4l) was explored to investigate the role of the N–H •• O=P hydrogen bond in the 
reaction of indole with trans-β-nitrostyrene since this interaction is blocked in this case. This change 
resulted in a reduction in the yield from 81% to 5% and in the ee from 70% to 30% under the same 
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reaction conditions.23 These results indicate that the hydrogen bond between indole and the phosphoryl 
oxygen of the phosphoric acid is important both in terms of the reaction efficiency and stereoselectivity. 
A kinetic study with catalytic loadings of 2b ranging from 5-20 mol % was also carried out. A plot of 
the second-order rate constants vs. the mol % of the catalyst is linear indicating a first-order dependence 
on the catalyst concentration (Figure 2). Alternatively, the same conclusion is reached by carrying out a 
normalized time scale analysis.24 Interestingly, even though the background process is not competitive, 
the ee was found to correlate with the catalyst loading. That is, when 5, 10 and 20 mol % of 2b, were 
used, ee values of 60%, 70% and 73% were observed. This may be due to the changes in the medium 
arising from differences in the catalyst concentration since it is a soluble salt. These results, nevertheless, 
suggest that the operating mechanism is analogous to noncharged phosphoric acid derivatives,20b and 
that a pair of hydrogen bond interactions play a key role in the efficiency and stereoselectivity of this 




Figure 2. Linear least squares fit of second-order rate constants vs the catalyst (2b) mol %; k (M–1 h–1) 






Figure 3. Proposed Friedel-Crafts alkylation transition state. 
  
4.3. Conclusion 
In summary, we demonstrated the successful synthesis of a series of electrostatically enhanced 
pyridinium-containing and phosphonium ion-tagged phosphoric acids, and studied their catalytic 
performance in the Friedel-Crafts alkylation of indoles with trans-β-nitrostyrenes. Unfortunately, the 
pyridinium-containing phosphoric acids failed to afford high stereoselectivity. On the other hand, the 
phosphonium ion-containing phosphoric acids are good catalysts for a wide range of substrates, 
promoting higher reactivities and enantioselectivities than their noncharged analogues. Charge activated 
organocatalysts consequently continue to show promise in the development of new hydrogen bond and 
Brønsted acid catalysts. 
 
4.4. Experimental 
4.4.1. Materials and General Methods 
All the reagents used in this work were obtained from commercial sources and used without further 
purification. Reaction solvents were dried with oven-activated 3 Å molecular sieves. Proton and carbon 
chemical shifts are reported in ppm (δ) based upon internal reference signals from the solvent: CDCl3 
(7.26 and 77.0 δ) and CD2Cl2 (5.32 and 54.0 δ). For 19F and 31P, external calibrants were used as follows: 
CF3COOH (-76.55 δ) and 85% aqueous H3PO4 (0.00 δ). High-resolution electrospray ionization mass 
spectra (HRMS-ESI) were obtained with a time of flight (TOF) instrument using methanol solutions 
and polyethylene glycol (PEG) or polypropylene glycol (PPG) as an internal standard. HPLC analyses 
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were carried out on chiral RegisCell and RegisPack columns. 
 
4.4.2. Synthesis Procedures. 
(R)-2,2'-Bis(ethoxymethoxy)-1,1'-binaphthyl (7).26 (R)-1,1'-Bi-2-naphthol (0.50 g, 1.75 mmol) was 
transferred into a 250 mL round-bottomed flask under a dry nitrogen atmosphere, and 20 mL of 
anhydrous THF was added via syringe. The resulting solution was stirred and cooled to -20 ˚C before 
adding 0.43 g (3.83 mmol) of potassium tert-butoxide in one portion. This mixture was stirred for 15 
min before 0.35 mL (0.356 g, 3.83 mmol) chloromethyl ethyl ether was syringed in over 5 min. The 
resulting solution was allowed to warm to room temperature and stirred for 1 hour, after which brine 
(30 mL) was added to quench the reaction and the solvent was removed under vacuum. Ethyl acetate 
(30 mL x 3) was used to extract the crude product and the combined organic material was washed with 
water (30 mL x 2) and brine (30 mL), dried over MgSO4, and concentrated to give a yellow oil. 
Purification by MPLC was carried out using the following protocol: a hexanes wash with a flow rate of 
40 mL min–1 was carried out for 5 min, then the eluent was switched via a linear gradient over the course 
of 5 min to 1:1 hexanes/CH2Cl2 and maintained for 20 min. The last fraction was concentrated to afford 
0.47 g (67%) of the product as a colorless viscous oil. 1H NMR (500 MHz, CD2Cl2) δ 8.01 (d, J = 9.0 
Hz, 2H), 7.94 (d, J = 8.2 Hz, 2H), 7.68 (d, J = 9.1 Hz, 2H), 7.40 (t, J = 7.8 Hz, 2H), 7.28 (t, J = 7.6 Hz, 
2H), 7.23 (d, J = 8.5 Hz, 2H), 5.21 (d, J = 7.0 Hz, 2H), 5.09 (d, J = 7.0 Hz, 2H), 3.51-3.36 (m, 4H), 1.07 
(t, J = 7.1 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 152.8, 134.0, 129.8, 129.3, 127.8, 126.2, 125.5, 
123.9, 121.2, 117.4, 93.8, 63.9, 14.8. HRMS-ESI: calc for C26H26O4Na+ (M + Na+)+ 425.1729, found 
425.1748. 
(R)-3,3'-dibromo-2,2'-bis(ethoxymethoxy)-1,1'-binaphthyl (8). (R)-2,2'-Bis(ethoxymethoxy)-1,1'-
binaphthyl (7, 3.10 g, 7.70 mmol) was dissolved into 50 mL of diethyl ether in a 250 mL round-bottomed 
flask under a dry nitrogen atmosphere, after which n-butyllithium (9.25 mL, 2.5 M in hexane, 23.1 
mmol) was added dropwise at room temperature. The resulting solution was stirred for 2 h before being 
cooled to -20 ˚C and slowly adding 1,2-dibromotetrachloroethane (7.52 g, 23.1 mmol) in THF (30 mL). 
Upon warming to room temperature and stirring overnight, the reaction was quenched with 30 mL of 
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brine. Removal of the solvents with a rotary evaporator afforded a residue which was extracted with 
EtOAc (30 mL x 3). The combined organic material was washed with 30 mL of water and 30 mL of 
brine, and then dried over MgSO4. Evaporation of the solvent under vacuum gave a yellow solid which 
was purified by MPLC; hexanes were used for 2 min. then a linear gradient to a 9:1 hexanes/EtOAc 
mixture was applied over a 3 min period, and this binary solution was maintained until the product 
eluted off the column. It was concentrated under reduced pressure to afford 3.88 g (90%) of a white 
solid (mp 107 – 113 ˚C). 1H NMR (500 MHz, CDCl3) δ 8.27 (s, 2H), 7.81 (d, J = 8.2 Hz, 2H), 7.43 (t, 
J = 7.7 Hz, 2H), 7.30 (t, J = 8.2 Hz, 2H), 7.17 (d, J = 8.5 Hz, 2H), 4.91 (d, J = 5.9 Hz, 2H), 4.84 (d, J = 
5.9 Hz, 2H), 3.08-2.98 (m, 2H), 2.72-2.62 (m, 2H), 0.60 (t, J = 7.1 Hz, 6H). 13C NMR (100 MHz, CDCl3) 
δ 150.2, 133.0, 132.9, 131.5, 127.2, 127.0, 126.9, 126.5, 126.0, 117.5, 97.9, 64.8, 14.3. HRMS-ESI: calc 
for C26H24O4Br2Na+ (M + Na+)+ 582.9919, found 582.9899. 
General procedure for the synthesis of 9a-9b. (R)-3,3'-Dibromo-2,2'-bis(ethoxymethoxy)-1,1'-
binaphthyl (8) (0.70 g, 1.25 mmol), 3-pyridinylboronic acid (0.54 g, 4.37 mmol) [or 5-methylpyridine-
3-boronic acid (0.60 g, 4.37 mmol)] and tetrakis(triphenylphosphine)palladium (0.14 g, 0.13 mmol) 
were mixed together in a 250 mL round-bottomed flask and then dissolved in degassed 1,2-
dimethoxylethane (8 mL), after which 3.3 mL of a 2.0 M aqueous Na2CO3 solution was added. The 
resulting mixture was refluxed at 93 ˚C with stirring for 16 h and upon cooling to room temperature the 
volatiles were removed with a rotary evaporator. Dichloromethane (30 mL x 3) was used to extract the 
resulting residue and the combined organic solutions were washed with 30 mL of saturated NH4Cl and 
30 mL of brine before being dried over Na2SO4. Concentration of this material under vacuum gave a 
yellow oil that was purified by MPLC using EtOAc as the eluent. The resulting white solid was 
dissolved in 5 mL of ethanol and then 1.5 mL of 6.0 M HCl was added dropwise over 5 min with stirring. 
After 3 h at room temperature a white precipitate had formed and the reaction was quenched with 30 
mL of aqueous NaHCO3. A rotary evaporator was used to remove the ethanol and the remaining material 
was extracted with EtOAc (50 mL x 2). The combined organic layers were washed with water and brine, 
and then dried over Na2SO4. Concentration of this solution afforded a viscous yellow liquid that was 
purified by MPLC with EtOAc as the eluent. 
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(R)-3,3'-Di(3-pyridyl)-2,2'-dihydroxyl-1,1'-binaphthyl (9a). This compound was obtained as a white 
solid (0.40 g) in a 73% yield (mp 206 - 212 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 11.42 (s, 2H), 9.10 (s, 
2H), 7.72 (d, J = 7.8 Hz, 2H), 7.58 (d, J = 7.1 Hz, 2H), 7.35-7.25 (m, 4H), 7.23-7.15 (m, 4H), 6.77 (dd, 
J = 5.0 and 7.6 Hz, 2H), 6.58 (d, J = 4.3 Hz, 2H). 13C NMR (100 MHz, CD2Cl2) δ 152.7, 150.2, 144.8, 
135.7, 135.6, 134.6, 130.5, 129.6, 129.4, 128.9, 127.2, 125.1, 123.5, 123.3, 116.1. HRMS-ESI: calc for 
C30H21N2O2+ (M + H+)+ 441.1603, found 441.1588. 
(R)-3,3'-Di[3-(5-methyl)pyridyl]-2,2'-dihydroxyl-1,1'-binaphthyl (9b). This species was obtained as 
a white solid (0.42 g) in a 72% yield (mp 201 - 208 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 11.68 (s, 2H), 
8.89 (s, 2H), 7.59 (d, J = 8.8 Hz, 2H), 7.52 (s, 2H), 7.33-7.26 (m, 4H), 7.19 (d, J = 9.3 Hz, 2H), 7.17 
(s, 2H), 6.30 (s, 2H), 2.03 (s, 6H). 13C NMR (100 MHz, CD2Cl2) δ 152.9, 147.7, 145.2, 136.0, 135.6, 
134.0, 132.7, 130.2, 129.8, 129.7, 128.5, 127.0, 125.1, 123.2, 116.0, 18.7. HRMS-ESI: calc for 
C32H25N2O2+ (M + H+)+ 469.1916, found 469.1933.  
General procedure for the synthesis of 10a-10b. Compound 9a or 9b (0.227 mmol) was added into a 
100 mL round-bottomed flask under an atmosphere of dry nitrogen and then was dissolved in 15 mL of 
anhydrous acetonitrile. After stirring for 5 min, 0.164 mL of 1-iodooctane (0.218 g, 0.908 mmol) was 
syringed into the flask in one portion and the solution was heated to 100 ˚C and refluxed overnight. 
Upon cooling to room temperature, the reaction mixture was concentrated under vacuum. The crude 
product was dissolved in 5 mL of CH2Cl2 and triturated by adding it dropwise to 100 mL of hexanes. 
Filtration of the resulting precipitate and a subsequent wash with hexanes gave the desired product. 
(R)-3,3'-Di(3-N-octylpyridinium)-2,2'-dihydroxyl-1,1'-binaphthyl iodide (10a). A yellow solid (0.16 
g) was obtained in a 77% yield (mp 278 - 282 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 9.98 (s, 2H), 8.86-
8.77 (m, 4H), 8.34 (s, 2H), 8.10-8.01 (m, 4H), 7.43 (t, J = 7.2 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 7.14 (d, 
J = 8.5 Hz, 2H), 4.80-4.65 (m, 4H), 2.09-1.98 (m, 4H), 1.40-1.18 (m, 22H), 0.82 (t, J = 6.6 Hz, 6H). 13C 
NMR (100 MHz, CD2Cl2) δ 149.7, 146.4, 145.6, 145.5, 142.0, 139.6, 135.0, 132.6, 130.1, 129.5, 128.9, 
128.5, 125.6, 125.1, 118.6, 62.7, 32.3, 32.2, 29.50, 29.48, 26.5, 23.1, 14.4. HRMS-ESI: calc for 
C46H53N2O2+ (M - H+ - 2I–)+ 665.4107, found 665.4139. 
(R)-3,3'-Di(3-(N-octyl-5-methyl)pyridinium)-2,2'-dihydroxyl-1,1'-binaphthyl iodide (10b). A yellow 
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solid (0.19 g) was obtained in an 88% yield (mp 265 - 270 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 9.86 (s, 
2H), 8.71 (s, 2H), 8.65 (s, 2H), 8.30 (s, 2H), 8.04 (d, J = 7.9 Hz, 2H), 7.45 (t, J = 7.8 Hz, 2H), 7.35 (t, J 
= 8.3 Hz, 2H), 7.14 (d, J = 8.3 Hz, 2H), 6.53 (s, 2H), 4.79-4.62 (m, 4H), 2.67 (s, 6H), 2.12-2.00 (m, 4H), 
1.42-1.18 (m, 20H), 0.83 (d, J = 6.8 Hz, 6H). 13C NMR (100 MHz, CD2Cl2) δ 149.5, 146.2, 144.2, 141.3, 
139.8, 139.0, 135.0, 132.5, 130.2, 129.5, 128.9, 125.7, 125.3, 125.1, 118.5, 62.5, 32.3, 32.2, 29.53, 29.51, 
26.5, 23.1, 19.2, 14.4. HRMS-ESI: calc for C48H57N2O2+ (M - H+ - 2I–)+ 693.4420, found 693.4401. 
General procedure for the synthesis of 11a-11b. Iodide salt 10a or 10b (0.218 mmol) was dissolved 
into 20 mL of anhydrous acetonitrile under a N2 atmosphere and 64 μL (0.10 g, 0.654 mmol) of POCl3 
was added with stirring in one portion followed by 44 μL (0.044 g, 0.544 mmol) of anhydrous pyridine. 
The resulting solution was heated to 90 ˚C and refluxed for 16 h before cooling to room temperature 
and adding 0.5 mL of water. This material was heated back to 90 ˚C for 1 h and then allowed to return 
to room temperature. Removal of the solvent under vacuum afforded a residue which was dissolved in 
40 mL of CH2Cl2 and washed with 2.0 M HCl (15 mL), 15 mL of brine and then dried over Na2SO4. 
Rotary evaporation of this material gave a brown oil that was purified by MPLC. A linear gradient from 
EtOAc to a 1:1 EtOAc/MeOH mixture over 10 min followed by a 10 min wash with this solution eluted 
the product. This material was concentrated under reduced pressure to give the desired compound as a 
yellow solid. 
(R)-3,3'-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(1-
octylpyridin-1-ium) chloride (11a). This compound (0.12 g) was generated in a 69% yield (mp 195 - 
202 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 10.38 (s, 2H), 9.11 (d, J = 5.6 Hz, 2H), 8.82 (d, J = 7.7 Hz, 
2H), 8.20 (s, 2H), 8.08-7.95 (m, 4H), 7.48 (t, J = 7.3 Hz, 2H), 7.30 (t, J = 7.9 Hz, 2H), 7.19 (d, J = 8.7 
Hz, 2H), 4.86-4.60 (m, 4H), 2.19 (bs, OH, 1H) 2.10-1.93 (m, 4H), 1.37-1.15 (m, 20H), 0.82 (t, J = 6.7 
Hz, 6H). 13C NMR (100 MHz, CD2Cl2) δ 155.31, 155.26, 153.64, 153.58, 137.64, 137.58, 137.0, 136.7, 
136.6, 129.7, 128.7, 123.9, 123.8, 121.0, 120.9, 63.0, 32.2, 32.1, 29.5, 29.4, 26.6, 23.1, 14.4. 31P NMR 





1-octylpyridin-1-ium) chloride (11b). This compound (0.15 g) was produced in an 83% yield (mp 194 - 
200 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 10.25 (s, 2H), 9.19 (s, 2H), 8.62 (s, 2H), 8.20 (s, 2H), 8.02 (d, 
J = 8.2 Hz, 2H), 7.47 (t, J = 7.1 Hz, 2H), 7.30 (t, J = 8.5 Hz, 2H), 7.21 (d, J = 8.6 Hz, 2H), 4.72 (t, J = 
7.3 Hz, 4H), 2.63 (s, 6H), 2.54 (bs, OH, 1H), 2.15-1.95 (m, 4H), 1.45-1.14 (m, 20H), 0.82 (t, J = 6.8 Hz, 
6H). 13C NMR (100 MHz, CD2Cl2) δ 147.2, 146.5, 144.7, 142.6, 139.7, 138.8, 133.9, 132.5, 131.0, 
129.4, 128.1, 127.6, 127.3, 126.4, 124.0, 62.6, 32.3, 32.1, 29.6, 29.5, 26.7, 23.1, 19.0, 14.4. 31P NMR 
(162 MHz, CD2Cl2) δ 6.19. HRMS-ESI: calc for C48H56N2O4P+ (M - H+ - 2Cl–)+ 755.3978, found 
755.4002.  
General procedure for the synthesis of 1a-1b. Chloride salt 11a or 11b (0.0755 mmol), sodium 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (0.141 g, 0.159 mmol) and 3 Å molecular sieves (0.10 g) 
were mixed in a 23 x 85 mm vial, and then 7 mL of CH2Cl2 was added. The resulting solution was 
stirred at room temperature for 3 h before being filtered through a 0.45 μm polytetrafluoroethylene 
(PTFE) membrane. The filtered solution was washed with 2.0 M H2SO4 (7 mL x 2) and water (7 mL x 
3), and then was dried over Na2SO4 before being concentrated to afford the product. 
(R)-3,3'-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(1-
octylpyridin-1-ium) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (1a). A yellow solid (0.17 g) was 
formed in a 92% yield (mp 77 - 81 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 9.54 (s, 2H), 8.90 (d, J = 7.8 
Hz, 2H), 8.29 (d, J = 5.9 Hz, 2H), 8.12 (s, 2H), 8.06 (d, J = 8.3 Hz, 2H), 8.00 (dd, J = 5.9 and 7.9 Hz, 
2H), 7.77 (s, 16H), 7.65-7.57 (m, 10H), 7.47 (t, J = 8.3 Hz, 2H), 7.35 (d, J = 8.8 Hz, 2H), 4.62-4.44 (m, 
4H), 2.60 (bs, OH, 1H) 2.07-1.93 (m, 4H), 1.36-1.21 (m, 20H), 0.84 (t, J = 6.9 Hz, 6H). 13C NMR (100 
MHz, CD2Cl2) δ 162.4 (q, J = 48.9 Hz), 147.1, 145.7, 145.4, 141.4, 140.7, 140.5, 135.5, 134.0, 133.1, 
131.3, 129.5 (qq, J = 2.92 and 31.4 Hz), 128.6, 127.9, 127.7, 127.2, 125.9, 125.2 (q, J = 270 Hz), 124.1, 
118.2 (septet, J = 3.64 Hz), 63.9, 32.1, 32.0, 29.4, 29.3, 26.6, 23.0, 14.2. 19F NMR (376 MHz, CD2Cl2) 
δ -62.68. 31P NMR (162 MHz, CD2Cl2) δ 6.76. HRMS-ESI: calc for C46H52N2O4P+ (M - H+ - 2BArF4–)+ 
727.3665, found 727.3679.  
(R)-5,5'-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(3-methyl-
1-octylpyridin-1-ium) tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (1b). A yellow solid (0.17 g) was 
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generated in a 91% yield (mp 54 - 58 ˚C). 1H NMR (500 MHz, CD2Cl2) δ 9.06 (s, 2H), 8.55 (s, 2H), 
8.21 (s, 2H), 8.13 (s, 2H), 8.06 (d, J = 7.8 Hz, 2H), 7.74 (s, 16H), 7.63 (t, J = 7.1 Hz, 2H), 7.56 (s, 8H), 
7.48 (t, J = 8.5 Hz, 2H), 7.34 (d, J = 8.3 Hz, 2H), 4.83 (bs, OH, 1H), 4.45 (t, J = 7.3 Hz, 4H), 2.55 (s, 
6H), 2.07-1.90 (m, 4H), 1.36-1.17 (m, 20H), 0.82 (t, J = 6.8 Hz, 6H). 13C NMR (100 MHz, CD2Cl2) δ 
162.3 (q, J = 49.6 Hz), 147.6, 143.9, 142.5, 141.6, 141.3, 139.0, 135.4, 133.65, 133.63, 131.7, 129.5 
(qq, J = 2.92 and 31.4 Hz), 128.4, 127.3, 125.47, 125.45, 125.2 (q, J = 270 Hz), 123.58, 123.56, 118.1 
(septet, J = 3.64 Hz), 63.7, 32.1, 32.0, 29.4, 29.3, 26.6, 23.0, 19.1, 14.2. 19F NMR (376 MHz, CD2Cl2) 
δ -62.76. 31P NMR (162 MHz, CD2Cl2) δ 5.68. HRMS-ESI: calc for C48H56N2O4P+ (M - H+ - 2BArF4–)+ 
755.3978, found 755.3998. 
General procedure for the synthesis of 2f-2g. In a 23 x 85 mm vial, (R)-(4-hydroxy-4-
oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(triphenylphosphonium) chloride 
(0.188 g, 0.200 mmol), sodium tetrafluoroborate (0.046 g, 0.420 mmol) or potassium 
hexafluorophosphate (0.077 g, 0.420 mmol) and 3 Å molecular sieves (0.50 g) were mixed together and 
then 3 mL of methanol was added. After stirring at room temperature for 2 h, 10 mL of CH2Cl2 was 
added and the reaction was stirred for an additional 1 h before filtering the solution through a 0.45 μm 
PTFE membrane. The solvent was removed under vacuum and the residue was redissolved in 8 mL of 
CH2Cl2. It was then washed twice with 8 mL of 2.0 M H2SO4 and three times with 8 mL of water before 
being dried over Na2SO4. Concentration of the solution under reduced pressure afforded the desired 
product. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(triphenyl-
phosphonium) tetrafluoroborate (2f). A yellow solid (0.141 g) was afforded in a 67% yield (mp 233 – 
236 ˚C). 1H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 16.3 Hz, 2H), 7.87 (d, J = 7.7 Hz, 2H), 7.83-7.72 
(m, 18H), 7.68-7.62 (m, 12H), 7.57-7.48 (m, 4H), 7.28 (d, J = 8.3 Hz, 2H), 1.25 (bs, OH, 1H). 13C NMR 
(100 MHz, CDCl3) δ 150.7 (d, J = 9.9 Hz), 141.0 (d, J = 8.4 Hz), 136.2 (d, J = 2.4 Hz), 135.03, 134.95 
(d, J = 10.5 Hz), 131.0, 130.0 (d, J = 13.1 Hz), 129.8, 129.2 (d, J = 14.3 Hz), 127.0, 126.5, 124.5 (d, J 
= 10.1 Hz), 118.9 (d, J = 90.4 Hz), 110.8 (d, J = 91.0 Hz). 19F NMR (376 MHz, CD2Cl2) δ -154.11. 31P 





phosphonium) hexafluorophosphate (2g). A yellow solid (0.177 g) was produced in a 76% yield (mp 
225 – 230 ˚C). 1H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 16.3 Hz, 2H), 7.88 (d, J = 7.7 Hz, 2H), 7.81-
7.72 (m, 18H), 7.68-7.62 (m, 12H), 7.58-7.50 (m, 4H), 7.28 (d, J = 8.3 Hz, 2H), 2.11 (bs, OH, 1H). 13C 
NMR (100 MHz, CDCl3) δ 144.7 (d, J = 8.6 Hz), 141.0 (d, J = 8.4 Hz), 136.2 (d, J = 2.9 Hz), 135.1, 
135.0 (d, J = 10.6 Hz), 131.0, 130.1 (d, J = 13.2 Hz), 129.8, 129.2 (d, J = 14.4 Hz), 127.0, 126.5, 124.5 
(d, J = 7.0 Hz), 118.9 (d, J = 90.5 Hz), 110.7 (d, J = 91.1 Hz). 19F NMR (376 MHz, CDCl3) δ -73.62 (d, 
J = 712 Hz). 31P NMR (162 MHz, CDCl3) δ 22.94, 0.77, -144.43 (septet, J = 712 Hz). HRMS-ESI: calc 
for C56H40O4P3+ (M - H+ - 2PF6–)+ 869.2134, found 869.2155. 
(R)-(4-Hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(triphenyl-
phosphonium) tetrakis(pentafluorophenyl)borate (2h). In a 23 x 85 mm vial, (R)-(4-hydroxy-4-
oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-2,6-diyl)bis(triphenylphosphonium) chloride 
(0.188 g, 0.200 mmol), potassium tetrakis(pentafluorophenyl)borate (0.302 g, 0.420 mmol) and 3 Å 
molecular sieves (0.50 g) were mixed together and then 8 mL of CH2Cl2 was added. The solution was 
stirred at room temperature for 3 h and then filtered through a 0.45 μm PTFE membrane. It was 
subsequently washed twice with 2.0 M H2SO4 and three times with water before being dried over 
Na2SO4. Removal of the CH2Cl2 gave 2h as a yellow solid (0.337 g) in a 76% yield (mp 178 – 182 ˚C). 
1H NMR (500 MHz, CD2Cl2) δ 8.10 (d, J = 16.5 Hz, 2H), 7.91 (d, J = 8.1 Hz, 2H), 7.84-7.77 (m, 6H), 
7.77-7.69 (m, 12H), 7.69-7.59 (m, 14H), 7.54 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 8.5 Hz, 2H), 2.20 (bs, 
OH, 1H). 13C NMR (100 MHz, CD2Cl2) δ 149.7 (d, J = 9.4 Hz), 148.7 (d, J = 236.4 Hz), 142.5 (d, J = 
8.5 Hz), 138.8 (d, J = 242.9 Hz), 136.9 (d, J = 231.2 Hz), 135.7 (d, J = 3.0 Hz), 136.7, 135.5 (d, J = 
10.5 Hz), 132.0, 130.6 (d, J = 13.1 Hz), 130.5, 130.2 (d, J = 14.3 Hz), 128.1, 127.0, 124.7 (d, J = 6.9 
Hz), 124.2 (m), 119.1 (d, J = 90.6 Hz), 110.6 (d, J = 91.2 Hz). 19F NMR (376 MHz, CD2Cl2) δ -133.12, 
-163.39 (t, J = 20.4 Hz), -167.38 (t, J = 17.1 Hz). 31P NMR (162 MHz, CD2Cl2) δ 22.81, 0.89. HRMS-




4.4.3. General Procedure for the Friedel-Crafts Alkylations 
A 23 x 85 mm vial was charged with a catalyst (10 mol %) and 3 Å molecular sieves (10 mg), and 
then was sealed followed by a 1 min purge with dry nitrogen. After adding 250 μL of CH2Cl2 via syringe, 
the resulting solution was cooled if the reaction was being carried out at subambient temperature. Indole 
(0.100 mmol) and trans-β-nitrostyrene (0.200 mmol) were dissolved in 250 μL of CH2Cl2 and this 
solution was then added dropwise over 10-15 s. The reaction mixture was shaken and the transformation 
was allowed to proceed over the course of 5-164 h. Reaction conversions were determined by removing 
1-2 drops of the reaction mixture and dissolving it in 0.5 mL of CDCl3 after flowing dry nitrogen over 
the sample for ≤ 15 s to evaporate the CH2Cl2. Upon completion of reaction, the solution was injected 
on to a 4 g silica gel column followed by 0.2-0.3 mL of CH2Cl2 that had been used to rinse the molecular 
sieves. MPLC purification was carried out first with hexanes (1 min) followed by a linear gradient to 
100% CH2Cl2 over the course of 7 min, and then this solvent was maintained until all of the components 
eluted off the column. Racemic reference materials were obtained in the same way using 
diphenylphosphate as the reaction catalyst. 
 
4.4.4. Analytical Data for the Friedel-Crafts Products 
3-(2-Nitro-1-phenylethyl)-1H-indole (6a).20b 1H NMR (500 MHz, CDCl3) δ 8.10 (bs, NH, 1H), 7.46 
(d, J = 8.0 Hz, 1H), 7.39-7.30 (m, 5H), 7.29-7.24 (m, 1H), 7.23-7.18 (m, 1H), 7.12-7.06 (m, 1H), 7.03 
(d, J = 2.5 Hz, 1H), 5.20 (t, J = 8.2 Hz, 1H), 5.07 (dd, J = 7.7 Hz and 12.6 Hz, 1H), 4.95 (dd, J = 8.4 Hz 
and 12.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 139.2, 136.5, 128.9, 127.7, 127.5, 126.1, 122.7, 121.6, 
119.9, 118.9, 114.4, 111.4, 79.5, 41.5. HRMS-ESI: calc for C16H13N2O2– (M - H+)– 265.0977, found 
265.0971. Enantiomeric excess was determined with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL 
min–1, 20 ˚C, 250 nm, τmajor = 17.0 min, τminor = 20.1 min). 
5-Fluoro-3-(2-nitro-1-phenylethyl)-1H-indole (6b).27 Reaction conversion was determined by  
relative integration of the 1H NMR signals at δ 6.42 (4b) and 4.78 (6b). Enantiomeric excess was 
measured with a Regiscell column (92:8 hexanes/iPrOH, 1.0 mL min–1, 20 ̊ C, 254 nm, τmajor = 56.1 min, 
τminor = 48.2 min). 
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5-Chloro-3-(2-nitro-1-phenylethyl)-1H-indole (6c).20b,28 Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.41 (4c) and 4.82 (6c). Enantiomeric excess was 
measured with a Regiscell column (80:20 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 16.8 
min, τminor = 13.8 min). 
6-Chloro-3-(2-nitro-1-phenylethyl)-1H-indole (6d).29 Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.43 (4d) and 4.82 (6d). Enantiomeric excess was 
measured with a Regiscell column (85:15 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 21.2 
min, τminor = 19.8 min). 
7-Chloro-3-(2-nitro-1-phenylethyl)-1H-indole (6e). A yellow solid was isolated with a mp of 58 - 62 
˚C. 1H NMR (500 MHz, CDCl3) δ 8.32 (bs, NH, 1H), 7.37-7.29 (m, 5H), 7.29-7.26 (m, 1H), 7.20 (d, J 
= 7.6 Hz, 1H), 7.13 (d, J = 2.4 Hz, 1H), 7.00 (t, J = 7.8 Hz, 1H), 5.17 (t, J = 8.0 Hz, 1H), 5.06 (dd, J = 
8.0 Hz and 12.5 Hz, 1H), 4.95 (dd, J = 8.0 Hz and 12.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 138.8, 
133.8, 129.0, 127.71, 127.691, 127.688, 127.5, 122.1, 120.8, 117.6, 116.9, 115.6, 79.4, 41.5. HRMS-
ESI: calc for C16H12N2O2Cl– (M - H+)– 299.0587 and 301.0558, found 299.0577 and 301.0553. Reaction 
conversion was determined by relative integration of the 1H NMR signals at δ 6.60 (4e) and 4.95 (6e). 
Enantiomeric excess was measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 
˚C, 250 nm, τmajor = 34.7 min, τminor = 39.6 min). 
5-Bromo-3-(2-nitro-1-phenylethyl)-1H-indole (6f).20b Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.40 (4f) and 4.82 (6f). Enantiomeric excess was 
measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 12.1 
min, τminor = 10.8 min). 
5-Methoxy-3-(2-nitro-1-phenylethyl)-1H-indole (6g).28 Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.39 (4g) and 4.84 (6g). Enantiomeric excess was 
measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 12.9 
min, τminor = 11.4 min). 
6-Methoxy-3-(2-nitro-1-phenylethyl)-1H-indole (6h). A white solid was isolated with a mp of 82 - 85 
˚C.1H NMR (500 MHz, CDCl3) δ 7.96 (bs, NH, 1H), 7.35-7.29 (m, 4H), 7.29-7.24 (m, 2H), 6.92 (dd, J 
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= 0.8 Hz and 2.3 Hz, 1H), 6.83 (d, J = 2.2 Hz, 1H), 6.74 (dd, J = 2.3 Hz and 8.8 Hz, 1H), 5.14 (t, J = 
8.1 Hz, 1H), 5.05 (dd, J = 7.7 Hz and 12.40 Hz, 1H), 4.92 (dd, J = 8.3 Hz and 12.5 Hz, 1H), 3.82 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ 156.9, 139.2, 137.3, 128.9, 127.7, 127.5, 120.5, 120.3, 119.6, 114.4, 
110.0, 94.7, 79.6, 55.6, 41.6. HRMS-ESI: calc for C17H16N2O3Na+ (M + Na+)+ 319.1059, found 
319.1074. Reaction conversion was determined by relative integration of the 1H NMR signals at δ 6.39 
(4h) and 4.92 (6h). Enantiomeric excess was measured with a Regiscell column (75:25 hexanes/iPrOH, 
1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 20.7 min, τminor = 16.6 min). 
6-Methyl-3-(2-nitro-1-phenylethyl)-1H-indole (6i). This compound was isolated as a colorless 
viscous oil. 1H NMR (500 MHz, CDCl3) δ 7.94 (bs, NH, 1H), 7.41-7.28 (m, 5H), 7.28-7.23 (m, 1H), 
7.15 (s, 1H), 6.94 (d, J = 2.4 Hz, 1H), 6.92 (d, J = 8.1 Hz, 1H), 5.17 (t, J = 8.0 Hz, 1H), 5.06 (dd, J = 
7.7 Hz and 12.5 Hz, 1H), 4.94 (dd, J = 8.4 Hz and 12.5 Hz, 1H), 2.44 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ 139.2, 136.9, 132.6, 128.9, 127.7, 127.5, 123.9, 121.7, 120.9, 118.5, 114.3, 111.3, 79.5, 41.6, 
21.6. HRMS-ESI: calc for C17H15N2O2– (M - H+)– 279.1134, found 279.1149. Reaction conversion was 
determined by relative integration of the 1H NMR signals at δ 6.51 (4i) and 4.94 (6i). Enantiomeric 
excess was measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, 
τmajor = 13.1 min, τminor = 12.0 min). 
7-Methyl-3-(2-nitro-1-phenylethyl)-1H-indole (6j).20b Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.57 (4j) and 4.95 (6j). Enantiomeric excess was 
measured with a Regispack column (97:3 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 40.1 
min, τminor = 35.6 min). 
7-Ethyl-3-(2-nitro-1-phenylethyl)-1H-indole (6k).30 Reaction conversion was determined by relative 
integration of the 1H NMR signals at δ 6.58 (4k) and 4.96 (6k). Enantiomeric excess was measured with 
a Regispack column (97:3 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 33.3 min, τminor = 29.7 
min). 
3-(1-(4-Fluorophenyl)-2-nitroethyl)-1H-indole (6l).31 Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.47 (4a) and 4.79 (6l). Enantiomeric excess was 
measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 18.1 
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min, τminor = 22.8 min). 
3-(1-(2-Chlorophenyl)-2-nitroethyl)-1H-indole (6m).32 Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.47 (4a) and 5.64 (6m). Enantiomeric excess was 
measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 20.5 
min, τminor = 13.3 min). 
3-(1-(3-Bromophenyl)-2-nitroethyl)-1H-indole (6n).32 Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.47 (4a) and 4.81 (6n). Enantiomeric excess was 
measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 20.2 
min, τminor = 27.7 min). 
3-(1-(4-Bromophenyl)-2-nitroethyl)-1H-indole (6o).32 Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.47 (4a) and 4.81 (6o). Enantiomeric excess was 
measured with a Regiscell column (75:25 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 21.7 
min, τminor = 27.0 min). 
3-(1-(4-Methoxylphenyl)-2-nitroethyl)-1H-indole (6p).20b Reaction conversion was determined by 
relative integration of the 1H NMR signals at δ 6.47 (4a) and 4.79 (6p). Enantiomeric excess was 
measured with a Regiscell column (80:20 hexanes/iPrOH, 1.0 mL min–1, 20 ˚C, 250 nm, τmajor = 25.3 
min, τminor = 27.9 min). 
3-(2-Nitro-1-phenylethyl)-1-methylindole (6q).33 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 8.0 Hz, 
1H), 7.45-7.27 (m, 7H), 7.16 (t, J = 7.0 Hz, 1H), 6.91 (s, 1H), 5.25 (t, J = 8.1 Hz, 1H), 5.09 (dd, J = 7.6 
Hz and 12.6 Hz, 1H), 4.98 (dd, J = 8.5 Hz and 12.6 Hz, 1H), 3.75 (s, 3H). 13C NMR (100 MHz, CDCl3) 
δ 139.3, 137.2, 128.8, 127.6, 127.4, 126.4, 126.2, 122.1, 119.3, 118.9, 112.6, 109.4, 79.4, 41.4, 32.6. 
HRMS-ESI: calc for C17H16N2O2Na+ (M + Na+)+ 303.1109, found 303.1118. Enantiomeric excess was 
measured with a Regiscell column (95:5 hexanes/iPrOH, 1.0 mL min–1, 20 ̊ C, 250 nm, τmajor = 59.6 min, 
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Appendix for Chapter 2 
 





Table S1. Kinetic data of Friedel-Crafts reactions of indole and β-nitrostyrene. 
 
[indole]0 = [β-nitrostyrene]0 = 94.8 mM 
catalyst, solvent time (h) conversion (%) [reactants], mM 
























10% DPP*, CD2Cl2 10.5 7.48 87.7 
10% 1, CD2Cl2 2.0 5.00 90.1 
5.0 12.71 82.8 
26.3 35.24 61.4 
71.5 59.70 38.2 

















Continued Table S1. 
 






















































5% 1, CDCl3 2.0 4.28 90.7 
5.0 8.55 86.7 
26.3 26.58 69.6 
71.5 49.68 47.7 













































Continued Table S1. 
 
5% DPP, THF-d8 96.0 1.13 93.7 
5% 2, THF-d8 96.0 1.15 93.7 
 
Table S2. Kinetic data of Friedel-Crafts reactions of N-methylindole and β-nitrostyrene. 
 
[N-methylindole]0 = [β-nitrostyrene]0 = 94.8 mM 
catalyst, solvent time (h) conversion (%) [reactants], mM 
























10% 1, CD2Cl2 2.0 1.98 92.9 
5.0 8.65 86.6 
26.3 38.44 58.4 
71.5 66.39 31.9 


















































Continued Table S2. 
 
 267.0 3.09 91.9 









 220.0 4.06 91.0 
5% 1, CDCl3 5.0 1.82 93.1 
 26.5 21.06 74.8 
 71.5 40.73 56.2 
 76.0 43.22 53.8 



















Table S3. Kinetic data of Diels-Alder reactions. 
 
[cyclopentadiene]0 = [methyl vinyl ketone]0 = 100 mM in CDCl3 
catalyst time (h) conversion (%) [reactants], mM 
























1% DPP* 1.50 36.83 63.2 
1% 1 0.0333 (120 s) 29.85 70.2 
0.0667 (240 s) 47.89 52.1 
0.100 (360 s) 59.25 40.8 
0.133 (480 s) 67.27 32.7 
1% 2 0.0306 (110 s) 







Continued Table S3. 
 
 0.0500 (180 s) 
0.0633 (228 s) 







0.1% 2 0.20 (12 min) 
0.28 (17 min) 
0.35 (21 min) 
0.55 (33 min) 











[cyclopentadiene]0 = [acrylonitrile]0 = 100 mM in CDCl3 






























1% 1 2.0 7.11 92.9 
19.0 24.02 76.0 
26.0 28.13 71.9 
44.0 36.68 63.3 












5% 2 0.38 (23 min) 
0.58 (35 min) 
0.92 (55 min) 









[cyclopentadiene]0 = [methyl vinyl ketone]0 = 10.0 mM in CDCl3 















Continued Table S3. 
 












1% 2 0.100 (360 s) 14.90 85.1 
0.200 (720 s) 25.05 75.0 
0.300 (1080 s) 32.97 67.0 
0.450 (1620 s) 40.10 59.9 
 
Table S4. Kinetic data of polymerizations. 
 
[δ-valerolactone]0 = 0.50 M, [monomer]0 : [initiator]0 : [cat.]0 = 100 : 1.0 : 0.50 
solvent, catalyst time (h) conversion (%) Mn, NMR (Da) 
toluene-d8, DPP 0.5 20.83 3096 
1.0 39.83 6352 
2.0 64.48 10120 
3.0 78.36 13124 
4.0 85.51 - 
5.0 88.71 - 
benzene-d6, DPP 0.5 16.92 2295 
1.0 30.70 4393 
2.0 51.52 7776 
3.0 65.61 10220 
4.0 74.72 - 




0.5 3.55 909 
1.0 5.47 1162 
2.0 8.85 1483 
3.0 12.58 2167 
4.0 16.21 2588 
5.0 18.33 2824 
CDCl3, DPP 0.5 2.95 903 
1.0 6.47 1237 
2.0 11.11 1888 
3.0 14.78 2295 
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Continued Table S4. 
 
 4.0 18.15 2852 
 5.0 22.14 3335 
 6.0 25.36 - 
 7.0 28.64 - 
toluene-d8, 2 0.100 13.12 2079 
 0.250 24.36 3912 
 0.383 34.40 5915 
 0.567 45.18 7266 
 0.717 52.82 9095 
 0.883 59.42 10019 
 1.02 64.27 - 
 2.33 86.49 - 
benzene-d6, 2 0.150 12.99 3212 
0.283 22.85 4212 
0.433 30.88 5414 
0.600 39.20 6519 
0.767 44.87 6928 
0.933 50.95 7717 
1.05 54.39 8218 
2.33 75.62 - 
CD2Cl2, 2 0.5 7.75 1352 
1.0 11.33 1726 
2.0 19.71 2828 
3.0 25.92 3640 
4.0 30.18 4257 
5.0 34.09 4723 
CDCl3, 2 0.5 9.49 1411 
1.0 14.61 2210 
2.0 26.74 3511 
3.0 36.41 4413 
4.0 42.57 4988 
5.0 47.21 - 
6.0 49.84 - 





Continued Table S4. 
 
solvent = CD2Cl2, [monomer] 0 : [initiator] 0 : [cat.] 0 = 100 : 1.0 : 1.0 
[monomer] 0 (M) catalyst time (h) conversion (%) 
1.0 DPP 0.5 20.37 
  1.0 35.21 
  1.5 46.50 
  2.0 52.79 
 2 0.5 28.51 
  1.0 44.70 
  1.5 52.98 
  2.0 58.33 
0.50 DPP 1.0 12.66 
 2.0 25.80 
 3.0 32.15 
 4.0 37.39 
2 1.0 20.28 
 2.0 35.09 
 3.0 43.47 
 4.0 48.81 
0.25 DPP 1.0 3.70 
 2.0 5.33 
 3.0 6.19 
 4.0 6.95 
2 1.0 6.76 
 2.0 9.05 
 3.0 11.11 





Figure S1. Observed rate constants versus catalyst mol % loadings for the Friedel-Crafts reactions of 







Figure S2. Number-average molecular weight (Mn,NMR) versus conversion plots in toluene-d8 (a), 













































































Scheme S1. Synthetic scheme of 2a-2e.  
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I. NMR Spectra 





















Figure S3. 1H, 13C and 31P NMR of (R)-(2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(tri-










Figure S4. 1H, 13C and 31P NMR of (R)-(2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(tri-p-











Figure S5. 1H, 13C and 31P NMR of (R)-(2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(tris(4-










Figure S6. 1H, 13C and 31P NMR of (R)-(2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(tris(4-












Figure S7. 1H, 13C and 31P NMR of (R)-(2,2'-dihydroxy-[1,1'-binaphthalene]-3,3'-diyl)bis(di-phenyl(p-










Figure S8. 1H, 13C and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxa-












Figure S9. 1H, 13C and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxa-










Figure S10. 1H, 13C and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxa-












Figure S11. 1H, 13C and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxa-










Figure S12. 1H, 13C and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxa-






























































































































































































































































































































































II. HPLC traces 
 




















































































































































































































































































Appendix for Chapter 4 
 
 




Table S1. Kinetic data for the Friedel-Crafts alkylation of indole with trans-β-nitrostyrene.a 
 
catalyst, solvent time (h) conversion (%) rate constant (M-1 h-1) 
10% 3a, CH2Cl2/C6H6 1:2 18.0 17 0.0270 
 23.5 23  
 40.5 36  
10% 3b, CH2Cl2/C6H6 1:2 18.0 17 0.0331 
 23.5 22  
 40.5 33  
10% 2b, CH2Cl2/C6H6 1:2 18.0 61 0.158 
 23.5 69  
 40.5 84  
5% 2b, CH2Cl2 22.0 47 0.0790
b 
 28.0 54  
10% 2b, CH2Cl2 22.0 68 0.158
c 
 28.0 75  
20% 2b, CH2Cl2 2.2 38 0.326
d 
 5.0 53  
 
a[indole]0 = 200 mM, [β-nitrostyrene]0 = 400 mM, T = -30 ˚C. 
bt1/2 = 26 h, ee =60%. 
ct1/2 = 13 h, ee 




I. NMR Spectra 









































Figure S6. 1H and 13C NMR of (R)-3,3'-di(3-(N-octyl-5-methyl)pyridinium)-2,2'-dihydroxyl-1,1'-








Figure S7. 1H, 13C and 31P NMR of (R)-3,3'-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]di-











Figure S8. 1H, 13C and 31P NMR of (R)-5,5'-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]di-













































Figure S11. 1H, 13C, 19F and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]di-














Figure S12. 1H, 13C, 19F and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]di-














Figure S13. 1H, 13C, 19F and 31P NMR of (R)-(4-hydroxy-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]di-




















































II. HPLC traces of the Friedel-Crafts products 
3-(2-Nitro-1-phenylethyl)-1H-indole (6a) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
244 
 
5-Fluoro-3-(2-nitro-1-phenylethyl)-1H-indole (6b) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
245 
 
5-Chloro-3-(2-nitro-1-phenylethyl)-1H-indole (6c) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
246 
 
6-Chloro-3-(2-nitro-1-phenylethyl)-1H-indole (6d) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
247 
 
7-Chloro-3-(2-nitro-1-phenylethyl)-1H-indole (6e) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
248 
 
5-Bromo-3-(2-nitro-1-phenylethyl)-1H-indole (6f) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
249 
 
5-Methoxy-3-(2-nitro-1-phenylethyl)-1H-indole (6g) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
250 
 
6-Methoxy-3-(2-nitro-1-phenylethyl)-1H-indole (6h) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
251 
 
6-Methyl-3-(2-nitro-1-phenylethyl)-1H-indole (6i) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
252 
 
7-Methyl-3-(2-nitro-1-phenylethyl)-1H-indole (6j) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
 
  
253 
 
7-Ethyl-3-(2-nitro-1-phenylethyl)-1H-indole (6k) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
254 
 
3-(1-(4-Fluorophenyl)-2-nitroethyl)-1H-indole (6l) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
255 
 
3-(1-(2-Chlorophenyl)-2-nitroethyl)-1H-indole (6m) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
256 
 
3-(1-(3-Bromophenyl)-2-nitroethyl)-1H-indole (6n) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
257 
 
3-(1-(4-Bromophenyl)-2-nitroethyl)-1H-indole (6o) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
  
258 
 
3-(1-(4-Methoxylphenyl)-2-nitroethyl)-1H-indole (6p) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
 
  
259 
 
3-(2-Nitro-1-phenylethyl)-1-methyl-indole (6q) 
 
 
 
Racemic: 
 
 
 
Enantiomeric enriched: 
 
 
 
